id	sid	tid	token	lemma	pos
dpc-4157	1	1	dermatology	dermatology	NOUN
dpc-4157	1	2	:	:	PUNCT
dpc-4157	1	3	practical	practical	ADJ
dpc-4157	1	4	and	and	CCONJ
dpc-4157	1	5	conceptual	conceptual	ADJ
dpc-4157	1	6	original	original	ADJ
dpc-4157	1	7	article	article	NOUN
dpc-4157	1	8	|	|	ADV
dpc-4157	1	9	dermatol	dermatol	ADJ
dpc-4157	1	10	pract	pract	NOUN
dpc-4157	1	11	concept	concept	NOUN
dpc-4157	1	12	.	.	PUNCT
dpc-4157	2	1	2024;14(2):e2024150	2024;14(2):e2024150	NUM
dpc-4157	2	2	1	1	NUM
dpc-4157	2	3	efficacy	efficacy	NOUN
dpc-4157	2	4	of	of	ADP
dpc-4157	2	5	long	long	ADV
dpc-4157	2	6	-	-	PUNCT
dpc-4157	2	7	pulsed	pulse	VERB
dpc-4157	2	8	nd	nd	NOUN
dpc-4157	2	9	:	:	PUNCT
dpc-4157	2	10	yag	yag	NOUN
dpc-4157	2	11	laser	laser	NOUN
dpc-4157	2	12	for	for	ADP
dpc-4157	2	13	classic	classic	ADJ
dpc-4157	2	14	kaposi	kaposi	PROPN
dpc-4157	2	15	’s	’s	PART
dpc-4157	2	16	sarcoma	sarcoma	NOUN
dpc-4157	2	17	:	:	PUNCT
dpc-4157	2	18	a	a	DET
dpc-4157	2	19	dermoscopic	dermoscopic	PROPN
dpc-4157	2	20	study	study	NOUN
dpc-4157	2	21	seher	seher	PROPN
dpc-4157	3	1	bostanci1	bostanci1	PROPN
dpc-4157	3	2	,	,	PUNCT
dpc-4157	3	3	merve	merve	VERB
dpc-4157	3	4	aygun	aygun	ADJ
dpc-4157	3	5	alizada2	alizada2	PROPN
dpc-4157	3	6	,	,	PUNCT
dpc-4157	3	7	banu	banu	PROPN
dpc-4157	3	8	farabi3	farabi3	PROPN
dpc-4157	3	9	,	,	PUNCT
dpc-4157	3	10	bengu	bengu	PROPN
dpc-4157	3	11	nisa	nisa	PROPN
dpc-4157	3	12	akay1	akay1	PROPN
dpc-4157	3	13	1	1	NUM
dpc-4157	3	14	dermatology	dermatology	NOUN
dpc-4157	3	15	and	and	CCONJ
dpc-4157	3	16	venerology	venerology	PROPN
dpc-4157	3	17	department	department	PROPN
dpc-4157	3	18	of	of	ADP
dpc-4157	3	19	ankara	ankara	PROPN
dpc-4157	3	20	university	university	PROPN
dpc-4157	3	21	,	,	PUNCT
dpc-4157	3	22	ankara	ankara	PROPN
dpc-4157	3	23	,	,	PUNCT
dpc-4157	3	24	turkey	turkey	NOUN
dpc-4157	3	25	2	2	NUM
dpc-4157	3	26	dermatology	dermatology	NOUN
dpc-4157	3	27	department	department	NOUN
dpc-4157	3	28	of	of	ADP
dpc-4157	3	29	mamak	mamak	PROPN
dpc-4157	3	30	state	state	PROPN
dpc-4157	3	31	hospital	hospital	NOUN
dpc-4157	3	32	,	,	PUNCT
dpc-4157	3	33	ankara	ankara	PROPN
dpc-4157	3	34	,	,	PUNCT
dpc-4157	3	35	turkey	turkey	PROPN
dpc-4157	3	36	3	3	NUM
dpc-4157	3	37	dermatology	dermatology	NOUN
dpc-4157	3	38	department	department	NOUN
dpc-4157	3	39	,	,	PUNCT
dpc-4157	3	40	nyc	nyc	PROPN
dpc-4157	3	41	health	health	PROPN
dpc-4157	3	42	+	+	CCONJ
dpc-4157	3	43	hospitals	hospital	NOUN
dpc-4157	3	44	/	/	SYM
dpc-4157	3	45	south	south	PROPN
dpc-4157	3	46	brooklyn	brooklyn	PROPN
dpc-4157	3	47	health	health	PROPN
dpc-4157	3	48	,	,	PUNCT
dpc-4157	3	49	ny	ny	PROPN
dpc-4157	3	50	key	key	ADJ
dpc-4157	3	51	words	word	NOUN
dpc-4157	3	52	:	:	PUNCT
dpc-4157	3	53	classic	classic	ADJ
dpc-4157	3	54	kaposi	kaposi	PROPN
dpc-4157	3	55	’s	’s	PART
dpc-4157	3	56	sarcoma	sarcoma	NOUN
dpc-4157	3	57	,	,	PUNCT
dpc-4157	3	58	dermoscopy	dermoscopy	NOUN
dpc-4157	3	59	,	,	PUNCT
dpc-4157	3	60	long	long	ADV
dpc-4157	3	61	-	-	PUNCT
dpc-4157	3	62	pulsed	pulse	VERB
dpc-4157	3	63	neodymium	neodymium	NOUN
dpc-4157	3	64	-	-	PUNCT
dpc-4157	3	65	doped	dope	VERB
dpc-4157	3	66	yttrium	yttrium	NOUN
dpc-4157	3	67	–	–	PUNCT
dpc-4157	3	68	aluminum	aluminum	NOUN
dpc-4157	3	69	–	–	PUNCT
dpc-4157	3	70	garnet	garnet	NOUN
dpc-4157	3	71	laser	laser	NOUN
dpc-4157	3	72	,	,	PUNCT
dpc-4157	3	73	treatment	treatment	NOUN
dpc-4157	3	74	citation	citation	NOUN
dpc-4157	3	75	:	:	PUNCT
dpc-4157	3	76	bostanci	bostanci	PROPN
dpc-4157	3	77	s	s	PROPN
dpc-4157	3	78	,	,	PUNCT
dpc-4157	3	79	aygun	aygun	VERB
dpc-4157	3	80	alizada	alizada	PROPN
dpc-4157	3	81	m	m	PROPN
dpc-4157	3	82	,	,	PUNCT
dpc-4157	3	83	farabi	farabi	PROPN
dpc-4157	3	84	b	b	PROPN
dpc-4157	3	85	,	,	PUNCT
dpc-4157	3	86	akay	akay	PROPN
dpc-4157	3	87	bn	bn	PROPN
dpc-4157	3	88	.	.	PUNCT
dpc-4157	4	1	efficacy	efficacy	NOUN
dpc-4157	4	2	of	of	ADP
dpc-4157	4	3	long	long	ADV
dpc-4157	4	4	-	-	PUNCT
dpc-4157	4	5	pulsed	pulse	VERB
dpc-4157	4	6	nd	nd	NOUN
dpc-4157	4	7	:	:	PUNCT
dpc-4157	4	8	yag	yag	NOUN
dpc-4157	4	9	laser	laser	NOUN
dpc-4157	4	10	for	for	ADP
dpc-4157	4	11	classic	classic	ADJ
dpc-4157	4	12	kaposi	kaposi	PROPN
dpc-4157	4	13	’s	’s	PART
dpc-4157	4	14	sarcoma	sarcoma	NOUN
dpc-4157	4	15	:	:	PUNCT
dpc-4157	4	16	a	a	DET
dpc-4157	4	17	 	 	SPACE
dpc-4157	4	18	dermoscopic	dermoscopic	ADJ
dpc-4157	4	19	study	study	NOUN
dpc-4157	4	20	.	.	PUNCT
dpc-4157	5	1	dermatol	dermatol	NOUN
dpc-4157	5	2	pract	pract	PROPN
dpc-4157	5	3	concept	concept	NOUN
dpc-4157	5	4	.	.	PUNCT
dpc-4157	6	1	2024;14(2):e2024150	2024;14(2):e2024150	X
dpc-4157	6	2	.	.	PUNCT
dpc-4157	7	1	doi	doi	NOUN
dpc-4157	7	2	:	:	PUNCT
dpc-4157	7	3	https://doi.org/10.5826/dpc.1402a150	https://doi.org/10.5826/dpc.1402a150	PROPN
dpc-4157	7	4	accepted	accept	VERB
dpc-4157	7	5	:	:	PUNCT
dpc-4157	7	6	march	march	PROPN
dpc-4157	7	7	17	17	NUM
dpc-4157	7	8	,	,	PUNCT
dpc-4157	7	9	2024	2024	NUM
dpc-4157	7	10	;	;	PUNCT
dpc-4157	7	11	published	publish	VERB
dpc-4157	7	12	:	:	PUNCT
dpc-4157	8	1	april	april	PROPN
dpc-4157	8	2	2024	2024	NUM
dpc-4157	8	3	copyright	copyright	NOUN
dpc-4157	8	4	:	:	PUNCT
dpc-4157	8	5	©	©	PROPN
dpc-4157	8	6	2024	2024	NUM
dpc-4157	8	7	bostanci	bostanci	NOUN
dpc-4157	8	8	et	et	PROPN
dpc-4157	8	9	al	al	PROPN
dpc-4157	8	10	.	.	PUNCT
dpc-4157	9	1	this	this	PRON
dpc-4157	9	2	is	be	AUX
dpc-4157	9	3	an	an	DET
dpc-4157	9	4	open	open	ADJ
dpc-4157	9	5	-	-	PUNCT
dpc-4157	9	6	access	access	NOUN
dpc-4157	9	7	article	article	NOUN
dpc-4157	9	8	distributed	distribute	VERB
dpc-4157	9	9	under	under	ADP
dpc-4157	9	10	the	the	DET
dpc-4157	9	11	terms	term	NOUN
dpc-4157	9	12	of	of	ADP
dpc-4157	9	13	the	the	DET
dpc-4157	9	14	creative	creative	ADJ
dpc-4157	9	15	commons	common	NOUN
dpc-4157	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4157	9	17	license	license	NOUN
dpc-4157	9	18	(	(	PUNCT
dpc-4157	9	19	by	by	ADP
dpc-4157	9	20	-	-	PUNCT
dpc-4157	9	21	nc-4.0	nc-4.0	NOUN
dpc-4157	9	22	)	)	PUNCT
dpc-4157	9	23	,	,	PUNCT
dpc-4157	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4157	9	25	,	,	PUNCT
dpc-4157	9	26	which	which	PRON
dpc-4157	9	27	permits	permit	VERB
dpc-4157	9	28	unrestricted	unrestricted	ADJ
dpc-4157	9	29	noncommercial	noncommercial	ADJ
dpc-4157	9	30	use	use	NOUN
dpc-4157	9	31	,	,	PUNCT
dpc-4157	9	32	distribution	distribution	NOUN
dpc-4157	9	33	,	,	PUNCT
dpc-4157	9	34	and	and	CCONJ
dpc-4157	9	35	reproduction	reproduction	NOUN
dpc-4157	9	36	in	in	ADP
dpc-4157	9	37	any	any	DET
dpc-4157	9	38	medium	medium	NOUN
dpc-4157	9	39	,	,	PUNCT
dpc-4157	9	40	provided	provide	VERB
dpc-4157	9	41	the	the	DET
dpc-4157	9	42	original	original	ADJ
dpc-4157	9	43	authors	author	NOUN
dpc-4157	9	44	and	and	CCONJ
dpc-4157	9	45	source	source	NOUN
dpc-4157	9	46	are	be	AUX
dpc-4157	9	47	credited	credit	VERB
dpc-4157	9	48	.	.	PUNCT
dpc-4157	10	1	funding	funding	NOUN
dpc-4157	10	2	:	:	PUNCT
dpc-4157	10	3	none	none	NOUN
dpc-4157	10	4	.	.	PUNCT
dpc-4157	11	1	competing	compete	VERB
dpc-4157	11	2	interests	interest	NOUN
dpc-4157	11	3	:	:	PUNCT
dpc-4157	11	4	none	none	NOUN
dpc-4157	11	5	.	.	PUNCT
dpc-4157	12	1	authorship	authorship	NOUN
dpc-4157	12	2	:	:	PUNCT
dpc-4157	12	3	all	all	DET
dpc-4157	12	4	authors	author	NOUN
dpc-4157	12	5	have	have	AUX
dpc-4157	12	6	contributed	contribute	VERB
dpc-4157	12	7	significantly	significantly	ADV
dpc-4157	12	8	to	to	ADP
dpc-4157	12	9	this	this	DET
dpc-4157	12	10	publication	publication	NOUN
dpc-4157	12	11	.	.	PUNCT
dpc-4157	13	1	m.a	m.a	PROPN
dpc-4157	13	2	.	.	PROPN
dpc-4157	13	3	:	:	PUNCT
dpc-4157	14	1	study	study	NOUN
dpc-4157	14	2	design	design	NOUN
dpc-4157	14	3	;	;	PUNCT
dpc-4157	14	4	conceptualization	conceptualization	NOUN
dpc-4157	14	5	;	;	PUNCT
dpc-4157	14	6	methodology	methodology	NOUN
dpc-4157	14	7	;	;	PUNCT
dpc-4157	14	8	writing	writing	NOUN
dpc-4157	14	9	;	;	PUNCT
dpc-4157	14	10	databases	database	VERB
dpc-4157	14	11	strategy	strategy	NOUN
dpc-4157	14	12	research	research	NOUN
dpc-4157	14	13	and	and	CCONJ
dpc-4157	14	14	extraction	extraction	NOUN
dpc-4157	14	15	of	of	ADP
dpc-4157	14	16	data	datum	NOUN
dpc-4157	14	17	,	,	PUNCT
dpc-4157	14	18	s.b	s.b	PROPN
dpc-4157	14	19	.	.	PROPN
dpc-4157	14	20	:	:	PUNCT
dpc-4157	15	1	supervision	supervision	NOUN
dpc-4157	15	2	;	;	PUNCT
dpc-4157	15	3	data	datum	NOUN
dpc-4157	15	4	curation	curation	PROPN
dpc-4157	15	5	b.f	b.f	PROPN
dpc-4157	15	6	.	.	PROPN
dpc-4157	15	7	:	:	PUNCT
dpc-4157	15	8	databases	database	VERB
dpc-4157	15	9	strategy	strategy	NOUN
dpc-4157	15	10	research	research	NOUN
dpc-4157	15	11	,	,	PUNCT
dpc-4157	15	12	supervision	supervision	NOUN
dpc-4157	15	13	,	,	PUNCT
dpc-4157	15	14	b.n.a	b.n.a	NOUN
dpc-4157	15	15	.	.	PUNCT
dpc-4157	15	16	:	:	PUNCT
dpc-4157	16	1	data	datum	NOUN
dpc-4157	16	2	curation	curation	NOUN
dpc-4157	16	3	,	,	PUNCT
dpc-4157	16	4	study	study	NOUN
dpc-4157	16	5	design	design	NOUN
dpc-4157	16	6	;	;	PUNCT
dpc-4157	16	7	methodology	methodology	NOUN
dpc-4157	16	8	;	;	PUNCT
dpc-4157	16	9	supervision	supervision	NOUN
dpc-4157	16	10	.	.	PUNCT
dpc-4157	17	1	all	all	DET
dpc-4157	17	2	authors	author	NOUN
dpc-4157	17	3	have	have	AUX
dpc-4157	17	4	read	read	VERB
dpc-4157	17	5	and	and	CCONJ
dpc-4157	17	6	agreed	agree	VERB
dpc-4157	17	7	to	to	ADP
dpc-4157	17	8	the	the	DET
dpc-4157	17	9	published	publish	VERB
dpc-4157	17	10	version	version	NOUN
dpc-4157	17	11	of	of	ADP
dpc-4157	17	12	the	the	DET
dpc-4157	17	13	manuscript	manuscript	NOUN
dpc-4157	17	14	.	.	PUNCT
dpc-4157	18	1	corresponding	correspond	VERB
dpc-4157	18	2	author	author	NOUN
dpc-4157	18	3	:	:	PUNCT
dpc-4157	18	4	merve	merve	VERB
dpc-4157	18	5	aygun	aygun	PROPN
dpc-4157	18	6	alizada	alizada	PROPN
dpc-4157	18	7	,	,	PUNCT
dpc-4157	18	8	md	md	PROPN
dpc-4157	18	9	,	,	PUNCT
dpc-4157	18	10	mamak	mamak	PROPN
dpc-4157	18	11	state	state	NOUN
dpc-4157	18	12	hospital	hospital	NOUN
dpc-4157	18	13	,	,	PUNCT
dpc-4157	18	14	department	department	NOUN
dpc-4157	18	15	of	of	ADP
dpc-4157	18	16	dermatology	dermatology	NOUN
dpc-4157	18	17	ankara	ankara	PROPN
dpc-4157	18	18	,	,	PUNCT
dpc-4157	18	19	uregıl	uregıl	VERB
dpc-4157	18	20	mah	mah	PROPN
dpc-4157	18	21	,	,	PUNCT
dpc-4157	18	22	06230	06230	NUM
dpc-4157	18	23	mamak	mamak	PROPN
dpc-4157	18	24	/	/	SYM
dpc-4157	18	25	ankara	ankara	PROPN
dpc-4157	18	26	/	/	SYM
dpc-4157	18	27	turkey	turkey	PROPN
dpc-4157	18	28	.	.	PUNCT
dpc-4157	19	1	telephone	telephone	NOUN
dpc-4157	19	2	:	:	PUNCT
dpc-4157	19	3	+905375102289	+905375102289	NUM
dpc-4157	19	4	fax	fax	NOUN
dpc-4157	19	5	number	number	NOUN
dpc-4157	19	6	:	:	PUNCT
dpc-4157	19	7	+903123108636	+903123108636	DET
dpc-4157	19	8	e	e	NOUN
dpc-4157	19	9	-	-	NOUN
dpc-4157	19	10	mail	mail	NOUN
dpc-4157	19	11	:	:	PUNCT
dpc-4157	19	12	werve2007@gmail.com	werve2007@gmail.com	X
dpc-4157	20	1	introduction	introduction	NOUN
dpc-4157	20	2	:	:	PUNCT
dpc-4157	20	3	classic	classic	ADJ
dpc-4157	20	4	kaposi	kaposi	PROPN
dpc-4157	20	5	’s	’s	PART
dpc-4157	20	6	sarcoma	sarcoma	NOUN
dpc-4157	20	7	(	(	PUNCT
dpc-4157	20	8	cks	ck	NOUN
dpc-4157	20	9	)	)	PUNCT
dpc-4157	20	10	is	be	AUX
dpc-4157	20	11	a	a	DET
dpc-4157	20	12	chronic	chronic	ADJ
dpc-4157	20	13	and	and	CCONJ
dpc-4157	20	14	indolent	indolent	ADJ
dpc-4157	20	15	skin	skin	NOUN
dpc-4157	20	16	tumor	tumor	NOUN
dpc-4157	20	17	.	.	PUNCT
dpc-4157	21	1	because	because	SCONJ
dpc-4157	21	2	cks	ck	NOUN
dpc-4157	21	3	has	have	VERB
dpc-4157	21	4	a	a	DET
dpc-4157	21	5	low	low	ADJ
dpc-4157	21	6	mortality	mortality	NOUN
dpc-4157	21	7	rate	rate	NOUN
dpc-4157	21	8	but	but	CCONJ
dpc-4157	21	9	can	can	AUX
dpc-4157	21	10	have	have	VERB
dpc-4157	21	11	a	a	DET
dpc-4157	21	12	significant	significant	ADJ
dpc-4157	21	13	impact	impact	NOUN
dpc-4157	21	14	on	on	ADP
dpc-4157	21	15	quality	quality	NOUN
dpc-4157	21	16	of	of	ADP
dpc-4157	21	17	life	life	NOUN
dpc-4157	21	18	,	,	PUNCT
dpc-4157	21	19	it	it	PRON
dpc-4157	21	20	is	be	AUX
dpc-4157	21	21	important	important	ADJ
dpc-4157	21	22	to	to	PART
dpc-4157	21	23	choose	choose	VERB
dpc-4157	21	24	safe	safe	ADJ
dpc-4157	21	25	,	,	PUNCT
dpc-4157	21	26	long	long	ADJ
dpc-4157	21	27	-	-	PUNCT
dpc-4157	21	28	term	term	NOUN
dpc-4157	21	29	treatments	treatment	NOUN
dpc-4157	21	30	with	with	ADP
dpc-4157	21	31	minimal	minimal	ADJ
dpc-4157	21	32	side	side	NOUN
dpc-4157	21	33	effects	effect	NOUN
dpc-4157	21	34	.	.	PUNCT
dpc-4157	22	1	objectives	objective	NOUN
dpc-4157	22	2	:	:	PUNCT
dpc-4157	22	3	the	the	DET
dpc-4157	22	4	aim	aim	NOUN
dpc-4157	22	5	was	be	AUX
dpc-4157	22	6	to	to	PART
dpc-4157	22	7	assess	assess	VERB
dpc-4157	22	8	the	the	DET
dpc-4157	22	9	efficacy	efficacy	NOUN
dpc-4157	22	10	of	of	ADP
dpc-4157	22	11	long	long	ADV
dpc-4157	22	12	-	-	PUNCT
dpc-4157	22	13	pulsed	pulse	VERB
dpc-4157	22	14	nd	nd	NOUN
dpc-4157	22	15	:	:	PUNCT
dpc-4157	22	16	yag	yag	NOUN
dpc-4157	22	17	laser	laser	NOUN
dpc-4157	22	18	therapy	therapy	NOUN
dpc-4157	22	19	in	in	ADP
dpc-4157	22	20	treating	treat	VERB
dpc-4157	22	21	cks	ck	NOUN
dpc-4157	22	22	based	base	VERB
dpc-4157	22	23	on	on	ADP
dpc-4157	22	24	clinical	clinical	ADJ
dpc-4157	22	25	and	and	CCONJ
dpc-4157	22	26	dermoscopic	dermoscopic	ADJ
dpc-4157	22	27	observations	observation	NOUN
dpc-4157	22	28	.	.	PUNCT
dpc-4157	23	1	methods	method	NOUN
dpc-4157	23	2	:	:	PUNCT
dpc-4157	23	3	forty	forty	NUM
dpc-4157	23	4	-	-	PUNCT
dpc-4157	23	5	two	two	NUM
dpc-4157	23	6	nodular	nodular	ADJ
dpc-4157	23	7	lesions	lesion	NOUN
dpc-4157	23	8	from	from	ADP
dpc-4157	23	9	three	three	NUM
dpc-4157	23	10	cks	ck	NOUN
dpc-4157	23	11	patients	patient	NOUN
dpc-4157	23	12	(	(	PUNCT
dpc-4157	23	13	stage	stage	NOUN
dpc-4157	23	14	4	4	NUM
dpc-4157	23	15	)	)	PUNCT
dpc-4157	23	16	were	be	AUX
dpc-4157	23	17	treated	treat	VERB
dpc-4157	23	18	using	use	VERB
dpc-4157	23	19	a	a	DET
dpc-4157	23	20	longpulsed	longpulsed	ADJ
dpc-4157	23	21	nd	nd	PRON
dpc-4157	23	22	:	:	PUNCT
dpc-4157	23	23	yag	yag	NOUN
dpc-4157	23	24	laser	laser	NOUN
dpc-4157	23	25	with	with	ADP
dpc-4157	23	26	a	a	DET
dpc-4157	23	27	spot	spot	NOUN
dpc-4157	23	28	size	size	NOUN
dpc-4157	23	29	ranging	range	VERB
dpc-4157	23	30	from	from	ADP
dpc-4157	23	31	3	3	NUM
dpc-4157	23	32	to	to	PART
dpc-4157	23	33	7	7	NUM
dpc-4157	23	34	mm	mm	NOUN
dpc-4157	23	35	,	,	PUNCT
dpc-4157	23	36	a	a	DET
dpc-4157	23	37	fluence	fluence	NOUN
dpc-4157	23	38	of	of	ADP
dpc-4157	23	39	200–250	200–250	NUM
dpc-4157	23	40	j	j	PROPN
dpc-4157	23	41	/	/	SYM
dpc-4157	23	42	cm2	cm2	PROPN
dpc-4157	23	43	,	,	PUNCT
dpc-4157	23	44	and	and	CCONJ
dpc-4157	23	45	a	a	DET
dpc-4157	23	46	pulse	pulse	NOUN
dpc-4157	23	47	duration	duration	NOUN
dpc-4157	23	48	lasting	last	VERB
dpc-4157	23	49	between	between	ADP
dpc-4157	23	50	10	10	NUM
dpc-4157	23	51	and	and	CCONJ
dpc-4157	23	52	20	20	NUM
dpc-4157	23	53	milliseconds	millisecond	NOUN
dpc-4157	23	54	in	in	ADP
dpc-4157	23	55	one	one	NUM
dpc-4157	23	56	or	or	CCONJ
dpc-4157	23	57	two	two	NUM
dpc-4157	23	58	sessions	session	NOUN
dpc-4157	23	59	.	.	PUNCT
dpc-4157	24	1	patients	patient	NOUN
dpc-4157	24	2	were	be	AUX
dpc-4157	24	3	photographed	photograph	VERB
dpc-4157	24	4	clinically	clinically	ADV
dpc-4157	24	5	and	and	CCONJ
dpc-4157	24	6	dermoscopically	dermoscopically	ADV
dpc-4157	24	7	before	before	ADP
dpc-4157	24	8	the	the	DET
dpc-4157	24	9	procedure	procedure	NOUN
dpc-4157	24	10	,	,	PUNCT
dpc-4157	24	11	immediately	immediately	ADV
dpc-4157	24	12	after	after	ADP
dpc-4157	24	13	the	the	DET
dpc-4157	24	14	procedure	procedure	NOUN
dpc-4157	24	15	,	,	PUNCT
dpc-4157	24	16	and	and	CCONJ
dpc-4157	24	17	at	at	ADP
dpc-4157	24	18	1	1	NUM
dpc-4157	24	19	,	,	PUNCT
dpc-4157	24	20	6	6	NUM
dpc-4157	24	21	,	,	PUNCT
dpc-4157	24	22	and	and	CCONJ
dpc-4157	24	23	12	12	NUM
dpc-4157	24	24	months	month	NOUN
dpc-4157	24	25	after	after	ADP
dpc-4157	24	26	the	the	DET
dpc-4157	24	27	procedure	procedure	NOUN
dpc-4157	24	28	.	.	PUNCT
dpc-4157	25	1	results	result	NOUN
dpc-4157	25	2	:	:	PUNCT
dpc-4157	25	3	all	all	DET
dpc-4157	25	4	participants	participant	NOUN
dpc-4157	25	5	displayed	display	VERB
dpc-4157	25	6	significant	significant	ADJ
dpc-4157	25	7	clinical	clinical	ADJ
dpc-4157	25	8	and	and	CCONJ
dpc-4157	25	9	dermoscopic	dermoscopic	ADJ
dpc-4157	25	10	improvements	improvement	NOUN
dpc-4157	25	11	,	,	PUNCT
dpc-4157	25	12	and	and	CCONJ
dpc-4157	25	13	all	all	DET
dpc-4157	25	14	lesions	lesion	NOUN
dpc-4157	25	15	healed	heal	VERB
dpc-4157	25	16	within	within	ADP
dpc-4157	25	17	2–3	2–3	NUM
dpc-4157	25	18	weeks	week	NOUN
dpc-4157	25	19	,	,	PUNCT
dpc-4157	25	20	resulting	result	VERB
dpc-4157	25	21	in	in	ADP
dpc-4157	25	22	only	only	ADJ
dpc-4157	25	23	minor	minor	ADJ
dpc-4157	25	24	atrophic	atrophic	ADJ
dpc-4157	25	25	scars	scar	NOUN
dpc-4157	25	26	.	.	PUNCT
dpc-4157	26	1	no	no	DET
dpc-4157	26	2	instance	instance	NOUN
dpc-4157	26	3	of	of	ADP
dpc-4157	26	4	recurrence	recurrence	NOUN
dpc-4157	26	5	was	be	AUX
dpc-4157	26	6	found	find	VERB
dpc-4157	26	7	among	among	ADP
dpc-4157	26	8	any	any	PRON
dpc-4157	26	9	of	of	ADP
dpc-4157	26	10	the	the	DET
dpc-4157	26	11	patients	patient	NOUN
dpc-4157	26	12	during	during	ADP
dpc-4157	26	13	the	the	DET
dpc-4157	26	14	1	1	NUM
dpc-4157	26	15	-	-	PUNCT
dpc-4157	26	16	year	year	NOUN
dpc-4157	26	17	follow	follow	NOUN
dpc-4157	26	18	-	-	PUNCT
dpc-4157	26	19	up	up	NOUN
dpc-4157	26	20	.	.	PUNCT
dpc-4157	27	1	conclusions	conclusion	NOUN
dpc-4157	27	2	:	:	PUNCT
dpc-4157	27	3	nd	nd	NUM
dpc-4157	27	4	:	:	PUNCT
dpc-4157	27	5	yag	yag	NOUN
dpc-4157	27	6	laser	laser	NOUN
dpc-4157	27	7	therapy	therapy	NOUN
dpc-4157	27	8	may	may	AUX
dpc-4157	27	9	prove	prove	VERB
dpc-4157	27	10	to	to	PART
dpc-4157	27	11	be	be	AUX
dpc-4157	27	12	an	an	DET
dpc-4157	27	13	effective	effective	ADJ
dpc-4157	27	14	therapeutic	therapeutic	ADJ
dpc-4157	27	15	alternative	alternative	NOUN
dpc-4157	27	16	for	for	ADP
dpc-4157	27	17	both	both	CCONJ
dpc-4157	27	18	early	early	ADJ
dpc-4157	27	19	and	and	CCONJ
dpc-4157	27	20	advanced	advanced	ADJ
dpc-4157	27	21	-	-	PUNCT
dpc-4157	27	22	stage	stage	NOUN
dpc-4157	27	23	cks	ck	NOUN
dpc-4157	27	24	,	,	PUNCT
dpc-4157	27	25	specifically	specifically	ADV
dpc-4157	27	26	in	in	ADP
dpc-4157	27	27	instances	instance	NOUN
dpc-4157	27	28	of	of	ADP
dpc-4157	27	29	stubborn	stubborn	ADJ
dpc-4157	27	30	cutaneous	cutaneous	ADJ
dpc-4157	27	31	lesions	lesion	NOUN
dpc-4157	27	32	or	or	CCONJ
dpc-4157	27	33	patients	patient	NOUN
dpc-4157	27	34	receiving	receive	VERB
dpc-4157	27	35	systemic	systemic	ADJ
dpc-4157	27	36	therapy	therapy	NOUN
dpc-4157	27	37	.	.	PUNCT
dpc-4157	28	1	the	the	DET
dpc-4157	28	2	treatment	treatment	NOUN
dpc-4157	28	3	results	result	VERB
dpc-4157	28	4	in	in	ADP
dpc-4157	28	5	quick	quick	ADJ
dpc-4157	28	6	improvement	improvement	NOUN
dpc-4157	28	7	,	,	PUNCT
dpc-4157	28	8	typically	typically	ADV
dpc-4157	28	9	within	within	ADP
dpc-4157	28	10	2–3	2–3	NUM
dpc-4157	28	11	weeks	week	NOUN
dpc-4157	28	12	,	,	PUNCT
dpc-4157	28	13	and	and	CCONJ
dpc-4157	28	14	is	be	AUX
dpc-4157	28	15	well	well	ADV
dpc-4157	28	16	tolerated	tolerate	VERB
dpc-4157	28	17	.	.	PUNCT
dpc-4157	29	1	nd	nd	X
dpc-4157	29	2	:	:	PUNCT
dpc-4157	29	3	yag	yag	NOUN
dpc-4157	29	4	laser	laser	NOUN
dpc-4157	29	5	therapy	therapy	NOUN
dpc-4157	29	6	could	could	AUX
dpc-4157	29	7	provide	provide	VERB
dpc-4157	29	8	potential	potential	ADJ
dpc-4157	29	9	benefits	benefit	NOUN
dpc-4157	29	10	for	for	ADP
dpc-4157	29	11	hiv	hiv	PROPN
dpc-4157	29	12	-	-	PUNCT
dpc-4157	29	13	positive	positive	ADJ
dpc-4157	29	14	patients	patient	NOUN
dpc-4157	29	15	as	as	SCONJ
dpc-4157	29	16	it	it	PRON
dpc-4157	29	17	is	be	AUX
dpc-4157	29	18	free	free	ADJ
dpc-4157	29	19	from	from	ADP
dpc-4157	29	20	immunosuppression	immunosuppression	NOUN
dpc-4157	29	21	,	,	PUNCT
dpc-4157	29	22	easy	easy	ADJ
dpc-4157	29	23	to	to	PART
dpc-4157	29	24	apply	apply	VERB
dpc-4157	29	25	to	to	ADP
dpc-4157	29	26	recurring	recur	VERB
dpc-4157	29	27	lesions	lesion	NOUN
dpc-4157	29	28	,	,	PUNCT
dpc-4157	29	29	and	and	CCONJ
dpc-4157	29	30	demonstrates	demonstrate	VERB
dpc-4157	29	31	overall	overall	ADJ
dpc-4157	29	32	effectiveness	effectiveness	NOUN
dpc-4157	29	33	and	and	CCONJ
dpc-4157	29	34	safety	safety	NOUN
dpc-4157	29	35	.	.	PUNCT
dpc-4157	30	1	abstract	abstract	ADJ
dpc-4157	30	2	2	2	NUM
dpc-4157	30	3	original	original	ADJ
dpc-4157	30	4	article	article	NOUN
dpc-4157	30	5	|	|	ADV
dpc-4157	30	6	dermatol	dermatol	ADJ
dpc-4157	30	7	pract	pract	NOUN
dpc-4157	30	8	concept	concept	NOUN
dpc-4157	30	9	.	.	PUNCT
dpc-4157	31	1	2024;14(2):e2024150	2024;14(2):e2024150	NUM
dpc-4157	31	2	introduction	introduction	NOUN
dpc-4157	31	3	classic	classic	ADJ
dpc-4157	31	4	kaposi	kaposi	PROPN
dpc-4157	31	5	’s	’s	PART
dpc-4157	31	6	sarcoma	sarcoma	NOUN
dpc-4157	31	7	(	(	PUNCT
dpc-4157	31	8	cks	ck	NOUN
dpc-4157	31	9	)	)	PUNCT
dpc-4157	31	10	is	be	AUX
dpc-4157	31	11	a	a	DET
dpc-4157	31	12	chronic	chronic	ADJ
dpc-4157	31	13	indolent	indolent	ADJ
dpc-4157	31	14	angioproliferative	angioproliferative	ADJ
dpc-4157	31	15	skin	skin	NOUN
dpc-4157	31	16	tumor	tumor	NOUN
dpc-4157	31	17	associated	associate	VERB
dpc-4157	31	18	with	with	ADP
dpc-4157	31	19	human	human	ADJ
dpc-4157	31	20	herpesvirus	herpesvirus	NOUN
dpc-4157	31	21	8	8	NUM
dpc-4157	31	22	(	(	PUNCT
dpc-4157	31	23	hhv8	hhv8	PROPN
dpc-4157	31	24	)	)	PUNCT
dpc-4157	31	25	and	and	CCONJ
dpc-4157	31	26	is	be	AUX
dpc-4157	31	27	characterized	characterize	VERB
dpc-4157	31	28	by	by	ADP
dpc-4157	31	29	violaceous	violaceous	ADJ
dpc-4157	31	30	macules	macule	NOUN
dpc-4157	31	31	,	,	PUNCT
dpc-4157	31	32	papules	papule	NOUN
dpc-4157	31	33	,	,	PUNCT
dpc-4157	31	34	and	and	CCONJ
dpc-4157	31	35	nodules	nodule	NOUN
dpc-4157	31	36	.	.	PUNCT
dpc-4157	32	1	the	the	DET
dpc-4157	32	2	lesions	lesion	NOUN
dpc-4157	32	3	are	be	AUX
dpc-4157	32	4	often	often	ADV
dpc-4157	32	5	located	locate	VERB
dpc-4157	32	6	in	in	ADP
dpc-4157	32	7	the	the	DET
dpc-4157	32	8	lower	low	ADJ
dpc-4157	32	9	extremities	extremity	NOUN
dpc-4157	32	10	and	and	CCONJ
dpc-4157	32	11	include	include	VERB
dpc-4157	32	12	macules	macule	NOUN
dpc-4157	32	13	,	,	PUNCT
dpc-4157	32	14	nodules	nodule	NOUN
dpc-4157	32	15	,	,	PUNCT
dpc-4157	32	16	and	and	CCONJ
dpc-4157	32	17	plaques	plaque	NOUN
dpc-4157	32	18	,	,	PUNCT
dpc-4157	32	19	depending	depend	VERB
dpc-4157	32	20	on	on	ADP
dpc-4157	32	21	stage	stage	NOUN
dpc-4157	32	22	of	of	ADP
dpc-4157	32	23	the	the	DET
dpc-4157	32	24	lesions	lesion	NOUN
dpc-4157	32	25	.	.	PUNCT
dpc-4157	33	1	cks	ck	NOUN
dpc-4157	33	2	predominantly	predominantly	ADV
dpc-4157	33	3	affects	affect	VERB
dpc-4157	33	4	males	male	NOUN
dpc-4157	33	5	,	,	PUNCT
dpc-4157	33	6	with	with	ADP
dpc-4157	33	7	a	a	DET
dpc-4157	33	8	male	male	NOUN
dpc-4157	33	9	-	-	PUNCT
dpc-4157	33	10	to	to	ADP
dpc-4157	33	11	-	-	PUNCT
dpc-4157	33	12	female	female	ADJ
dpc-4157	33	13	ratio	ratio	NOUN
dpc-4157	33	14	of	of	ADP
dpc-4157	33	15	3:1	3:1	NUM
dpc-4157	33	16	,	,	PUNCT
dpc-4157	33	17	with	with	ADP
dpc-4157	33	18	the	the	DET
dpc-4157	33	19	highest	high	ADJ
dpc-4157	33	20	incidence	incidence	NOUN
dpc-4157	33	21	observed	observe	VERB
dpc-4157	33	22	in	in	ADP
dpc-4157	33	23	the	the	DET
dpc-4157	33	24	sixth	sixth	ADJ
dpc-4157	33	25	decade	decade	NOUN
dpc-4157	33	26	of	of	ADP
dpc-4157	33	27	life	life	NOUN
dpc-4157	33	28	[	[	X
dpc-4157	33	29	1	1	NUM
dpc-4157	33	30	]	]	PUNCT
dpc-4157	33	31	.	.	PUNCT
dpc-4157	34	1	cks	ck	NOUN
dpc-4157	34	2	is	be	AUX
dpc-4157	34	3	prevalent	prevalent	ADJ
dpc-4157	34	4	in	in	ADP
dpc-4157	34	5	mediterranean	mediterranean	PROPN
dpc-4157	34	6	and	and	CCONJ
dpc-4157	34	7	eastern	eastern	ADJ
dpc-4157	34	8	european	european	ADJ
dpc-4157	34	9	regions	region	NOUN
dpc-4157	34	10	,	,	PUNCT
dpc-4157	34	11	and	and	CCONJ
dpc-4157	34	12	risk	risk	NOUN
dpc-4157	34	13	factors	factor	NOUN
dpc-4157	34	14	are	be	AUX
dpc-4157	34	15	advanced	advanced	ADJ
dpc-4157	34	16	age	age	NOUN
dpc-4157	34	17	,	,	PUNCT
dpc-4157	34	18	immune	immune	ADJ
dpc-4157	34	19	deficiency	deficiency	NOUN
dpc-4157	34	20	,	,	PUNCT
dpc-4157	34	21	and	and	CCONJ
dpc-4157	34	22	sexual	sexual	ADJ
dpc-4157	34	23	activity	activity	NOUN
dpc-4157	34	24	[	[	X
dpc-4157	34	25	1	1	NUM
dpc-4157	34	26	]	]	PUNCT
dpc-4157	34	27	.	.	PUNCT
dpc-4157	35	1	the	the	DET
dpc-4157	35	2	definitive	definitive	ADJ
dpc-4157	35	3	diagnosis	diagnosis	NOUN
dpc-4157	35	4	of	of	ADP
dpc-4157	35	5	cks	ck	NOUN
dpc-4157	35	6	relies	rely	VERB
dpc-4157	35	7	on	on	ADP
dpc-4157	35	8	histopathological	histopathological	ADJ
dpc-4157	35	9	analysis	analysis	NOUN
dpc-4157	35	10	,	,	PUNCT
dpc-4157	35	11	with	with	ADP
dpc-4157	35	12	clinical	clinical	ADJ
dpc-4157	35	13	and	and	CCONJ
dpc-4157	35	14	dermoscopic	dermoscopic	ADJ
dpc-4157	35	15	findings	finding	NOUN
dpc-4157	35	16	playing	play	VERB
dpc-4157	35	17	a	a	DET
dpc-4157	35	18	crucial	crucial	ADJ
dpc-4157	35	19	role	role	NOUN
dpc-4157	35	20	.	.	PUNCT
dpc-4157	36	1	while	while	SCONJ
dpc-4157	36	2	cks	ck	NOUN
dpc-4157	36	3	has	have	VERB
dpc-4157	36	4	a	a	DET
dpc-4157	36	5	low	low	ADJ
dpc-4157	36	6	mortality	mortality	NOUN
dpc-4157	36	7	rate	rate	NOUN
dpc-4157	36	8	,	,	PUNCT
dpc-4157	36	9	it	it	PRON
dpc-4157	36	10	  	  	SPACE
dpc-4157	36	11	significantly	significantly	ADV
dpc-4157	36	12	impacts	impact	VERB
dpc-4157	36	13	the	the	DET
dpc-4157	36	14	quality	quality	NOUN
dpc-4157	36	15	of	of	ADP
dpc-4157	36	16	life	life	NOUN
dpc-4157	36	17	of	of	ADP
dpc-4157	36	18	affected	affect	VERB
dpc-4157	36	19	individuals	individual	NOUN
dpc-4157	36	20	[	[	X
dpc-4157	36	21	2	2	NUM
dpc-4157	36	22	]	]	PUNCT
dpc-4157	36	23	.	.	PUNCT
dpc-4157	37	1	therefore	therefore	ADV
dpc-4157	37	2	,	,	PUNCT
dpc-4157	37	3	it	it	PRON
dpc-4157	37	4	is	be	AUX
dpc-4157	37	5	important	important	ADJ
dpc-4157	37	6	to	to	PART
dpc-4157	37	7	choose	choose	VERB
dpc-4157	37	8	a	a	DET
dpc-4157	37	9	reproducible	reproducible	ADJ
dpc-4157	37	10	local	local	ADJ
dpc-4157	37	11	treatment	treatment	NOUN
dpc-4157	37	12	that	that	PRON
dpc-4157	37	13	is	be	AUX
dpc-4157	37	14	long	long	ADJ
dpc-4157	37	15	-	-	PUNCT
dpc-4157	37	16	term	term	NOUN
dpc-4157	37	17	,	,	PUNCT
dpc-4157	37	18	fast	fast	ADV
dpc-4157	37	19	-	-	PUNCT
dpc-4157	37	20	acting	act	VERB
dpc-4157	37	21	,	,	PUNCT
dpc-4157	37	22	and	and	CCONJ
dpc-4157	37	23	safe	safe	ADJ
dpc-4157	37	24	and	and	CCONJ
dpc-4157	37	25	that	that	PRON
dpc-4157	37	26	has	have	VERB
dpc-4157	37	27	minimal	minimal	ADJ
dpc-4157	37	28	side	side	NOUN
dpc-4157	37	29	effects	effect	NOUN
dpc-4157	37	30	in	in	ADP
dpc-4157	37	31	this	this	DET
dpc-4157	37	32	cutaneous	cutaneous	ADJ
dpc-4157	37	33	limited	limited	ADJ
dpc-4157	37	34	disease	disease	NOUN
dpc-4157	37	35	.	.	PUNCT
dpc-4157	38	1	local	local	ADJ
dpc-4157	38	2	treatments	treatment	NOUN
dpc-4157	38	3	using	use	VERB
dpc-4157	38	4	various	various	ADJ
dpc-4157	38	5	types	type	NOUN
dpc-4157	38	6	of	of	ADP
dpc-4157	38	7	lasers	laser	NOUN
dpc-4157	38	8	have	have	AUX
dpc-4157	38	9	been	be	AUX
dpc-4157	38	10	reported	report	VERB
dpc-4157	38	11	in	in	ADP
dpc-4157	38	12	the	the	DET
dpc-4157	38	13	literature	literature	NOUN
dpc-4157	38	14	.	.	PUNCT
dpc-4157	39	1	objective	objective	ADJ
dpc-4157	39	2	here	here	ADV
dpc-4157	39	3	,	,	PUNCT
dpc-4157	39	4	we	we	PRON
dpc-4157	39	5	aimed	aim	VERB
dpc-4157	39	6	to	to	PART
dpc-4157	39	7	investigate	investigate	VERB
dpc-4157	39	8	the	the	DET
dpc-4157	39	9	clinical	clinical	ADJ
dpc-4157	39	10	and	and	CCONJ
dpc-4157	39	11	dermoscopic	dermoscopic	NOUN
dpc-4157	39	12	features	feature	NOUN
dpc-4157	39	13	as	as	ADV
dpc-4157	39	14	well	well	ADV
dpc-4157	39	15	as	as	ADP
dpc-4157	39	16	the	the	DET
dpc-4157	39	17	outcomes	outcome	NOUN
dpc-4157	39	18	of	of	ADP
dpc-4157	39	19	neodymium	neodymium	NOUN
dpc-4157	39	20	-	-	PUNCT
dpc-4157	39	21	doped	dope	VERB
dpc-4157	39	22	yttrium	yttrium	NOUN
dpc-4157	39	23	-	-	PUNCT
dpc-4157	39	24	aluminum	aluminum	NOUN
dpc-4157	39	25	-	-	PUNCT
dpc-4157	39	26	garnet	garnet	NOUN
dpc-4157	39	27	(	(	PUNCT
dpc-4157	39	28	nd	nd	NOUN
dpc-4157	39	29	:	:	PUNCT
dpc-4157	39	30	yag	yag	NOUN
dpc-4157	39	31	)	)	PUNCT
dpc-4157	39	32	laser	laser	NOUN
dpc-4157	39	33	treatment	treatment	NOUN
dpc-4157	39	34	in	in	ADP
dpc-4157	39	35	three	three	NUM
dpc-4157	39	36	cks	ck	NOUN
dpc-4157	39	37	patients	patient	NOUN
dpc-4157	39	38	.	.	PUNCT
dpc-4157	40	1	methods	method	NOUN
dpc-4157	40	2	we	we	PRON
dpc-4157	40	3	evaluated	evaluate	VERB
dpc-4157	40	4	a	a	DET
dpc-4157	40	5	total	total	NOUN
dpc-4157	40	6	of	of	ADP
dpc-4157	40	7	42	42	NUM
dpc-4157	40	8	nodular	nodular	ADJ
dpc-4157	40	9	lesions	lesion	NOUN
dpc-4157	40	10	located	locate	VERB
dpc-4157	40	11	in	in	ADP
dpc-4157	40	12	the	the	DET
dpc-4157	40	13	lower	low	ADJ
dpc-4157	40	14	and	and	CCONJ
dpc-4157	40	15	upper	upper	ADJ
dpc-4157	40	16	extremities	extremity	NOUN
dpc-4157	40	17	of	of	ADP
dpc-4157	40	18	three	three	NUM
dpc-4157	40	19	cks	ck	NOUN
dpc-4157	40	20	patients	patient	NOUN
dpc-4157	40	21	who	who	PRON
dpc-4157	40	22	visited	visit	VERB
dpc-4157	40	23	our	our	PRON
dpc-4157	40	24	clinic	clinic	NOUN
dpc-4157	40	25	between	between	ADP
dpc-4157	40	26	march	march	PROPN
dpc-4157	40	27	2018	2018	NUM
dpc-4157	40	28	and	and	CCONJ
dpc-4157	40	29	january	january	PROPN
dpc-4157	40	30	2020	2020	NUM
dpc-4157	40	31	.	.	PUNCT
dpc-4157	41	1	the	the	DET
dpc-4157	41	2	retrospective	retrospective	ADJ
dpc-4157	41	3	study	study	NOUN
dpc-4157	41	4	protocol	protocol	NOUN
dpc-4157	41	5	was	be	AUX
dpc-4157	41	6	approved	approve	VERB
dpc-4157	41	7	by	by	ADP
dpc-4157	41	8	our	our	PRON
dpc-4157	41	9	ethics	ethic	NOUN
dpc-4157	41	10	committee	committee	PROPN
dpc-4157	41	11	(	(	PUNCT
dpc-4157	41	12	ethics	ethic	NOUN
dpc-4157	41	13	committee	committee	PROPN
dpc-4157	41	14	approval	approval	PROPN
dpc-4157	41	15	n.	n.	PROPN
dpc-4157	41	16	i̇10	i̇10	PROPN
dpc-4157	41	17	-	-	PUNCT
dpc-4157	41	18	701	701	NUM
dpc-4157	41	19	-	-	NUM
dpc-4157	41	20	23	23	NUM
dpc-4157	41	21	)	)	PUNCT
dpc-4157	41	22	,	,	PUNCT
dpc-4157	41	23	and	and	CCONJ
dpc-4157	41	24	informed	inform	VERB
dpc-4157	41	25	consent	consent	NOUN
dpc-4157	41	26	was	be	AUX
dpc-4157	41	27	obtained	obtain	VERB
dpc-4157	41	28	from	from	ADP
dpc-4157	41	29	the	the	DET
dpc-4157	41	30	patients	patient	NOUN
dpc-4157	41	31	.	.	PUNCT
dpc-4157	42	1	all	all	PRON
dpc-4157	42	2	of	of	ADP
dpc-4157	42	3	our	our	PRON
dpc-4157	42	4	patients	patient	NOUN
dpc-4157	42	5	had	have	AUX
dpc-4157	42	6	been	be	AUX
dpc-4157	42	7	diagnosed	diagnose	VERB
dpc-4157	42	8	pathologically	pathologically	ADV
dpc-4157	42	9	with	with	ADP
dpc-4157	42	10	ks	ks	NOUN
dpc-4157	42	11	prior	prior	ADV
dpc-4157	42	12	to	to	ADP
dpc-4157	42	13	enrolling	enrol	VERB
dpc-4157	42	14	to	to	ADP
dpc-4157	42	15	this	this	DET
dpc-4157	42	16	study	study	NOUN
dpc-4157	42	17	.	.	PUNCT
dpc-4157	43	1	the	the	DET
dpc-4157	43	2	patients	patient	NOUN
dpc-4157	43	3	had	have	VERB
dpc-4157	43	4	no	no	DET
dpc-4157	43	5	history	history	NOUN
dpc-4157	43	6	of	of	ADP
dpc-4157	43	7	immunosuppressive	immunosuppressive	ADJ
dpc-4157	43	8	drug	drug	NOUN
dpc-4157	43	9	use	use	NOUN
dpc-4157	43	10	,	,	PUNCT
dpc-4157	43	11	systemic	systemic	ADJ
dpc-4157	43	12	disease	disease	NOUN
dpc-4157	43	13	,	,	PUNCT
dpc-4157	43	14	or	or	CCONJ
dpc-4157	43	15	organ	organ	NOUN
dpc-4157	43	16	transplantation	transplantation	NOUN
dpc-4157	43	17	,	,	PUNCT
dpc-4157	43	18	and	and	CCONJ
dpc-4157	43	19	their	their	PRON
dpc-4157	43	20	medical	medical	ADJ
dpc-4157	43	21	histories	history	NOUN
dpc-4157	43	22	were	be	AUX
dpc-4157	43	23	unremarkable	unremarkable	ADJ
dpc-4157	43	24	.	.	PUNCT
dpc-4157	44	1	the	the	DET
dpc-4157	44	2	complete	complete	ADJ
dpc-4157	44	3	blood	blood	NOUN
dpc-4157	44	4	count	count	NOUN
dpc-4157	44	5	,	,	PUNCT
dpc-4157	44	6	complete	complete	ADJ
dpc-4157	44	7	metabolic	metabolic	NOUN
dpc-4157	44	8	panel	panel	NOUN
dpc-4157	44	9	,	,	PUNCT
dpc-4157	44	10	and	and	CCONJ
dpc-4157	44	11	hiv	hiv	PROPN
dpc-4157	44	12	serology	serology	NOUN
dpc-4157	44	13	were	be	AUX
dpc-4157	44	14	normal	normal	ADJ
dpc-4157	44	15	for	for	ADP
dpc-4157	44	16	all	all	DET
dpc-4157	44	17	patients	patient	NOUN
dpc-4157	44	18	.	.	PUNCT
dpc-4157	45	1	none	none	NOUN
dpc-4157	45	2	of	of	ADP
dpc-4157	45	3	the	the	DET
dpc-4157	45	4	patients	patient	NOUN
dpc-4157	45	5	had	have	VERB
dpc-4157	45	6	endemic	endemic	ADJ
dpc-4157	45	7	,	,	PUNCT
dpc-4157	45	8	epidemic	epidemic	NOUN
dpc-4157	45	9	,	,	PUNCT
dpc-4157	45	10	or	or	CCONJ
dpc-4157	45	11	iatrogenic	iatrogenic	ADJ
dpc-4157	45	12	ks	k	NOUN
dpc-4157	45	13	.	.	PUNCT
dpc-4157	46	1	all	all	DET
dpc-4157	46	2	patients	patient	NOUN
dpc-4157	46	3	were	be	AUX
dpc-4157	46	4	staged	stage	VERB
dpc-4157	46	5	using	use	VERB
dpc-4157	46	6	lymph	lymph	NOUN
dpc-4157	46	7	node	node	PROPN
dpc-4157	46	8	ultrasound	ultrasound	PROPN
dpc-4157	46	9	,	,	PUNCT
dpc-4157	46	10	thoraco	thoraco	PROPN
dpc-4157	46	11	-	-	PUNCT
dpc-4157	46	12	abdominopelvic	abdominopelvic	VERB
dpc-4157	46	13	computed	compute	VERB
dpc-4157	46	14	tomography	tomography	NOUN
dpc-4157	46	15	,	,	PUNCT
dpc-4157	46	16	and	and	CCONJ
dpc-4157	46	17	endo	endo	NOUN
dpc-4157	46	18	-	-	PUNCT
dpc-4157	46	19	colonoscopy	colonoscopy	NOUN
dpc-4157	46	20	.	.	PUNCT
dpc-4157	47	1	none	none	NOUN
dpc-4157	47	2	of	of	ADP
dpc-4157	47	3	the	the	DET
dpc-4157	47	4	patients	patient	NOUN
dpc-4157	47	5	had	have	VERB
dpc-4157	47	6	extracutaneous	extracutaneous	ADJ
dpc-4157	47	7	or	or	CCONJ
dpc-4157	47	8	mucosal	mucosal	NOUN
dpc-4157	47	9	involvement	involvement	NOUN
dpc-4157	47	10	,	,	PUNCT
dpc-4157	47	11	and	and	CCONJ
dpc-4157	47	12	all	all	DET
dpc-4157	47	13	patients	patient	NOUN
dpc-4157	47	14	had	have	VERB
dpc-4157	47	15	stage	stage	NOUN
dpc-4157	47	16	4	4	NUM
dpc-4157	47	17	cks	ck	NOUN
dpc-4157	47	18	according	accord	VERB
dpc-4157	47	19	to	to	ADP
dpc-4157	47	20	the	the	DET
dpc-4157	47	21	classification	classification	NOUN
dpc-4157	47	22	of	of	ADP
dpc-4157	47	23	brambilla	brambilla	NOUN
dpc-4157	47	24	et	et	PROPN
dpc-4157	47	25	al	al	PROPN
dpc-4157	47	26	.	.	PUNCT
dpc-4157	48	1	[	[	X
dpc-4157	48	2	3	3	NUM
dpc-4157	48	3	]	]	PUNCT
dpc-4157	48	4	.	.	PUNCT
dpc-4157	49	1	the	the	DET
dpc-4157	49	2	study	study	NOUN
dpc-4157	49	3	excluded	exclude	VERB
dpc-4157	49	4	patients	patient	NOUN
dpc-4157	49	5	who	who	PRON
dpc-4157	49	6	had	have	AUX
dpc-4157	49	7	received	receive	VERB
dpc-4157	49	8	systemic	systemic	ADJ
dpc-4157	49	9	treatments	treatment	NOUN
dpc-4157	49	10	for	for	ADP
dpc-4157	49	11	cks	ck	NOUN
dpc-4157	49	12	in	in	ADP
dpc-4157	49	13	the	the	DET
dpc-4157	49	14	previous	previous	ADJ
dpc-4157	49	15	months	month	NOUN
dpc-4157	49	16	and	and	CCONJ
dpc-4157	49	17	lesions	lesion	NOUN
dpc-4157	49	18	that	that	PRON
dpc-4157	49	19	had	have	AUX
dpc-4157	49	20	previously	previously	ADV
dpc-4157	49	21	undergone	undergo	VERB
dpc-4157	49	22	local	local	ADJ
dpc-4157	49	23	treatments	treatment	NOUN
dpc-4157	49	24	.	.	PUNCT
dpc-4157	50	1	none	none	NOUN
dpc-4157	50	2	of	of	ADP
dpc-4157	50	3	the	the	DET
dpc-4157	50	4	patients	patient	NOUN
dpc-4157	50	5	included	include	VERB
dpc-4157	50	6	in	in	ADP
dpc-4157	50	7	the	the	DET
dpc-4157	50	8	study	study	NOUN
dpc-4157	50	9	had	have	VERB
dpc-4157	50	10	a	a	DET
dpc-4157	50	11	history	history	NOUN
dpc-4157	50	12	of	of	ADP
dpc-4157	50	13	hypertrophic	hypertrophic	ADJ
dpc-4157	50	14	scars	scar	NOUN
dpc-4157	50	15	or	or	CCONJ
dpc-4157	50	16	coagulation	coagulation	NOUN
dpc-4157	50	17	disorders	disorder	NOUN
dpc-4157	50	18	.	.	PUNCT
dpc-4157	51	1	all	all	DET
dpc-4157	51	2	42	42	NUM
dpc-4157	51	3	nodular	nodular	ADJ
dpc-4157	51	4	lesions	lesion	NOUN
dpc-4157	51	5	,	,	PUNCT
dpc-4157	51	6	ranging	range	VERB
dpc-4157	51	7	in	in	ADP
dpc-4157	51	8	diameter	diameter	NOUN
dpc-4157	51	9	from	from	ADP
dpc-4157	51	10	3	3	NUM
dpc-4157	51	11	to	to	PART
dpc-4157	51	12	12	12	NUM
dpc-4157	51	13	mm	mm	NOUN
dpc-4157	51	14	,	,	PUNCT
dpc-4157	51	15	underwent	underwent	ADJ
dpc-4157	51	16	long	long	ADV
dpc-4157	51	17	-	-	PUNCT
dpc-4157	51	18	pulsed	pulse	VERB
dpc-4157	51	19	nd	nd	NOUN
dpc-4157	51	20	:	:	PUNCT
dpc-4157	51	21	yag	yag	NOUN
dpc-4157	51	22	laser	laser	NOUN
dpc-4157	51	23	treatment	treatment	NOUN
dpc-4157	51	24	,	,	PUNCT
dpc-4157	51	25	administered	administer	VERB
dpc-4157	51	26	in	in	ADP
dpc-4157	51	27	one	one	NUM
dpc-4157	51	28	or	or	CCONJ
dpc-4157	51	29	two	two	NUM
dpc-4157	51	30	sessions	session	NOUN
dpc-4157	51	31	.	.	PUNCT
dpc-4157	52	1	the	the	DET
dpc-4157	52	2	laser	laser	NOUN
dpc-4157	52	3	parameters	parameter	NOUN
dpc-4157	52	4	employed	employ	VERB
dpc-4157	52	5	during	during	ADP
dpc-4157	52	6	treatments	treatment	NOUN
dpc-4157	52	7	were	be	AUX
dpc-4157	52	8	as	as	SCONJ
dpc-4157	52	9	follows	follow	VERB
dpc-4157	52	10	:	:	PUNCT
dpc-4157	52	11	spot	spot	NOUN
dpc-4157	52	12	diameter	diameter	NOUN
dpc-4157	52	13	of	of	ADP
dpc-4157	52	14	3–7	3–7	NUM
dpc-4157	52	15	mm	mm	NOUN
dpc-4157	52	16	;	;	PUNCT
dpc-4157	52	17	energy	energy	NOUN
dpc-4157	52	18	density	density	NOUN
dpc-4157	52	19	of	of	ADP
dpc-4157	52	20	200–250	200–250	PROPN
dpc-4157	52	21	j	j	PROPN
dpc-4157	52	22	/	/	SYM
dpc-4157	52	23	cm2	cm2	PROPN
dpc-4157	52	24	;	;	PUNCT
dpc-4157	52	25	pulse	pulse	NOUN
dpc-4157	52	26	duration	duration	NOUN
dpc-4157	52	27	of	of	ADP
dpc-4157	52	28	10–20	10–20	NUM
dpc-4157	52	29	msn	msn	NOUN
dpc-4157	52	30	.	.	PUNCT
dpc-4157	53	1	a	a	DET
dpc-4157	53	2	satisfactory	satisfactory	ADJ
dpc-4157	53	3	treatment	treatment	NOUN
dpc-4157	53	4	outcome	outcome	NOUN
dpc-4157	53	5	was	be	AUX
dpc-4157	53	6	defined	define	VERB
dpc-4157	53	7	by	by	ADP
dpc-4157	53	8	the	the	DET
dpc-4157	53	9	grey	grey	PROPN
dpc-4157	53	10	whitening	whitening	NOUN
dpc-4157	53	11	of	of	ADP
dpc-4157	53	12	the	the	DET
dpc-4157	53	13	nodular	nodular	ADJ
dpc-4157	53	14	lesions	lesion	NOUN
dpc-4157	53	15	accompanied	accompany	VERB
dpc-4157	53	16	by	by	ADP
dpc-4157	53	17	a	a	DET
dpc-4157	53	18	significant	significant	ADJ
dpc-4157	53	19	popping	popping	ADJ
dpc-4157	53	20	sound	sound	NOUN
dpc-4157	53	21	.	.	PUNCT
dpc-4157	54	1	patients	patient	NOUN
dpc-4157	54	2	were	be	AUX
dpc-4157	54	3	instructed	instruct	VERB
dpc-4157	54	4	to	to	PART
dpc-4157	54	5	report	report	VERB
dpc-4157	54	6	any	any	DET
dpc-4157	54	7	severe	severe	ADJ
dpc-4157	54	8	pain	pain	NOUN
dpc-4157	54	9	or	or	CCONJ
dpc-4157	54	10	discomfort	discomfort	NOUN
dpc-4157	54	11	experienced	experience	VERB
dpc-4157	54	12	during	during	ADP
dpc-4157	54	13	the	the	DET
dpc-4157	54	14	procedure	procedure	NOUN
dpc-4157	54	15	.	.	PUNCT
dpc-4157	55	1	local	local	ADJ
dpc-4157	55	2	anesthesia	anesthesia	NOUN
dpc-4157	55	3	was	be	AUX
dpc-4157	55	4	not	not	PART
dpc-4157	55	5	administered	administer	VERB
dpc-4157	55	6	prior	prior	ADV
dpc-4157	55	7	to	to	ADP
dpc-4157	55	8	the	the	DET
dpc-4157	55	9	procedure	procedure	NOUN
dpc-4157	55	10	.	.	PUNCT
dpc-4157	56	1	for	for	ADP
dpc-4157	56	2	selected	select	VERB
dpc-4157	56	3	thick	thick	ADJ
dpc-4157	56	4	nodular	nodular	ADJ
dpc-4157	56	5	lesions	lesion	NOUN
dpc-4157	56	6	,	,	PUNCT
dpc-4157	56	7	a	a	DET
dpc-4157	56	8	second	second	ADJ
dpc-4157	56	9	session	session	NOUN
dpc-4157	56	10	of	of	ADP
dpc-4157	56	11	long	long	ADJ
dpc-4157	56	12	-	-	PUNCT
dpc-4157	56	13	pulse	pulse	NOUN
dpc-4157	56	14	nd	nd	NOUN
dpc-4157	56	15	:	:	PUNCT
dpc-4157	56	16	yag	yag	NOUN
dpc-4157	56	17	laser	laser	NOUN
dpc-4157	56	18	treatment	treatment	NOUN
dpc-4157	56	19	administered	administer	VERB
dpc-4157	56	20	at	at	ADP
dpc-4157	56	21	4	4	NUM
dpc-4157	56	22	–	–	PUNCT
dpc-4157	56	23	week	week	NOUN
dpc-4157	56	24	intervals	interval	NOUN
dpc-4157	56	25	.	.	PUNCT
dpc-4157	57	1	nikon	nikon	PROPN
dpc-4157	57	2	1	1	NUM
dpc-4157	57	3	aw1	aw1	PROPN
dpc-4157	57	4	camera	camera	NOUN
dpc-4157	57	5	apple	apple	PROPN
dpc-4157	57	6	ipad	ipad	PROPN
dpc-4157	57	7	mini	mini	ADJ
dpc-4157	57	8	retina	retina	NOUN
dpc-4157	57	9	were	be	AUX
dpc-4157	57	10	used	use	VERB
dpc-4157	57	11	to	to	PART
dpc-4157	57	12	image	image	VERB
dpc-4157	57	13	the	the	DET
dpc-4157	57	14	lesions	lesion	NOUN
dpc-4157	57	15	clinically	clinically	ADV
dpc-4157	57	16	,	,	PUNCT
dpc-4157	57	17	and	and	CCONJ
dpc-4157	57	18	a	a	DET
dpc-4157	57	19	dermlite	dermlite	ADJ
dpc-4157	57	20	dl3n	dl3n	NOUN
dpc-4157	57	21	and	and	CCONJ
dpc-4157	57	22	dermlite	dermlite	NOUN
dpc-4157	57	23	dl4	dl4	NOUN
dpc-4157	57	24	coupled	couple	VERB
dpc-4157	57	25	to	to	ADP
dpc-4157	57	26	a	a	DET
dpc-4157	57	27	nikon	nikon	PROPN
dpc-4157	57	28	1	1	NUM
dpc-4157	57	29	aw1	aw1	PROPN
dpc-4157	57	30	camera	camera	NOUN
dpc-4157	57	31	was	be	AUX
dpc-4157	57	32	used	use	VERB
dpc-4157	57	33	for	for	ADP
dpc-4157	57	34	dermoscopic	dermoscopic	ADJ
dpc-4157	57	35	imaging	imaging	NOUN
dpc-4157	57	36	before	before	ADP
dpc-4157	57	37	the	the	DET
dpc-4157	57	38	procedure	procedure	NOUN
dpc-4157	57	39	,	,	PUNCT
dpc-4157	57	40	immediately	immediately	ADV
dpc-4157	57	41	after	after	ADP
dpc-4157	57	42	the	the	DET
dpc-4157	57	43	procedure	procedure	NOUN
dpc-4157	57	44	,	,	PUNCT
dpc-4157	57	45	and	and	CCONJ
dpc-4157	57	46	at	at	ADP
dpc-4157	57	47	1	1	NUM
dpc-4157	57	48	,	,	PUNCT
dpc-4157	57	49	6	6	NUM
dpc-4157	57	50	,	,	PUNCT
dpc-4157	57	51	and	and	CCONJ
dpc-4157	57	52	12	12	NUM
dpc-4157	57	53	months	month	NOUN
dpc-4157	57	54	after	after	ADP
dpc-4157	57	55	the	the	DET
dpc-4157	57	56	procedure	procedure	NOUN
dpc-4157	57	57	.	.	PUNCT
dpc-4157	58	1	results	result	VERB
dpc-4157	58	2	the	the	DET
dpc-4157	58	3	demographic	demographic	ADJ
dpc-4157	58	4	characteristics	characteristic	NOUN
dpc-4157	58	5	,	,	PUNCT
dpc-4157	58	6	skin	skin	NOUN
dpc-4157	58	7	type	type	NOUN
dpc-4157	58	8	,	,	PUNCT
dpc-4157	58	9	and	and	CCONJ
dpc-4157	58	10	clinical	clinical	ADJ
dpc-4157	58	11	characteristics	characteristic	NOUN
dpc-4157	58	12	of	of	ADP
dpc-4157	58	13	the	the	DET
dpc-4157	58	14	patients	patient	NOUN
dpc-4157	58	15	are	be	AUX
dpc-4157	58	16	presented	present	VERB
dpc-4157	58	17	in	in	ADP
dpc-4157	58	18	table	table	NOUN
dpc-4157	58	19	1	1	NUM
dpc-4157	58	20	.	.	PUNCT
dpc-4157	59	1	the	the	DET
dpc-4157	59	2	mean	mean	ADJ
dpc-4157	59	3	age	age	NOUN
dpc-4157	59	4	of	of	ADP
dpc-4157	59	5	the	the	DET
dpc-4157	59	6	patients	patient	NOUN
dpc-4157	59	7	was	be	AUX
dpc-4157	59	8	70	70	NUM
dpc-4157	59	9	(	(	PUNCT
dpc-4157	59	10	57–78	57–78	NUM
dpc-4157	59	11	)	)	PUNCT
dpc-4157	59	12	years	year	NOUN
dpc-4157	59	13	,	,	PUNCT
dpc-4157	59	14	and	and	CCONJ
dpc-4157	59	15	the	the	DET
dpc-4157	59	16	mean	mean	ADJ
dpc-4157	59	17	disease	disease	NOUN
dpc-4157	59	18	duration	duration	NOUN
dpc-4157	59	19	was	be	AUX
dpc-4157	59	20	6.6	6.6	NUM
dpc-4157	59	21	(	(	PUNCT
dpc-4157	59	22	5–8	5–8	NOUN
dpc-4157	59	23	)	)	PUNCT
dpc-4157	59	24	years	year	NOUN
dpc-4157	59	25	.	.	PUNCT
dpc-4157	60	1	the	the	DET
dpc-4157	60	2	clinical	clinical	ADJ
dpc-4157	60	3	findings	finding	NOUN
dpc-4157	60	4	of	of	ADP
dpc-4157	60	5	the	the	DET
dpc-4157	60	6	patients	patient	NOUN
dpc-4157	60	7	before	before	ADP
dpc-4157	60	8	and	and	CCONJ
dpc-4157	60	9	after	after	ADP
dpc-4157	60	10	treatment	treatment	NOUN
dpc-4157	60	11	are	be	AUX
dpc-4157	60	12	shown	show	VERB
dpc-4157	60	13	in	in	ADP
dpc-4157	60	14	figure	figure	NOUN
dpc-4157	60	15	1	1	NUM
dpc-4157	60	16	,	,	PUNCT
dpc-4157	60	17	and	and	CCONJ
dpc-4157	60	18	the	the	DET
dpc-4157	60	19	dermoscopic	dermoscopic	ADJ
dpc-4157	60	20	findings	finding	NOUN
dpc-4157	60	21	are	be	AUX
dpc-4157	60	22	shown	show	VERB
dpc-4157	60	23	in	in	ADP
dpc-4157	60	24	figure	figure	NOUN
dpc-4157	60	25	2	2	NUM
dpc-4157	60	26	.	.	PUNCT
dpc-4157	61	1	all	all	DET
dpc-4157	61	2	three	three	NUM
dpc-4157	61	3	patients	patient	NOUN
dpc-4157	61	4	had	have	VERB
dpc-4157	61	5	multiple	multiple	ADJ
dpc-4157	61	6	,	,	PUNCT
dpc-4157	61	7	slowly	slowly	ADV
dpc-4157	61	8	progressive	progressive	ADJ
dpc-4157	61	9	,	,	PUNCT
dpc-4157	61	10	nodular	nodular	ADJ
dpc-4157	61	11	lesions	lesion	NOUN
dpc-4157	61	12	located	locate	VERB
dpc-4157	61	13	in	in	ADP
dpc-4157	61	14	the	the	DET
dpc-4157	61	15	lower	low	ADJ
dpc-4157	61	16	and	and	CCONJ
dpc-4157	61	17	upper	upper	ADJ
dpc-4157	61	18	extremities	extremity	NOUN
dpc-4157	61	19	,	,	PUNCT
dpc-4157	61	20	and	and	CCONJ
dpc-4157	61	21	the	the	DET
dpc-4157	61	22	patients	patient	NOUN
dpc-4157	61	23	were	be	AUX
dpc-4157	61	24	considered	consider	VERB
dpc-4157	61	25	to	to	PART
dpc-4157	61	26	have	have	VERB
dpc-4157	61	27	stage	stage	NOUN
dpc-4157	61	28	4	4	NUM
dpc-4157	61	29	disease	disease	NOUN
dpc-4157	61	30	.	.	PUNCT
dpc-4157	62	1	among	among	ADP
dpc-4157	62	2	the	the	DET
dpc-4157	62	3	patients	patient	NOUN
dpc-4157	62	4	included	include	VERB
dpc-4157	62	5	in	in	ADP
dpc-4157	62	6	the	the	DET
dpc-4157	62	7	study	study	NOUN
dpc-4157	62	8	,	,	PUNCT
dpc-4157	62	9	one	one	NUM
dpc-4157	62	10	exhibited	exhibit	VERB
dpc-4157	62	11	lymphedema	lymphedema	NOUN
dpc-4157	62	12	associated	associate	VERB
dpc-4157	62	13	with	with	ADP
dpc-4157	62	14	cks	ck	NOUN
dpc-4157	62	15	in	in	ADP
dpc-4157	62	16	the	the	DET
dpc-4157	62	17	lower	low	ADJ
dpc-4157	62	18	extremities	extremity	NOUN
dpc-4157	62	19	(	(	PUNCT
dpc-4157	62	20	figure	figure	NOUN
dpc-4157	62	21	1	1	NUM
dpc-4157	62	22	,	,	PUNCT
dpc-4157	62	23	c	c	NOUN
dpc-4157	62	24	 	 	SPACE
dpc-4157	62	25	and	and	CCONJ
dpc-4157	62	26	d	d	NOUN
dpc-4157	62	27	)	)	PUNCT
dpc-4157	62	28	.	.	PUNCT
dpc-4157	63	1	all	all	DET
dpc-4157	63	2	patients	patient	NOUN
dpc-4157	63	3	had	have	AUX
dpc-4157	63	4	previously	previously	ADV
dpc-4157	63	5	undergone	undergo	VERB
dpc-4157	63	6	treatment	treatment	NOUN
dpc-4157	63	7	for	for	ADP
dpc-4157	63	8	their	their	PRON
dpc-4157	63	9	extensive	extensive	ADJ
dpc-4157	63	10	lesions	lesion	NOUN
dpc-4157	63	11	with	with	ADP
dpc-4157	63	12	interferon	interferon	ADJ
dpc-4157	63	13	α-2a	α-2a	PROPN
dpc-4157	63	14	,	,	PUNCT
dpc-4157	63	15	along	along	ADP
dpc-4157	63	16	with	with	ADP
dpc-4157	63	17	local	local	ADJ
dpc-4157	63	18	radiation	radiation	NOUN
dpc-4157	63	19	therapy	therapy	NOUN
dpc-4157	63	20	and	and	CCONJ
dpc-4157	63	21	surgery	surgery	NOUN
dpc-4157	63	22	.	.	PUNCT
dpc-4157	64	1	however	however	ADV
dpc-4157	64	2	,	,	PUNCT
dpc-4157	64	3	in	in	ADP
dpc-4157	64	4	the	the	DET
dpc-4157	64	5	three	three	NUM
dpc-4157	64	6	months	month	NOUN
dpc-4157	64	7	before	before	ADV
dpc-4157	64	8	,	,	PUNCT
dpc-4157	64	9	during	during	ADP
dpc-4157	64	10	,	,	PUNCT
dpc-4157	64	11	and	and	CCONJ
dpc-4157	64	12	one	one	NUM
dpc-4157	64	13	year	year	NOUN
dpc-4157	64	14	after	after	ADP
dpc-4157	64	15	laser	laser	NOUN
dpc-4157	64	16	treatment	treatment	NOUN
dpc-4157	64	17	,	,	PUNCT
dpc-4157	64	18	none	none	NOUN
dpc-4157	64	19	of	of	ADP
dpc-4157	64	20	the	the	DET
dpc-4157	64	21	patients	patient	NOUN
dpc-4157	64	22	received	receive	VERB
dpc-4157	64	23	any	any	DET
dpc-4157	64	24	systemic	systemic	ADJ
dpc-4157	64	25	or	or	CCONJ
dpc-4157	64	26	local	local	ADJ
dpc-4157	64	27	treatment	treatment	NOUN
dpc-4157	64	28	.	.	PUNCT
dpc-4157	65	1	long	long	ADV
dpc-4157	65	2	-	-	PUNCT
dpc-4157	65	3	pulsed	pulse	VERB
dpc-4157	65	4	nd	nd	NOUN
dpc-4157	65	5	:	:	PUNCT
dpc-4157	65	6	yag	yag	NOUN
dpc-4157	65	7	laser	laser	NOUN
dpc-4157	65	8	treatment	treatment	NOUN
dpc-4157	65	9	was	be	AUX
dpc-4157	65	10	successfully	successfully	ADV
dpc-4157	65	11	administered	administer	VERB
dpc-4157	65	12	to	to	ADP
dpc-4157	65	13	a	a	DET
dpc-4157	65	14	total	total	NOUN
dpc-4157	65	15	of	of	ADP
dpc-4157	65	16	42	42	NUM
dpc-4157	65	17	nodular	nodular	ADJ
dpc-4157	65	18	lesions	lesion	NOUN
dpc-4157	65	19	,	,	PUNCT
dpc-4157	65	20	located	locate	VERB
dpc-4157	65	21	in	in	ADP
dpc-4157	65	22	the	the	DET
dpc-4157	65	23	lower	low	ADJ
dpc-4157	65	24	and	and	CCONJ
dpc-4157	65	25	upper	upper	ADJ
dpc-4157	65	26	extremities	extremity	NOUN
dpc-4157	65	27	,	,	PUNCT
dpc-4157	65	28	with	with	ADP
dpc-4157	65	29	diameters	diameter	NOUN
dpc-4157	65	30	ranging	range	VERB
dpc-4157	65	31	from	from	ADP
dpc-4157	65	32	3	3	NUM
dpc-4157	65	33	 	 	SPACE
dpc-4157	65	34	to	to	ADP
dpc-4157	65	35	12	12	NUM
dpc-4157	65	36	mm	mm	NOUN
dpc-4157	65	37	.	.	PUNCT
dpc-4157	66	1	throughout	throughout	ADP
dpc-4157	66	2	the	the	DET
dpc-4157	66	3	treatment	treatment	NOUN
dpc-4157	66	4	sessions	session	NOUN
dpc-4157	66	5	,	,	PUNCT
dpc-4157	66	6	a	a	DET
dpc-4157	66	7	consistent	consistent	ADJ
dpc-4157	66	8	popping	popping	ADJ
dpc-4157	66	9	sound	sound	NOUN
dpc-4157	66	10	was	be	AUX
dpc-4157	66	11	noted	note	VERB
dpc-4157	66	12	,	,	PUNCT
dpc-4157	66	13	and	and	CCONJ
dpc-4157	66	14	no	no	DET
dpc-4157	66	15	bleeding	bleeding	NOUN
dpc-4157	66	16	was	be	AUX
dpc-4157	66	17	observed	observe	VERB
dpc-4157	66	18	.	.	PUNCT
dpc-4157	67	1	following	follow	VERB
dpc-4157	67	2	the	the	DET
dpc-4157	67	3	treatment	treatment	NOUN
dpc-4157	67	4	,	,	PUNCT
dpc-4157	67	5	a	a	DET
dpc-4157	67	6	crust	crust	NOUN
dpc-4157	67	7	formed	form	VERB
dpc-4157	67	8	in	in	ADP
dpc-4157	67	9	the	the	DET
dpc-4157	67	10	treated	treat	VERB
dpc-4157	67	11	area	area	NOUN
dpc-4157	67	12	,	,	PUNCT
dpc-4157	67	13	which	which	PRON
dpc-4157	67	14	subsequently	subsequently	ADV
dpc-4157	67	15	healed	heal	VERB
dpc-4157	67	16	with	with	ADP
dpc-4157	67	17	scarring	scar	VERB
dpc-4157	67	18	(	(	PUNCT
dpc-4157	67	19	figures	figure	NOUN
dpc-4157	67	20	1	1	NUM
dpc-4157	67	21	and	and	CCONJ
dpc-4157	67	22	2	2	NUM
dpc-4157	67	23	)	)	PUNCT
dpc-4157	67	24	within	within	ADP
dpc-4157	67	25	2–3	2–3	NUM
dpc-4157	67	26	weeks	week	NOUN
dpc-4157	67	27	.	.	PUNCT
dpc-4157	68	1	additionally	additionally	ADV
dpc-4157	68	2	,	,	PUNCT
dpc-4157	68	3	a	a	DET
dpc-4157	68	4	notable	notable	ADJ
dpc-4157	68	5	clinical	clinical	ADJ
dpc-4157	68	6	improvement	improvement	NOUN
dpc-4157	68	7	in	in	ADP
dpc-4157	68	8	lymphedema	lymphedema	NOUN
dpc-4157	68	9	was	be	AUX
dpc-4157	68	10	observed	observe	VERB
dpc-4157	68	11	in	in	ADP
dpc-4157	68	12	one	one	NUM
dpc-4157	68	13	patient	patient	NOUN
dpc-4157	68	14	with	with	ADP
dpc-4157	68	15	lymphedema	lymphedema	NOUN
dpc-4157	68	16	associated	associate	VERB
dpc-4157	68	17	with	with	ADP
dpc-4157	68	18	ks	ks	PROPN
dpc-4157	68	19	.	.	PUNCT
dpc-4157	69	1	the	the	DET
dpc-4157	69	2	procedure	procedure	NOUN
dpc-4157	69	3	was	be	AUX
dpc-4157	69	4	well	well	ADV
dpc-4157	69	5	tolerated	tolerate	VERB
dpc-4157	69	6	by	by	ADP
dpc-4157	69	7	the	the	DET
dpc-4157	69	8	patients	patient	NOUN
dpc-4157	69	9	,	,	PUNCT
dpc-4157	69	10	as	as	SCONJ
dpc-4157	69	11	none	none	NOUN
dpc-4157	69	12	reported	report	VERB
dpc-4157	69	13	pain	pain	NOUN
dpc-4157	69	14	requiring	require	VERB
dpc-4157	69	15	original	original	ADJ
dpc-4157	69	16	article	article	NOUN
dpc-4157	69	17	|	|	ADV
dpc-4157	69	18	dermatol	dermatol	ADJ
dpc-4157	69	19	pract	pract	NOUN
dpc-4157	69	20	concept	concept	NOUN
dpc-4157	69	21	.	.	PUNCT
dpc-4157	70	1	2024;14(2):e2024150	2024;14(2):e2024150	NUM
dpc-4157	70	2	3	3	NUM
dpc-4157	70	3	table	table	NOUN
dpc-4157	70	4	1	1	NUM
dpc-4157	70	5	.	.	PUNCT
dpc-4157	70	6	characteristics	characteristic	NOUN
dpc-4157	70	7	of	of	ADP
dpc-4157	70	8	patients	patient	NOUN
dpc-4157	70	9	.	.	PUNCT
dpc-4157	71	1	patient	patient	ADJ
dpc-4157	71	2	age	age	NOUN
dpc-4157	71	3	sex	sex	NOUN
dpc-4157	71	4	skin	skin	NOUN
dpc-4157	71	5	type	type	NOUN
dpc-4157	71	6	localization	localization	NOUN
dpc-4157	71	7	/	/	SYM
dpc-4157	71	8	number	number	NOUN
dpc-4157	71	9	of	of	ADP
dpc-4157	71	10	nodules	nodule	NOUN
dpc-4157	71	11	mucous	mucous	ADJ
dpc-4157	71	12	/	/	SYM
dpc-4157	71	13	lymph	lymph	NOUN
dpc-4157	71	14	node	node	NOUN
dpc-4157	71	15	/	/	SYM
dpc-4157	71	16	visceral	visceral	ADJ
dpc-4157	71	17	cks	ck	NOUN
dpc-4157	71	18	stage	stage	NOUN
dpc-4157	71	19	*	*	PUNCT
dpc-4157	72	1	disease	disease	NOUN
dpc-4157	72	2	duration/	duration/	NUM
dpc-4157	72	3	previous	previous	ADJ
dpc-4157	72	4	treatments	treatment	NOUN
dpc-4157	72	5	*	*	NOUN
dpc-4157	72	6	*	*	NOUN
dpc-4157	72	7	1	1	NUM
dpc-4157	72	8	57	57	NUM
dpc-4157	72	9	f	f	NOUN
dpc-4157	72	10	2	2	NUM
dpc-4157	72	11	lower	low	ADJ
dpc-4157	72	12	-	-	PUNCT
dpc-4157	72	13	upper	upper	ADJ
dpc-4157	72	14	extremity	extremity	NOUN
dpc-4157	72	15	/	/	SYM
dpc-4157	72	16	18	18	NUM
dpc-4157	72	17	−	−	NUM
dpc-4157	72	18	4	4	NUM
dpc-4157	72	19	5	5	NUM
dpc-4157	72	20	years	year	NOUN
dpc-4157	72	21	/	/	SYM
dpc-4157	72	22	excision	excision	NOUN
dpc-4157	72	23	,	,	PUNCT
dpc-4157	72	24	radiotherapy	radiotherapy	NOUN
dpc-4157	72	25	,	,	PUNCT
dpc-4157	72	26	interferon	interferon	ADJ
dpc-4157	72	27	α-2a	α-2a	NOUN
dpc-4157	72	28	2	2	NUM
dpc-4157	72	29	78	78	NUM
dpc-4157	72	30	m	m	NOUN
dpc-4157	72	31	4	4	NUM
dpc-4157	72	32	lower	low	ADJ
dpc-4157	72	33	-	-	PUNCT
dpc-4157	72	34	upper	upper	ADJ
dpc-4157	72	35	extremity	extremity	NOUN
dpc-4157	72	36	/	/	SYM
dpc-4157	72	37	20	20	NUM
dpc-4157	72	38	/	/	SYM
dpc-4157	72	39	lymphedema	lymphedema	NOUN
dpc-4157	72	40	4	4	NUM
dpc-4157	72	41	7	7	NUM
dpc-4157	72	42	years	year	NOUN
dpc-4157	72	43	/	/	SYM
dpc-4157	72	44	excision	excision	NOUN
dpc-4157	72	45	,	,	PUNCT
dpc-4157	72	46	radiotherapy	radiotherapy	NOUN
dpc-4157	72	47	,	,	PUNCT
dpc-4157	72	48	interferon	interferon	ADJ
dpc-4157	72	49	α-2a	α-2a	NOUN
dpc-4157	72	50	3	3	NUM
dpc-4157	72	51	76	76	NUM
dpc-4157	72	52	m	m	NOUN
dpc-4157	72	53	4	4	NUM
dpc-4157	72	54	lower	low	ADJ
dpc-4157	72	55	-	-	PUNCT
dpc-4157	72	56	upper	upper	ADJ
dpc-4157	72	57	extremity	extremity	NOUN
dpc-4157	72	58	/14	/14	NOUN
dpc-4157	72	59	−	−	NUM
dpc-4157	72	60	4	4	NUM
dpc-4157	72	61	8	8	NUM
dpc-4157	72	62	years	year	NOUN
dpc-4157	72	63	/	/	SYM
dpc-4157	72	64	excision	excision	NOUN
dpc-4157	72	65	,	,	PUNCT
dpc-4157	72	66	radiotherapy	radiotherapy	NOUN
dpc-4157	72	67	,	,	PUNCT
dpc-4157	72	68	interferon	interferon	ADJ
dpc-4157	72	69	α-2a	α-2a	NOUN
dpc-4157	72	70	*	*	PUNCT
dpc-4157	72	71	classic	classic	ADJ
dpc-4157	72	72	kaposi	kaposi	PROPN
dpc-4157	72	73	’s	’s	PART
dpc-4157	72	74	sarcoma	sarcoma	NOUN
dpc-4157	72	75	staging	staging	NOUN
dpc-4157	72	76	was	be	AUX
dpc-4157	72	77	performed	perform	VERB
dpc-4157	72	78	according	accord	VERB
dpc-4157	72	79	to	to	ADP
dpc-4157	72	80	the	the	DET
dpc-4157	72	81	classification	classification	NOUN
dpc-4157	72	82	of	of	ADP
dpc-4157	72	83	brambilla	brambilla	NOUN
dpc-4157	72	84	et	et	PROPN
dpc-4157	72	85	al	al	PROPN
dpc-4157	72	86	.	.	PUNCT
dpc-4157	73	1	[	[	X
dpc-4157	73	2	3	3	NUM
dpc-4157	73	3	]	]	PUNCT
dpc-4157	73	4	.	.	PUNCT
dpc-4157	74	1	*	*	PUNCT
dpc-4157	74	2	*	*	PUNCT
dpc-4157	74	3	in	in	ADP
dpc-4157	74	4	the	the	DET
dpc-4157	74	5	three	three	NUM
dpc-4157	74	6	months	month	NOUN
dpc-4157	74	7	prior	prior	ADV
dpc-4157	74	8	,	,	PUNCT
dpc-4157	74	9	during	during	ADP
dpc-4157	74	10	,	,	PUNCT
dpc-4157	74	11	and	and	CCONJ
dpc-4157	74	12	one	one	NUM
dpc-4157	74	13	year	year	NOUN
dpc-4157	74	14	after	after	ADP
dpc-4157	74	15	laser	laser	NOUN
dpc-4157	74	16	treatment	treatment	NOUN
dpc-4157	74	17	,	,	PUNCT
dpc-4157	74	18	none	none	NOUN
dpc-4157	74	19	of	of	ADP
dpc-4157	74	20	the	the	DET
dpc-4157	74	21	patients	patient	NOUN
dpc-4157	74	22	received	receive	VERB
dpc-4157	74	23	any	any	DET
dpc-4157	74	24	systemic	systemic	ADJ
dpc-4157	74	25	or	or	CCONJ
dpc-4157	74	26	local	local	ADJ
dpc-4157	74	27	treatment	treatment	NOUN
dpc-4157	74	28	.	.	PUNCT
dpc-4157	75	1	cks	ck	NOUN
dpc-4157	75	2	=	=	PUNCT
dpc-4157	75	3	classic	classic	ADJ
dpc-4157	75	4	kaposi	kaposi	PROPN
dpc-4157	75	5	’s	’s	PART
dpc-4157	75	6	sarcoma	sarcoma	NOUN
dpc-4157	75	7	figure	figure	NOUN
dpc-4157	75	8	1	1	NUM
dpc-4157	75	9	.	.	PUNCT
dpc-4157	76	1	clinical	clinical	ADJ
dpc-4157	76	2	manifestations	manifestation	NOUN
dpc-4157	76	3	of	of	ADP
dpc-4157	76	4	lesions	lesion	NOUN
dpc-4157	76	5	before	before	ADP
dpc-4157	76	6	and	and	CCONJ
dpc-4157	76	7	after	after	ADP
dpc-4157	76	8	treatment	treatment	NOUN
dpc-4157	76	9	:	:	PUNCT
dpc-4157	76	10	(	(	PUNCT
dpc-4157	76	11	a	a	PRON
dpc-4157	76	12	,	,	PUNCT
dpc-4157	76	13	b	b	NOUN
dpc-4157	76	14	)	)	PUNCT
dpc-4157	76	15	regression	regression	NOUN
dpc-4157	76	16	of	of	ADP
dpc-4157	76	17	multiple	multiple	ADJ
dpc-4157	76	18	redpurple	redpurple	ADJ
dpc-4157	76	19	papules	papule	NOUN
dpc-4157	76	20	with	with	ADP
dpc-4157	76	21	atrophic	atrophic	ADJ
dpc-4157	76	22	scar	scar	NOUN
dpc-4157	76	23	on	on	ADP
dpc-4157	76	24	left	left	ADJ
dpc-4157	76	25	upper	upper	ADJ
dpc-4157	76	26	leg	leg	NOUN
dpc-4157	76	27	after	after	ADP
dpc-4157	76	28	treatment	treatment	NOUN
dpc-4157	76	29	;	;	PUNCT
dpc-4157	76	30	(	(	PUNCT
dpc-4157	76	31	c	c	X
dpc-4157	76	32	,	,	PUNCT
dpc-4157	76	33	d	d	NOUN
dpc-4157	76	34	)	)	PUNCT
dpc-4157	76	35	regression	regression	NOUN
dpc-4157	76	36	of	of	ADP
dpc-4157	76	37	red	red	ADJ
dpc-4157	76	38	-	-	PUNCT
dpc-4157	76	39	purple	purple	ADJ
dpc-4157	76	40	nodules	nodule	NOUN
dpc-4157	76	41	and	and	CCONJ
dpc-4157	76	42	papules	papule	NOUN
dpc-4157	76	43	on	on	ADP
dpc-4157	76	44	the	the	DET
dpc-4157	76	45	right	right	ADJ
dpc-4157	76	46	upper	upper	ADJ
dpc-4157	76	47	leg	leg	NOUN
dpc-4157	76	48	with	with	ADP
dpc-4157	76	49	atrophic	atrophic	ADJ
dpc-4157	76	50	scarring	scarring	NOUN
dpc-4157	76	51	after	after	ADP
dpc-4157	76	52	treatment	treatment	NOUN
dpc-4157	76	53	.	.	PUNCT
dpc-4157	77	1	4	4	NUM
dpc-4157	77	2	original	original	ADJ
dpc-4157	77	3	article	article	NOUN
dpc-4157	77	4	|	|	ADV
dpc-4157	77	5	dermatol	dermatol	ADJ
dpc-4157	77	6	pract	pract	NOUN
dpc-4157	77	7	concept	concept	NOUN
dpc-4157	77	8	.	.	PUNCT
dpc-4157	78	1	2024;14(2):e2024150	2024;14(2):e2024150	NUM
dpc-4157	78	2	figure	figure	NOUN
dpc-4157	78	3	2	2	NUM
dpc-4157	78	4	.	.	PUNCT
dpc-4157	78	5	dermoscopic	dermoscopic	PROPN
dpc-4157	78	6	findings	finding	NOUN
dpc-4157	78	7	of	of	ADP
dpc-4157	78	8	lesions	lesion	NOUN
dpc-4157	78	9	before	before	ADP
dpc-4157	78	10	and	and	CCONJ
dpc-4157	78	11	after	after	ADP
dpc-4157	78	12	treatment	treatment	NOUN
dpc-4157	78	13	:	:	PUNCT
dpc-4157	78	14	(	(	PUNCT
dpc-4157	78	15	a	a	PRON
dpc-4157	78	16	,	,	PUNCT
dpc-4157	78	17	b	b	NOUN
dpc-4157	78	18	)	)	PUNCT
dpc-4157	78	19	regression	regression	NOUN
dpc-4157	78	20	of	of	ADP
dpc-4157	78	21	nodular	nodular	ADJ
dpc-4157	78	22	lesion	lesion	NOUN
dpc-4157	78	23	with	with	ADP
dpc-4157	78	24	scale	scale	NOUN
dpc-4157	78	25	consisting	consist	VERB
dpc-4157	78	26	of	of	ADP
dpc-4157	78	27	white	white	ADJ
dpc-4157	78	28	-	-	PUNCT
dpc-4157	78	29	blue	blue	ADJ
dpc-4157	78	30	-	-	PUNCT
dpc-4157	78	31	pink	pink	ADJ
dpc-4157	78	32	areas	area	NOUN
dpc-4157	78	33	with	with	ADP
dpc-4157	78	34	a	a	DET
dpc-4157	78	35	polychromatic	polychromatic	ADJ
dpc-4157	78	36	rainbow	rainbow	NOUN
dpc-4157	78	37	pattern	pattern	NOUN
dpc-4157	78	38	and	and	CCONJ
dpc-4157	78	39	surrounded	surround	VERB
dpc-4157	78	40	by	by	ADP
dpc-4157	78	41	a	a	DET
dpc-4157	78	42	sharply	sharply	ADV
dpc-4157	78	43	circumscribed	circumscribed	ADJ
dpc-4157	78	44	brown	brown	ADJ
dpc-4157	78	45	collarette	collarette	NOUN
dpc-4157	78	46	after	after	ADP
dpc-4157	78	47	treatment	treatment	NOUN
dpc-4157	78	48	;	;	PUNCT
dpc-4157	78	49	(	(	PUNCT
dpc-4157	78	50	c	c	X
dpc-4157	78	51	)	)	PUNCT
dpc-4157	78	52	irregular	irregular	ADJ
dpc-4157	78	53	white	white	ADJ
dpc-4157	78	54	clods	clod	NOUN
dpc-4157	78	55	and	and	CCONJ
dpc-4157	78	56	a	a	DET
dpc-4157	78	57	rainbow	rainbow	NOUN
dpc-4157	78	58	pattern	pattern	NOUN
dpc-4157	78	59	in	in	ADP
dpc-4157	78	60	a	a	DET
dpc-4157	78	61	nodular	nodular	ADJ
dpc-4157	78	62	lesion	lesion	NOUN
dpc-4157	78	63	with	with	ADP
dpc-4157	78	64	a	a	DET
dpc-4157	78	65	pink	pink	ADJ
dpc-4157	78	66	-	-	PUNCT
dpc-4157	78	67	white	white	ADJ
dpc-4157	78	68	-	-	PUNCT
dpc-4157	78	69	red	red	ADJ
dpc-4157	78	70	polychromatic	polychromatic	ADJ
dpc-4157	78	71	discoloration	discoloration	NOUN
dpc-4157	78	72	surrounded	surround	VERB
dpc-4157	78	73	by	by	ADP
dpc-4157	78	74	a	a	DET
dpc-4157	78	75	yellow	yellow	ADJ
dpc-4157	78	76	-	-	PUNCT
dpc-4157	78	77	brown	brown	NOUN
dpc-4157	78	78	color	color	NOUN
dpc-4157	78	79	;	;	PUNCT
dpc-4157	78	80	(	(	PUNCT
dpc-4157	78	81	d	d	X
dpc-4157	78	82	)	)	PUNCT
dpc-4157	78	83	atrophic	atrophic	ADJ
dpc-4157	78	84	scarring	scarring	NOUN
dpc-4157	78	85	of	of	ADP
dpc-4157	78	86	this	this	DET
dpc-4157	78	87	lesion	lesion	NOUN
dpc-4157	78	88	after	after	ADP
dpc-4157	78	89	treatment	treatment	NOUN
dpc-4157	78	90	;	;	PUNCT
dpc-4157	78	91	(	(	PUNCT
dpc-4157	78	92	e	e	NOUN
dpc-4157	78	93	)	)	PUNCT
dpc-4157	78	94	white	white	ADJ
dpc-4157	78	95	clods	clod	NOUN
dpc-4157	78	96	consisting	consist	VERB
dpc-4157	78	97	of	of	ADP
dpc-4157	78	98	white	white	ADJ
dpc-4157	78	99	-	-	PUNCT
dpc-4157	78	100	red	red	ADJ
dpc-4157	78	101	-	-	PUNCT
dpc-4157	78	102	pink	pink	ADJ
dpc-4157	78	103	areas	area	NOUN
dpc-4157	78	104	surrounded	surround	VERB
dpc-4157	78	105	by	by	ADP
dpc-4157	78	106	a	a	DET
dpc-4157	78	107	polychromatic	polychromatic	ADJ
dpc-4157	78	108	collarette	collarette	NOUN
dpc-4157	78	109	around	around	ADP
dpc-4157	78	110	the	the	DET
dpc-4157	78	111	hemorrhagic	hemorrhagic	ADJ
dpc-4157	78	112	ulcerated	ulcerated	ADJ
dpc-4157	78	113	area	area	NOUN
dpc-4157	78	114	in	in	ADP
dpc-4157	78	115	the	the	DET
dpc-4157	78	116	central	central	ADJ
dpc-4157	78	117	areas	area	NOUN
dpc-4157	78	118	of	of	ADP
dpc-4157	78	119	irregular	irregular	ADJ
dpc-4157	78	120	white	white	ADJ
dpc-4157	78	121	lines	line	NOUN
dpc-4157	78	122	with	with	ADP
dpc-4157	78	123	scale	scale	NOUN
dpc-4157	78	124	;	;	PUNCT
dpc-4157	78	125	(	(	PUNCT
dpc-4157	78	126	f	f	X
dpc-4157	78	127	)	)	PUNCT
dpc-4157	78	128	mild	mild	ADJ
dpc-4157	78	129	atrophic	atrophic	ADJ
dpc-4157	78	130	scarring	scarring	NOUN
dpc-4157	78	131	of	of	ADP
dpc-4157	78	132	this	this	DET
dpc-4157	78	133	lesion	lesion	NOUN
dpc-4157	78	134	after	after	ADP
dpc-4157	78	135	treatment	treatment	NOUN
dpc-4157	78	136	.	.	PUNCT
dpc-4157	79	1	interruption	interruption	NOUN
dpc-4157	79	2	or	or	CCONJ
dpc-4157	79	3	termination	termination	NOUN
dpc-4157	79	4	of	of	ADP
dpc-4157	79	5	the	the	DET
dpc-4157	79	6	treatment	treatment	NOUN
dpc-4157	79	7	.	.	PUNCT
dpc-4157	80	1	none	none	NOUN
dpc-4157	80	2	of	of	ADP
dpc-4157	80	3	the	the	DET
dpc-4157	80	4	patients	patient	NOUN
dpc-4157	80	5	experienced	experience	VERB
dpc-4157	80	6	any	any	DET
dpc-4157	80	7	treatment	treatment	NOUN
dpc-4157	80	8	-	-	PUNCT
dpc-4157	80	9	related	relate	VERB
dpc-4157	80	10	complications	complication	NOUN
dpc-4157	80	11	,	,	PUNCT
dpc-4157	80	12	including	include	VERB
dpc-4157	80	13	local	local	ADJ
dpc-4157	80	14	wound	wound	NOUN
dpc-4157	80	15	infections	infection	NOUN
dpc-4157	80	16	,	,	PUNCT
dpc-4157	80	17	hypertrophic	hypertrophic	ADJ
dpc-4157	80	18	scarring/	scarring/	NUM
dpc-4157	80	19	keloids	keloid	NOUN
dpc-4157	80	20	,	,	PUNCT
dpc-4157	80	21	pigmentation	pigmentation	NOUN
dpc-4157	80	22	,	,	PUNCT
dpc-4157	80	23	or	or	CCONJ
dpc-4157	80	24	hemorrhage	hemorrhage	NOUN
dpc-4157	80	25	at	at	ADP
dpc-4157	80	26	the	the	DET
dpc-4157	80	27	treatment	treatment	NOUN
dpc-4157	80	28	site	site	NOUN
dpc-4157	80	29	.	.	PUNCT
dpc-4157	81	1	no	no	DET
dpc-4157	81	2	recurrence	recurrence	NOUN
dpc-4157	81	3	was	be	AUX
dpc-4157	81	4	detected	detect	VERB
dpc-4157	81	5	in	in	ADP
dpc-4157	81	6	any	any	PRON
dpc-4157	81	7	of	of	ADP
dpc-4157	81	8	the	the	DET
dpc-4157	81	9	patients	patient	NOUN
dpc-4157	81	10	during	during	ADP
dpc-4157	81	11	the	the	DET
dpc-4157	81	12	1	1	NUM
dpc-4157	81	13	-	-	PUNCT
dpc-4157	81	14	year	year	NOUN
dpc-4157	81	15	follow	follow	NOUN
dpc-4157	81	16	-	-	PUNCT
dpc-4157	81	17	up	up	NOUN
dpc-4157	81	18	.	.	PUNCT
dpc-4157	82	1	discussion	discussion	NOUN
dpc-4157	82	2	ks	ks	PROPN
dpc-4157	82	3	,	,	PUNCT
dpc-4157	82	4	which	which	PRON
dpc-4157	82	5	originates	originate	VERB
dpc-4157	82	6	from	from	ADP
dpc-4157	82	7	vascular	vascular	ADJ
dpc-4157	82	8	and	and	CCONJ
dpc-4157	82	9	lymphatic	lymphatic	ADJ
dpc-4157	82	10	endothelial	endothelial	ADJ
dpc-4157	82	11	structures	structure	NOUN
dpc-4157	82	12	,	,	PUNCT
dpc-4157	82	13	is	be	AUX
dpc-4157	82	14	a	a	DET
dpc-4157	82	15	multisystem	multisystem	NOUN
dpc-4157	82	16	disease	disease	NOUN
dpc-4157	82	17	with	with	ADP
dpc-4157	82	18	prominent	prominent	ADJ
dpc-4157	82	19	skin	skin	NOUN
dpc-4157	82	20	involvement	involvement	NOUN
dpc-4157	82	21	.	.	PUNCT
dpc-4157	83	1	four	four	NUM
dpc-4157	83	2	subtypes	subtype	NOUN
dpc-4157	83	3	of	of	ADP
dpc-4157	83	4	ks	k	NOUN
dpc-4157	83	5	have	have	AUX
dpc-4157	83	6	been	be	AUX
dpc-4157	83	7	defined	define	VERB
dpc-4157	83	8	:	:	PUNCT
dpc-4157	83	9	classic	classic	ADJ
dpc-4157	83	10	,	,	PUNCT
dpc-4157	83	11	endemic	endemic	ADJ
dpc-4157	83	12	,	,	PUNCT
dpc-4157	83	13	iatrogenic	iatrogenic	ADJ
dpc-4157	83	14	,	,	PUNCT
dpc-4157	83	15	and	and	CCONJ
dpc-4157	83	16	aids	aid	NOUN
dpc-4157	83	17	-	-	PUNCT
dpc-4157	83	18	related	relate	VERB
dpc-4157	83	19	.	.	PUNCT
dpc-4157	84	1	in	in	ADP
dpc-4157	84	2	these	these	DET
dpc-4157	84	3	subtypes	subtype	NOUN
dpc-4157	84	4	,	,	PUNCT
dpc-4157	84	5	in	in	ADP
dpc-4157	84	6	which	which	PRON
dpc-4157	84	7	systemic	systemic	ADJ
dpc-4157	84	8	involvement	involvement	NOUN
dpc-4157	84	9	is	be	AUX
dpc-4157	84	10	seen	see	VERB
dpc-4157	84	11	at	at	ADP
dpc-4157	84	12	different	different	ADJ
dpc-4157	84	13	rates	rate	NOUN
dpc-4157	84	14	,	,	PUNCT
dpc-4157	84	15	the	the	DET
dpc-4157	84	16	prognoses	prognosis	NOUN
dpc-4157	84	17	also	also	ADV
dpc-4157	84	18	vary	vary	VERB
dpc-4157	84	19	.	.	PUNCT
dpc-4157	85	1	cks	ck	NOUN
dpc-4157	85	2	is	be	AUX
dpc-4157	85	3	characterized	characterize	VERB
dpc-4157	85	4	by	by	ADP
dpc-4157	85	5	chronic	chronic	ADJ
dpc-4157	85	6	blue-	blue-	NOUN
dpc-4157	85	7	,	,	PUNCT
dpc-4157	85	8	red-	red-	ADJ
dpc-4157	85	9	,	,	PUNCT
dpc-4157	85	10	and	and	CCONJ
dpc-4157	85	11	purple	purple	ADJ
dpc-4157	85	12	-	-	PUNCT
dpc-4157	85	13	colored	color	VERB
dpc-4157	85	14	macular	macular	ADJ
dpc-4157	85	15	papules	papule	NOUN
dpc-4157	85	16	,	,	PUNCT
dpc-4157	85	17	nodules	nodule	NOUN
dpc-4157	85	18	,	,	PUNCT
dpc-4157	85	19	and	and	CCONJ
dpc-4157	85	20	plaques	plaque	NOUN
dpc-4157	85	21	in	in	ADP
dpc-4157	85	22	elderly	elderly	ADJ
dpc-4157	85	23	patients	patient	NOUN
dpc-4157	85	24	,	,	PUNCT
dpc-4157	85	25	and	and	CCONJ
dpc-4157	85	26	ulceration	ulceration	NOUN
dpc-4157	85	27	,	,	PUNCT
dpc-4157	85	28	bleeding	bleeding	NOUN
dpc-4157	85	29	,	,	PUNCT
dpc-4157	85	30	and	and	CCONJ
dpc-4157	85	31	hyperkeratosis	hyperkeratosis	NOUN
dpc-4157	85	32	can	can	AUX
dpc-4157	85	33	be	be	AUX
dpc-4157	85	34	seen	see	VERB
dpc-4157	85	35	in	in	ADP
dpc-4157	85	36	nodular	nodular	ADJ
dpc-4157	85	37	lesions	lesion	NOUN
dpc-4157	86	1	[	[	X
dpc-4157	86	2	2	2	NUM
dpc-4157	86	3	]	]	PUNCT
dpc-4157	86	4	.	.	PUNCT
dpc-4157	87	1	lymphedema	lymphedema	NOUN
dpc-4157	87	2	is	be	AUX
dpc-4157	87	3	observed	observe	VERB
dpc-4157	87	4	in	in	ADP
dpc-4157	87	5	20	20	NUM
dpc-4157	87	6	%	%	NOUN
dpc-4157	87	7	of	of	ADP
dpc-4157	87	8	patients	patient	NOUN
dpc-4157	87	9	with	with	ADP
dpc-4157	87	10	cks	ck	NOUN
dpc-4157	87	11	starting	start	VERB
dpc-4157	87	12	from	from	ADP
dpc-4157	87	13	early	early	ADJ
dpc-4157	87	14	-	-	PUNCT
dpc-4157	87	15	stage	stage	NOUN
dpc-4157	87	16	disease	disease	NOUN
dpc-4157	87	17	,	,	PUNCT
dpc-4157	87	18	and	and	CCONJ
dpc-4157	87	19	it	it	PRON
dpc-4157	87	20	impairs	impair	VERB
dpc-4157	87	21	quality	quality	NOUN
dpc-4157	87	22	of	of	ADP
dpc-4157	87	23	life	life	NOUN
dpc-4157	87	24	[	[	X
dpc-4157	87	25	4	4	NUM
dpc-4157	87	26	]	]	PUNCT
dpc-4157	87	27	.	.	PUNCT
dpc-4157	88	1	skin	skin	NOUN
dpc-4157	88	2	lesions	lesion	NOUN
dpc-4157	88	3	are	be	AUX
dpc-4157	88	4	usually	usually	ADV
dpc-4157	88	5	located	locate	VERB
dpc-4157	88	6	on	on	ADP
dpc-4157	88	7	the	the	DET
dpc-4157	88	8	lower	low	ADJ
dpc-4157	88	9	extremities	extremity	NOUN
dpc-4157	88	10	,	,	PUNCT
dpc-4157	88	11	less	less	ADV
dpc-4157	88	12	frequently	frequently	ADV
dpc-4157	88	13	on	on	ADP
dpc-4157	88	14	the	the	DET
dpc-4157	88	15	upper	upper	ADJ
dpc-4157	88	16	extremities	extremity	NOUN
dpc-4157	88	17	,	,	PUNCT
dpc-4157	88	18	head	head	NOUN
dpc-4157	88	19	,	,	PUNCT
dpc-4157	88	20	and	and	CCONJ
dpc-4157	88	21	body	body	NOUN
dpc-4157	88	22	[	[	X
dpc-4157	88	23	3	3	NUM
dpc-4157	88	24	]	]	PUNCT
dpc-4157	88	25	.	.	PUNCT
dpc-4157	89	1	oral	oral	ADJ
dpc-4157	89	2	,	,	PUNCT
dpc-4157	89	3	genital	genital	ADJ
dpc-4157	89	4	,	,	PUNCT
dpc-4157	89	5	and	and	CCONJ
dpc-4157	89	6	conjunctival	conjunctival	ADJ
dpc-4157	89	7	mucosal	mucosal	NOUN
dpc-4157	89	8	involvement	involvement	NOUN
dpc-4157	89	9	can	can	AUX
dpc-4157	89	10	be	be	AUX
dpc-4157	89	11	seen	see	VERB
dpc-4157	89	12	,	,	PUNCT
dpc-4157	89	13	and	and	CCONJ
dpc-4157	89	14	lymph	lymph	NOUN
dpc-4157	89	15	node	node	NOUN
dpc-4157	89	16	and	and	CCONJ
dpc-4157	89	17	gastrointestinal	gastrointestinal	ADJ
dpc-4157	89	18	involvement	involvement	NOUN
dpc-4157	89	19	can	can	AUX
dpc-4157	89	20	be	be	AUX
dpc-4157	89	21	detected	detect	VERB
dpc-4157	89	22	in	in	ADP
dpc-4157	89	23	advanced	advanced	ADJ
dpc-4157	89	24	cks	ck	NOUN
dpc-4157	90	1	[	[	X
dpc-4157	90	2	3	3	NUM
dpc-4157	90	3	]	]	PUNCT
dpc-4157	90	4	.	.	PUNCT
dpc-4157	91	1	along	along	ADP
dpc-4157	91	2	with	with	ADP
dpc-4157	91	3	clinical	clinical	ADJ
dpc-4157	91	4	findings	finding	NOUN
dpc-4157	91	5	,	,	PUNCT
dpc-4157	91	6	dermoscopic	dermoscopic	PROPN
dpc-4157	91	7	findings	finding	NOUN
dpc-4157	91	8	are	be	AUX
dpc-4157	91	9	also	also	ADV
dpc-4157	91	10	very	very	ADV
dpc-4157	91	11	important	important	ADJ
dpc-4157	91	12	in	in	ADP
dpc-4157	91	13	the	the	DET
dpc-4157	91	14	diagnosis	diagnosis	NOUN
dpc-4157	91	15	and	and	CCONJ
dpc-4157	91	16	follow	follow	VERB
dpc-4157	91	17	-	-	PUNCT
dpc-4157	91	18	up	up	NOUN
dpc-4157	91	19	of	of	ADP
dpc-4157	91	20	the	the	DET
dpc-4157	91	21	disease	disease	NOUN
dpc-4157	91	22	[	[	X
dpc-4157	91	23	5	5	NUM
dpc-4157	91	24	]	]	PUNCT
dpc-4157	91	25	.	.	PUNCT
dpc-4157	92	1	dermoscopic	dermoscopic	PROPN
dpc-4157	92	2	findings	finding	NOUN
dpc-4157	92	3	such	such	ADJ
dpc-4157	92	4	as	as	ADP
dpc-4157	92	5	blue	blue	ADJ
dpc-4157	92	6	,	,	PUNCT
dpc-4157	92	7	purple	purple	ADJ
dpc-4157	92	8	,	,	PUNCT
dpc-4157	92	9	and	and	CCONJ
dpc-4157	92	10	red	red	ADJ
dpc-4157	92	11	areas	area	NOUN
dpc-4157	92	12	,	,	PUNCT
dpc-4157	92	13	rainbow	rainbow	NOUN
dpc-4157	92	14	pattern	pattern	NOUN
dpc-4157	92	15	,	,	PUNCT
dpc-4157	92	16	squam	squam	NOUN
dpc-4157	92	17	on	on	ADP
dpc-4157	92	18	the	the	DET
dpc-4157	92	19	surface	surface	NOUN
dpc-4157	92	20	,	,	PUNCT
dpc-4157	92	21	collar	collar	NOUN
dpc-4157	92	22	sign	sign	NOUN
dpc-4157	92	23	,	,	PUNCT
dpc-4157	92	24	small	small	ADJ
dpc-4157	92	25	brown	brown	ADJ
dpc-4157	92	26	globules	globule	NOUN
dpc-4157	92	27	,	,	PUNCT
dpc-4157	92	28	white	white	ADJ
dpc-4157	92	29	lines	line	NOUN
dpc-4157	92	30	,	,	PUNCT
dpc-4157	92	31	white	white	ADJ
dpc-4157	92	32	globules	globule	NOUN
dpc-4157	92	33	,	,	PUNCT
dpc-4157	92	34	and	and	CCONJ
dpc-4157	92	35	polychromatic	polychromatic	ADJ
dpc-4157	92	36	discoloration	discoloration	NOUN
dpc-4157	92	37	with	with	ADP
dpc-4157	92	38	dotted	dotted	ADJ
dpc-4157	92	39	,	,	PUNCT
dpc-4157	92	40	coiled	coil	VERB
dpc-4157	92	41	,	,	PUNCT
dpc-4157	92	42	and	and	CCONJ
dpc-4157	92	43	curved	curved	ADJ
dpc-4157	92	44	vessels	vessel	NOUN
dpc-4157	92	45	and	and	CCONJ
dpc-4157	92	46	polychromatic	polychromatic	ADJ
dpc-4157	92	47	discoloration	discoloration	NOUN
dpc-4157	92	48	are	be	AUX
dpc-4157	92	49	very	very	ADV
dpc-4157	92	50	helpful	helpful	ADJ
dpc-4157	92	51	in	in	ADP
dpc-4157	92	52	the	the	DET
dpc-4157	92	53	diagnosis	diagnosis	NOUN
dpc-4157	92	54	[	[	X
dpc-4157	92	55	5	5	NUM
dpc-4157	92	56	]	]	PUNCT
dpc-4157	92	57	.	.	PUNCT
dpc-4157	93	1	during	during	ADP
dpc-4157	93	2	pathological	pathological	ADJ
dpc-4157	93	3	examination	examination	NOUN
dpc-4157	93	4	,	,	PUNCT
dpc-4157	93	5	detection	detection	NOUN
dpc-4157	93	6	of	of	ADP
dpc-4157	93	7	hhv8	hhv8	PROPN
dpc-4157	93	8	+	+	CCONJ
dpc-4157	93	9	atypical	atypical	ADJ
dpc-4157	93	10	endothelial	endothelial	ADJ
dpc-4157	93	11	cell	cell	NOUN
dpc-4157	93	12	proliferation	proliferation	NOUN
dpc-4157	93	13	in	in	ADP
dpc-4157	93	14	dilated	dilated	ADJ
dpc-4157	93	15	original	original	ADJ
dpc-4157	93	16	article	article	NOUN
dpc-4157	93	17	|	|	ADV
dpc-4157	93	18	dermatol	dermatol	ADJ
dpc-4157	93	19	pract	pract	NOUN
dpc-4157	93	20	concept	concept	NOUN
dpc-4157	93	21	.	.	PUNCT
dpc-4157	94	1	2024;14(2):e2024150	2024;14(2):e2024150	NUM
dpc-4157	94	2	5	5	NUM
dpc-4157	94	3	destroying	destroy	VERB
dpc-4157	94	4	the	the	DET
dpc-4157	94	5	vascular	vascular	ADJ
dpc-4157	94	6	lesions	lesion	NOUN
dpc-4157	94	7	associated	associate	VERB
dpc-4157	94	8	with	with	ADP
dpc-4157	94	9	cks	ck	NOUN
dpc-4157	94	10	[	[	X
dpc-4157	94	11	9	9	NUM
dpc-4157	94	12	,	,	PUNCT
dpc-4157	94	13	11	11	NUM
dpc-4157	94	14	]	]	PUNCT
dpc-4157	94	15	.	.	PUNCT
dpc-4157	95	1	nd	nd	PRON
dpc-4157	95	2	:	:	PUNCT
dpc-4157	95	3	yag	yag	NOUN
dpc-4157	95	4	laser	laser	NOUN
dpc-4157	95	5	represents	represent	VERB
dpc-4157	95	6	a	a	DET
dpc-4157	95	7	safe	safe	ADJ
dpc-4157	95	8	and	and	CCONJ
dpc-4157	95	9	effective	effective	ADJ
dpc-4157	95	10	option	option	NOUN
dpc-4157	95	11	for	for	ADP
dpc-4157	95	12	patients	patient	NOUN
dpc-4157	95	13	with	with	ADP
dpc-4157	95	14	multiple	multiple	ADJ
dpc-4157	95	15	widespread	widespread	ADJ
dpc-4157	95	16	lesions	lesion	NOUN
dpc-4157	95	17	who	who	PRON
dpc-4157	95	18	are	be	AUX
dpc-4157	95	19	unable	unable	ADJ
dpc-4157	95	20	to	to	PART
dpc-4157	95	21	undergo	undergo	VERB
dpc-4157	95	22	systemic	systemic	ADJ
dpc-4157	95	23	treatment	treatment	NOUN
dpc-4157	95	24	.	.	PUNCT
dpc-4157	96	1	it	it	PRON
dpc-4157	96	2	may	may	AUX
dpc-4157	96	3	even	even	ADV
dpc-4157	96	4	be	be	AUX
dpc-4157	96	5	considered	consider	VERB
dpc-4157	96	6	the	the	DET
dpc-4157	96	7	primary	primary	ADJ
dpc-4157	96	8	choice	choice	NOUN
dpc-4157	96	9	for	for	ADP
dpc-4157	96	10	disseminated	disseminate	VERB
dpc-4157	96	11	disease	disease	NOUN
dpc-4157	96	12	[	[	X
dpc-4157	96	13	9	9	NUM
dpc-4157	96	14	]	]	PUNCT
dpc-4157	96	15	.	.	PUNCT
dpc-4157	97	1	our	our	PRON
dpc-4157	97	2	study	study	NOUN
dpc-4157	97	3	demonstrated	demonstrate	VERB
dpc-4157	97	4	both	both	CCONJ
dpc-4157	97	5	dermoscopic	dermoscopic	ADJ
dpc-4157	97	6	and	and	CCONJ
dpc-4157	97	7	clinical	clinical	ADJ
dpc-4157	97	8	evidence	evidence	NOUN
dpc-4157	97	9	of	of	ADP
dpc-4157	97	10	the	the	DET
dpc-4157	97	11	rapid	rapid	ADJ
dpc-4157	97	12	,	,	PUNCT
dpc-4157	97	13	effective	effective	ADJ
dpc-4157	97	14	,	,	PUNCT
dpc-4157	97	15	and	and	CCONJ
dpc-4157	97	16	safe	safe	ADJ
dpc-4157	97	17	outcomes	outcome	NOUN
dpc-4157	97	18	achieved	achieve	VERB
dpc-4157	97	19	with	with	ADP
dpc-4157	97	20	nd	nd	PRON
dpc-4157	97	21	:	:	PUNCT
dpc-4157	97	22	yag	yag	NOUN
dpc-4157	97	23	laser	laser	NOUN
dpc-4157	97	24	treatment	treatment	NOUN
dpc-4157	97	25	.	.	PUNCT
dpc-4157	98	1	in	in	ADP
dpc-4157	98	2	our	our	PRON
dpc-4157	98	3	cohort	cohort	NOUN
dpc-4157	98	4	of	of	ADP
dpc-4157	98	5	three	three	NUM
dpc-4157	98	6	patients	patient	NOUN
dpc-4157	98	7	with	with	ADP
dpc-4157	98	8	stage	stage	NOUN
dpc-4157	98	9	4	4	NUM
dpc-4157	98	10	cks	ck	NOUN
dpc-4157	98	11	,	,	PUNCT
dpc-4157	98	12	42	42	NUM
dpc-4157	98	13	nodular	nodular	ADJ
dpc-4157	98	14	lesions	lesion	NOUN
dpc-4157	98	15	were	be	AUX
dpc-4157	98	16	treated	treat	VERB
dpc-4157	98	17	with	with	ADP
dpc-4157	98	18	the	the	DET
dpc-4157	98	19	nd	nd	NOUN
dpc-4157	98	20	:	:	PUNCT
dpc-4157	98	21	yag	yag	NOUN
dpc-4157	98	22	laser	laser	NOUN
dpc-4157	98	23	in	in	ADP
dpc-4157	98	24	one	one	NUM
dpc-4157	98	25	or	or	CCONJ
dpc-4157	98	26	two	two	NUM
dpc-4157	98	27	sessions	session	NOUN
dpc-4157	98	28	.	.	PUNCT
dpc-4157	99	1	aside	aside	ADV
dpc-4157	99	2	from	from	ADP
dpc-4157	99	3	mild	mild	ADJ
dpc-4157	99	4	atrophic	atrophic	ADJ
dpc-4157	99	5	scarring	scarring	NOUN
dpc-4157	99	6	,	,	PUNCT
dpc-4157	99	7	no	no	DET
dpc-4157	99	8	other	other	ADJ
dpc-4157	99	9	side	side	NOUN
dpc-4157	99	10	effect	effect	NOUN
dpc-4157	99	11	was	be	AUX
dpc-4157	99	12	observed	observe	VERB
dpc-4157	99	13	in	in	ADP
dpc-4157	99	14	the	the	DET
dpc-4157	99	15	patients	patient	NOUN
dpc-4157	99	16	,	,	PUNCT
dpc-4157	99	17	and	and	CCONJ
dpc-4157	99	18	there	there	PRON
dpc-4157	99	19	were	be	VERB
dpc-4157	99	20	no	no	DET
dpc-4157	99	21	recurrences	recurrence	NOUN
dpc-4157	99	22	during	during	ADP
dpc-4157	99	23	the	the	DET
dpc-4157	99	24	1	1	NUM
dpc-4157	99	25	-	-	PUNCT
dpc-4157	99	26	year	year	NOUN
dpc-4157	99	27	follow	follow	NOUN
dpc-4157	99	28	-	-	PUNCT
dpc-4157	99	29	up	up	NOUN
dpc-4157	99	30	period	period	NOUN
dpc-4157	99	31	.	.	PUNCT
dpc-4157	100	1	these	these	DET
dpc-4157	100	2	findings	finding	NOUN
dpc-4157	100	3	are	be	AUX
dpc-4157	100	4	consistent	consistent	ADJ
dpc-4157	100	5	with	with	ADP
dpc-4157	100	6	studies	study	NOUN
dpc-4157	100	7	conducted	conduct	VERB
dpc-4157	100	8	by	by	ADP
dpc-4157	100	9	özdemir	özdemir	PROPN
dpc-4157	100	10	et	et	PROPN
dpc-4157	100	11	al	al	PROPN
dpc-4157	100	12	.	.	PROPN
dpc-4157	100	13	and	and	CCONJ
dpc-4157	100	14	nasca	nasca	PROPN
dpc-4157	100	15	et	et	PROPN
dpc-4157	100	16	al	al	PROPN
dpc-4157	100	17	.	.	PROPN
dpc-4157	100	18	,	,	PUNCT
dpc-4157	100	19	where	where	SCONJ
dpc-4157	100	20	nd	nd	NOUN
dpc-4157	100	21	:	:	PUNCT
dpc-4157	100	22	yag	yag	NOUN
dpc-4157	100	23	laser	laser	NOUN
dpc-4157	100	24	treatment	treatment	NOUN
dpc-4157	100	25	resulted	result	VERB
dpc-4157	100	26	in	in	ADP
dpc-4157	100	27	healing	healing	NOUN
dpc-4157	100	28	with	with	ADP
dpc-4157	100	29	mild	mild	ADJ
dpc-4157	100	30	atrophic	atrophic	ADJ
dpc-4157	100	31	scarring	scarring	NOUN
dpc-4157	100	32	,	,	PUNCT
dpc-4157	100	33	no	no	DET
dpc-4157	100	34	other	other	ADJ
dpc-4157	100	35	side	side	NOUN
dpc-4157	100	36	effects	effect	NOUN
dpc-4157	100	37	,	,	PUNCT
dpc-4157	100	38	and	and	CCONJ
dpc-4157	100	39	no	no	DET
dpc-4157	100	40	recurrence	recurrence	NOUN
dpc-4157	100	41	in	in	ADP
dpc-4157	100	42	follow	follow	NOUN
dpc-4157	100	43	-	-	PUNCT
dpc-4157	100	44	up	up	ADP
dpc-4157	100	45	periods	period	NOUN
dpc-4157	100	46	of	of	ADP
dpc-4157	100	47	six	six	NUM
dpc-4157	100	48	months	month	NOUN
dpc-4157	100	49	and	and	CCONJ
dpc-4157	100	50	one	one	NUM
dpc-4157	100	51	year	year	NOUN
dpc-4157	100	52	,	,	PUNCT
dpc-4157	100	53	respectively	respectively	ADV
dpc-4157	100	54	[	[	X
dpc-4157	100	55	9	9	NUM
dpc-4157	100	56	,	,	PUNCT
dpc-4157	100	57	12	12	NUM
dpc-4157	100	58	]	]	PUNCT
dpc-4157	100	59	.	.	PUNCT
dpc-4157	101	1	another	another	DET
dpc-4157	101	2	study	study	NOUN
dpc-4157	101	3	by	by	ADP
dpc-4157	101	4	silvestri	silvestri	PROPN
dpc-4157	101	5	et	et	PROPN
dpc-4157	101	6	al	al	PROPN
dpc-4157	101	7	.	.	PROPN
dpc-4157	101	8	explored	explore	VERB
dpc-4157	101	9	the	the	DET
dpc-4157	101	10	efficacy	efficacy	NOUN
dpc-4157	101	11	of	of	ADP
dpc-4157	101	12	nd	nd	ADP
dpc-4157	101	13	:	:	PUNCT
dpc-4157	101	14	yag	yag	NOUN
dpc-4157	101	15	laser	laser	NOUN
dpc-4157	101	16	treatment	treatment	NOUN
dpc-4157	101	17	in	in	ADP
dpc-4157	101	18	patients	patient	NOUN
dpc-4157	101	19	with	with	ADP
dpc-4157	101	20	stage	stage	NOUN
dpc-4157	101	21	1–2	1–2	NUM
dpc-4157	101	22	cks	ck	NOUN
dpc-4157	101	23	skin	skin	NOUN
dpc-4157	101	24	lesions	lesion	NOUN
dpc-4157	101	25	and	and	CCONJ
dpc-4157	101	26	aids	aid	NOUN
dpc-4157	101	27	-	-	PUNCT
dpc-4157	101	28	related	relate	VERB
dpc-4157	101	29	ks	ks	NOUN
dpc-4157	101	30	lesions	lesion	NOUN
dpc-4157	101	31	(	(	PUNCT
dpc-4157	101	32	epidemic	epidemic	NOUN
dpc-4157	101	33	form	form	NOUN
dpc-4157	101	34	)	)	PUNCT
dpc-4157	101	35	receiving	receive	VERB
dpc-4157	101	36	antiretroviral	antiretroviral	ADJ
dpc-4157	101	37	therapy	therapy	NOUN
dpc-4157	101	38	[	[	X
dpc-4157	101	39	10	10	NUM
dpc-4157	101	40	]	]	PUNCT
dpc-4157	101	41	.	.	PUNCT
dpc-4157	102	1	the	the	DET
dpc-4157	102	2	treatment	treatment	NOUN
dpc-4157	102	3	was	be	AUX
dpc-4157	102	4	effective	effective	ADJ
dpc-4157	102	5	in	in	ADP
dpc-4157	102	6	80	80	NUM
dpc-4157	102	7	%	%	NOUN
dpc-4157	102	8	of	of	ADP
dpc-4157	102	9	the	the	DET
dpc-4157	102	10	patients	patient	NOUN
dpc-4157	102	11	,	,	PUNCT
dpc-4157	102	12	with	with	ADP
dpc-4157	102	13	minimal	minimal	ADJ
dpc-4157	102	14	side	side	NOUN
dpc-4157	102	15	effects	effect	NOUN
dpc-4157	102	16	such	such	ADJ
dpc-4157	102	17	as	as	ADP
dpc-4157	102	18	post	post	ADJ
dpc-4157	102	19	-	-	ADJ
dpc-4157	102	20	inflammatory	inflammatory	ADJ
dpc-4157	102	21	hyperpigmentation	hyperpigmentation	NOUN
dpc-4157	102	22	and	and	CCONJ
dpc-4157	102	23	mild	mild	ADJ
dpc-4157	102	24	hypotrophic	hypotrophic	ADJ
dpc-4157	102	25	scars	scar	NOUN
dpc-4157	102	26	[	[	X
dpc-4157	102	27	10	10	NUM
dpc-4157	102	28	]	]	PUNCT
dpc-4157	102	29	.	.	PUNCT
dpc-4157	103	1	similar	similar	ADJ
dpc-4157	103	2	to	to	ADP
dpc-4157	103	3	our	our	PRON
dpc-4157	103	4	findings	finding	NOUN
dpc-4157	103	5	,	,	PUNCT
dpc-4157	103	6	nd	nd	PRON
dpc-4157	103	7	:	:	PUNCT
dpc-4157	103	8	yag	yag	NOUN
dpc-4157	103	9	laser	laser	NOUN
dpc-4157	103	10	therapy	therapy	NOUN
dpc-4157	103	11	was	be	AUX
dpc-4157	103	12	deemed	deem	VERB
dpc-4157	103	13	a	a	DET
dpc-4157	103	14	safe	safe	ADJ
dpc-4157	103	15	and	and	CCONJ
dpc-4157	103	16	effective	effective	ADJ
dpc-4157	103	17	treatment	treatment	NOUN
dpc-4157	103	18	option	option	NOUN
dpc-4157	103	19	.	.	PUNCT
dpc-4157	104	1	notably	notably	ADV
dpc-4157	104	2	,	,	PUNCT
dpc-4157	104	3	a	a	DET
dpc-4157	104	4	reduction	reduction	NOUN
dpc-4157	104	5	in	in	ADP
dpc-4157	104	6	lymphedema	lymphedema	NOUN
dpc-4157	104	7	has	have	AUX
dpc-4157	104	8	been	be	AUX
dpc-4157	104	9	reported	report	VERB
dpc-4157	104	10	in	in	ADP
dpc-4157	104	11	the	the	DET
dpc-4157	104	12	literature	literature	NOUN
dpc-4157	104	13	in	in	ADP
dpc-4157	104	14	two	two	NUM
dpc-4157	104	15	cks	ck	NOUN
dpc-4157	104	16	patients	patient	NOUN
dpc-4157	104	17	following	follow	VERB
dpc-4157	104	18	nd	nd	ADP
dpc-4157	104	19	:	:	PUNCT
dpc-4157	104	20	yag	yag	NOUN
dpc-4157	104	21	laser	laser	NOUN
dpc-4157	104	22	therapy	therapy	NOUN
dpc-4157	104	23	[	[	X
dpc-4157	104	24	9	9	NUM
dpc-4157	104	25	,	,	PUNCT
dpc-4157	104	26	13	13	NUM
dpc-4157	104	27	]	]	PUNCT
dpc-4157	104	28	.	.	PUNCT
dpc-4157	105	1	consistent	consistent	ADJ
dpc-4157	105	2	with	with	ADP
dpc-4157	105	3	these	these	DET
dpc-4157	105	4	reports	report	NOUN
dpc-4157	105	5	,	,	PUNCT
dpc-4157	105	6	our	our	PRON
dpc-4157	105	7	study	study	NOUN
dpc-4157	105	8	also	also	ADV
dpc-4157	105	9	observed	observe	VERB
dpc-4157	105	10	a	a	DET
dpc-4157	105	11	decrease	decrease	NOUN
dpc-4157	105	12	in	in	ADP
dpc-4157	105	13	lymphedema	lymphedema	NOUN
dpc-4157	105	14	in	in	ADP
dpc-4157	105	15	one	one	NUM
dpc-4157	105	16	patient	patient	NOUN
dpc-4157	105	17	.	.	PUNCT
dpc-4157	106	1	however	however	ADV
dpc-4157	106	2	,	,	PUNCT
dpc-4157	106	3	it	it	PRON
dpc-4157	106	4	is	be	AUX
dpc-4157	106	5	important	important	ADJ
dpc-4157	106	6	to	to	PART
dpc-4157	106	7	note	note	VERB
dpc-4157	106	8	that	that	SCONJ
dpc-4157	106	9	the	the	DET
dpc-4157	106	10	small	small	ADJ
dpc-4157	106	11	sample	sample	NOUN
dpc-4157	106	12	size	size	NOUN
dpc-4157	106	13	of	of	ADP
dpc-4157	106	14	our	our	PRON
dpc-4157	106	15	study	study	NOUN
dpc-4157	106	16	represents	represent	VERB
dpc-4157	106	17	a	a	DET
dpc-4157	106	18	limitation	limitation	NOUN
dpc-4157	106	19	.	.	PUNCT
dpc-4157	107	1	this	this	DET
dpc-4157	107	2	effect	effect	NOUN
dpc-4157	107	3	may	may	AUX
dpc-4157	107	4	be	be	AUX
dpc-4157	107	5	attributed	attribute	VERB
dpc-4157	107	6	to	to	ADP
dpc-4157	107	7	the	the	DET
dpc-4157	107	8	modulation	modulation	NOUN
dpc-4157	107	9	of	of	ADP
dpc-4157	107	10	cytokine	cytokine	ADJ
dpc-4157	107	11	balance	balance	NOUN
dpc-4157	107	12	and	and	CCONJ
dpc-4157	107	13	increased	increase	VERB
dpc-4157	107	14	lymphatic	lymphatic	ADJ
dpc-4157	107	15	circulation	circulation	NOUN
dpc-4157	107	16	,	,	PUNCT
dpc-4157	107	17	mediated	mediate	VERB
dpc-4157	107	18	by	by	ADP
dpc-4157	107	19	tissue	tissue	NOUN
dpc-4157	107	20	hypoxia	hypoxia	NOUN
dpc-4157	107	21	-	-	PUNCT
dpc-4157	107	22	induced	induce	VERB
dpc-4157	107	23	elevation	elevation	NOUN
dpc-4157	107	24	of	of	ADP
dpc-4157	107	25	vegf	vegf	PROPN
dpc-4157	107	26	levels	level	NOUN
dpc-4157	107	27	[	[	X
dpc-4157	107	28	14	14	NUM
dpc-4157	107	29	]	]	PUNCT
dpc-4157	107	30	.	.	PUNCT
dpc-4157	108	1	conclusions	conclusion	NOUN
dpc-4157	108	2	in	in	ADP
dpc-4157	108	3	summary	summary	NOUN
dpc-4157	108	4	,	,	PUNCT
dpc-4157	108	5	our	our	PRON
dpc-4157	108	6	study	study	NOUN
dpc-4157	108	7	,	,	PUNCT
dpc-4157	108	8	along	along	ADP
dpc-4157	108	9	with	with	ADP
dpc-4157	108	10	previous	previous	ADJ
dpc-4157	108	11	literature	literature	NOUN
dpc-4157	108	12	,	,	PUNCT
dpc-4157	108	13	supports	support	VERB
dpc-4157	108	14	the	the	DET
dpc-4157	108	15	use	use	NOUN
dpc-4157	108	16	of	of	ADP
dpc-4157	108	17	nd	nd	ADP
dpc-4157	108	18	:	:	PUNCT
dpc-4157	108	19	yag	yag	NOUN
dpc-4157	108	20	laser	laser	NOUN
dpc-4157	108	21	therapy	therapy	NOUN
dpc-4157	108	22	as	as	ADP
dpc-4157	108	23	a	a	DET
dpc-4157	108	24	rapid	rapid	ADJ
dpc-4157	108	25	,	,	PUNCT
dpc-4157	108	26	effective	effective	ADJ
dpc-4157	108	27	,	,	PUNCT
dpc-4157	108	28	and	and	CCONJ
dpc-4157	108	29	safe	safe	ADJ
dpc-4157	108	30	treatment	treatment	NOUN
dpc-4157	108	31	option	option	NOUN
dpc-4157	108	32	for	for	ADP
dpc-4157	108	33	cks	ck	NOUN
dpc-4157	108	34	.	.	PUNCT
dpc-4157	109	1	the	the	DET
dpc-4157	109	2	treatment	treatment	NOUN
dpc-4157	109	3	demonstrates	demonstrate	VERB
dpc-4157	109	4	favorable	favorable	ADJ
dpc-4157	109	5	outcomes	outcome	NOUN
dpc-4157	109	6	,	,	PUNCT
dpc-4157	109	7	with	with	ADP
dpc-4157	109	8	minimal	minimal	ADJ
dpc-4157	109	9	side	side	NOUN
dpc-4157	109	10	effects	effect	NOUN
dpc-4157	109	11	and	and	CCONJ
dpc-4157	109	12	no	no	DET
dpc-4157	109	13	recurrence	recurrence	NOUN
dpc-4157	109	14	.	.	PUNCT
dpc-4157	110	1	additionally	additionally	ADV
dpc-4157	110	2	,	,	PUNCT
dpc-4157	110	3	nd	nd	PRON
dpc-4157	110	4	:	:	PUNCT
dpc-4157	110	5	yag	yag	NOUN
dpc-4157	110	6	laser	laser	NOUN
dpc-4157	110	7	therapy	therapy	NOUN
dpc-4157	110	8	may	may	AUX
dpc-4157	110	9	contribute	contribute	VERB
dpc-4157	110	10	to	to	ADP
dpc-4157	110	11	reducing	reduce	VERB
dpc-4157	110	12	lymphedema	lymphedema	NOUN
dpc-4157	110	13	in	in	ADP
dpc-4157	110	14	cks	ck	NOUN
dpc-4157	110	15	patients	patient	NOUN
dpc-4157	110	16	through	through	ADP
dpc-4157	110	17	its	its	PRON
dpc-4157	110	18	impact	impact	NOUN
dpc-4157	110	19	on	on	ADP
dpc-4157	110	20	cytokine	cytokine	ADJ
dpc-4157	110	21	balance	balance	NOUN
dpc-4157	110	22	and	and	CCONJ
dpc-4157	110	23	increased	increase	VERB
dpc-4157	110	24	lymphatic	lymphatic	ADJ
dpc-4157	110	25	circulation	circulation	NOUN
dpc-4157	110	26	[	[	X
dpc-4157	110	27	13	13	NUM
dpc-4157	110	28	]	]	PUNCT
dpc-4157	110	29	.	.	PUNCT
dpc-4157	111	1	our	our	PRON
dpc-4157	111	2	study	study	NOUN
dpc-4157	111	3	provides	provide	VERB
dpc-4157	111	4	evidence	evidence	NOUN
dpc-4157	111	5	of	of	ADP
dpc-4157	111	6	the	the	DET
dpc-4157	111	7	effectiveness	effectiveness	NOUN
dpc-4157	111	8	and	and	CCONJ
dpc-4157	111	9	safety	safety	NOUN
dpc-4157	111	10	of	of	ADP
dpc-4157	111	11	nd	nd	PRON
dpc-4157	111	12	:	:	PUNCT
dpc-4157	111	13	yag	yag	NOUN
dpc-4157	111	14	laser	laser	NOUN
dpc-4157	111	15	therapy	therapy	NOUN
dpc-4157	111	16	for	for	ADP
dpc-4157	111	17	stage	stage	NOUN
dpc-4157	111	18	4	4	NUM
dpc-4157	111	19	cks	ck	NOUN
dpc-4157	111	20	,	,	PUNCT
dpc-4157	111	21	supported	support	VERB
dpc-4157	111	22	by	by	ADP
dpc-4157	111	23	dermoscopic	dermoscopic	NOUN
dpc-4157	111	24	findings	finding	NOUN
dpc-4157	111	25	.	.	PUNCT
dpc-4157	112	1	nd	nd	X
dpc-4157	112	2	:	:	PUNCT
dpc-4157	112	3	yag	yag	NOUN
dpc-4157	112	4	laser	laser	NOUN
dpc-4157	112	5	treatment	treatment	NOUN
dpc-4157	112	6	can	can	AUX
dpc-4157	112	7	be	be	AUX
dpc-4157	112	8	a	a	DET
dpc-4157	112	9	valuable	valuable	ADJ
dpc-4157	112	10	therapeutic	therapeutic	ADJ
dpc-4157	112	11	option	option	NOUN
dpc-4157	112	12	for	for	ADP
dpc-4157	112	13	both	both	DET
dpc-4157	112	14	earlyand	earlyand	NOUN
dpc-4157	112	15	advanced	advanced	ADJ
dpc-4157	112	16	-	-	PUNCT
dpc-4157	112	17	stage	stage	NOUN
dpc-4157	112	18	cks	ck	NOUN
dpc-4157	112	19	,	,	PUNCT
dpc-4157	112	20	particularly	particularly	ADV
dpc-4157	112	21	in	in	ADP
dpc-4157	112	22	cases	case	NOUN
dpc-4157	112	23	of	of	ADP
dpc-4157	112	24	resistant	resistant	ADJ
dpc-4157	112	25	skin	skin	NOUN
dpc-4157	112	26	lesions	lesion	NOUN
dpc-4157	112	27	or	or	CCONJ
dpc-4157	112	28	patients	patient	NOUN
dpc-4157	112	29	vascular	vascular	VERB
dpc-4157	112	30	structures	structure	NOUN
dpc-4157	112	31	and	and	CCONJ
dpc-4157	112	32	spindle	spindle	NOUN
dpc-4157	112	33	-	-	PUNCT
dpc-4157	112	34	cell	cell	NOUN
dpc-4157	112	35	infiltration	infiltration	NOUN
dpc-4157	112	36	in	in	ADP
dpc-4157	112	37	the	the	DET
dpc-4157	112	38	dermis	dermis	NOUN
dpc-4157	112	39	is	be	AUX
dpc-4157	112	40	diagnostic	diagnostic	ADJ
dpc-4157	112	41	[	[	X
dpc-4157	112	42	6	6	NUM
dpc-4157	112	43	]	]	PUNCT
dpc-4157	112	44	.	.	PUNCT
dpc-4157	113	1	hhv8	hhv8	PROPN
dpc-4157	113	2	,	,	PUNCT
dpc-4157	113	3	which	which	PRON
dpc-4157	113	4	is	be	AUX
dpc-4157	113	5	responsible	responsible	ADJ
dpc-4157	113	6	for	for	ADP
dpc-4157	113	7	the	the	DET
dpc-4157	113	8	pathogenesis	pathogenesis	NOUN
dpc-4157	113	9	of	of	ADP
dpc-4157	113	10	cks	ck	NOUN
dpc-4157	113	11	,	,	PUNCT
dpc-4157	113	12	remains	remain	VERB
dpc-4157	113	13	in	in	ADP
dpc-4157	113	14	endothelial	endothelial	ADJ
dpc-4157	113	15	cells	cell	NOUN
dpc-4157	113	16	in	in	ADP
dpc-4157	113	17	the	the	DET
dpc-4157	113	18	latent	latent	NOUN
dpc-4157	113	19	phase	phase	NOUN
dpc-4157	113	20	after	after	ADP
dpc-4157	113	21	infection	infection	NOUN
dpc-4157	113	22	,	,	PUNCT
dpc-4157	113	23	passes	pass	VERB
dpc-4157	113	24	into	into	ADP
dpc-4157	113	25	the	the	DET
dpc-4157	113	26	lytic	lytic	ADJ
dpc-4157	113	27	phase	phase	NOUN
dpc-4157	113	28	in	in	ADP
dpc-4157	113	29	certain	certain	ADJ
dpc-4157	113	30	cases	case	NOUN
dpc-4157	113	31	,	,	PUNCT
dpc-4157	113	32	such	such	ADJ
dpc-4157	113	33	as	as	ADP
dpc-4157	113	34	hypoxia	hypoxia	NOUN
dpc-4157	113	35	,	,	PUNCT
dpc-4157	113	36	viral	viral	ADJ
dpc-4157	113	37	infection	infection	NOUN
dpc-4157	113	38	,	,	PUNCT
dpc-4157	113	39	and	and	CCONJ
dpc-4157	113	40	immunosuppression	immunosuppression	NOUN
dpc-4157	113	41	,	,	PUNCT
dpc-4157	113	42	causing	cause	VERB
dpc-4157	113	43	clinical	clinical	ADJ
dpc-4157	113	44	findings	finding	NOUN
dpc-4157	113	45	of	of	ADP
dpc-4157	113	46	ks	ks	PROPN
dpc-4157	113	47	[	[	X
dpc-4157	113	48	7	7	NUM
dpc-4157	113	49	]	]	PUNCT
dpc-4157	113	50	.	.	PUNCT
dpc-4157	114	1	currently	currently	ADV
dpc-4157	114	2	,	,	PUNCT
dpc-4157	114	3	there	there	PRON
dpc-4157	114	4	is	be	VERB
dpc-4157	114	5	no	no	DET
dpc-4157	114	6	curative	curative	ADJ
dpc-4157	114	7	treatment	treatment	NOUN
dpc-4157	114	8	for	for	ADP
dpc-4157	114	9	ks	ks	NOUN
dpc-4157	114	10	as	as	SCONJ
dpc-4157	114	11	there	there	PRON
dpc-4157	114	12	is	be	VERB
dpc-4157	114	13	no	no	DET
dpc-4157	114	14	treatment	treatment	NOUN
dpc-4157	114	15	to	to	PART
dpc-4157	114	16	eliminate	eliminate	VERB
dpc-4157	114	17	hhv8	hhv8	PROPN
dpc-4157	114	18	infection	infection	NOUN
dpc-4157	114	19	,	,	PUNCT
dpc-4157	114	20	and	and	CCONJ
dpc-4157	114	21	there	there	PRON
dpc-4157	114	22	is	be	VERB
dpc-4157	114	23	no	no	DET
dpc-4157	114	24	randomized	randomized	ADJ
dpc-4157	114	25	controlled	control	VERB
dpc-4157	114	26	trial	trial	NOUN
dpc-4157	114	27	for	for	ADP
dpc-4157	114	28	treatment	treatment	NOUN
dpc-4157	114	29	.	.	PUNCT
dpc-4157	115	1	in	in	ADP
dpc-4157	115	2	the	the	DET
dpc-4157	115	3	selection	selection	NOUN
dpc-4157	115	4	of	of	ADP
dpc-4157	115	5	treatment	treatment	NOUN
dpc-4157	115	6	,	,	PUNCT
dpc-4157	115	7	the	the	DET
dpc-4157	115	8	individual	individual	NOUN
dpc-4157	115	9	’s	’s	PART
dpc-4157	115	10	ks	ks	NOUN
dpc-4157	115	11	subtype	subtype	NOUN
dpc-4157	115	12	,	,	PUNCT
dpc-4157	115	13	clinical	clinical	ADJ
dpc-4157	115	14	features	feature	NOUN
dpc-4157	115	15	/	/	SYM
dpc-4157	115	16	extent	extent	NOUN
dpc-4157	115	17	of	of	ADP
dpc-4157	115	18	lesions	lesion	NOUN
dpc-4157	115	19	,	,	PUNCT
dpc-4157	115	20	immune	immune	ADJ
dpc-4157	115	21	system	system	NOUN
dpc-4157	115	22	,	,	PUNCT
dpc-4157	115	23	comorbidities	comorbiditie	NOUN
dpc-4157	115	24	,	,	PUNCT
dpc-4157	115	25	and	and	CCONJ
dpc-4157	115	26	symptoms	symptom	NOUN
dpc-4157	115	27	should	should	AUX
dpc-4157	115	28	be	be	AUX
dpc-4157	115	29	considered	consider	VERB
dpc-4157	115	30	[	[	PUNCT
dpc-4157	115	31	2	2	NUM
dpc-4157	115	32	]	]	PUNCT
dpc-4157	115	33	.	.	PUNCT
dpc-4157	116	1	pegylated	pegylate	VERB
dpc-4157	116	2	liposomal	liposomal	ADJ
dpc-4157	116	3	doxorubicin	doxorubicin	PROPN
dpc-4157	116	4	,	,	PUNCT
dpc-4157	116	5	paclitaxel	paclitaxel	NOUN
dpc-4157	116	6	,	,	PUNCT
dpc-4157	116	7	pomalidomide	pomalidomide	NOUN
dpc-4157	116	8	,	,	PUNCT
dpc-4157	116	9	etoposide	etoposide	NOUN
dpc-4157	116	10	,	,	PUNCT
dpc-4157	116	11	vinblastine	vinblastine	NOUN
dpc-4157	116	12	or	or	CCONJ
dpc-4157	116	13	vincristine	vincristine	NOUN
dpc-4157	116	14	,	,	PUNCT
dpc-4157	116	15	bleomycin	bleomycin	PROPN
dpc-4157	116	16	,	,	PUNCT
dpc-4157	116	17	gemcitabine	gemcitabine	NOUN
dpc-4157	116	18	,	,	PUNCT
dpc-4157	116	19	rapamycin	rapamycin	NOUN
dpc-4157	116	20	,	,	PUNCT
dpc-4157	116	21	and	and	CCONJ
dpc-4157	116	22	antiangiogenic	antiangiogenic	ADJ
dpc-4157	116	23	agents	agent	NOUN
dpc-4157	116	24	are	be	AUX
dpc-4157	116	25	systemic	systemic	ADJ
dpc-4157	116	26	treatments	treatment	NOUN
dpc-4157	116	27	that	that	PRON
dpc-4157	116	28	can	can	AUX
dpc-4157	116	29	be	be	AUX
dpc-4157	116	30	used	use	VERB
dpc-4157	116	31	in	in	ADP
dpc-4157	116	32	the	the	DET
dpc-4157	116	33	presence	presence	NOUN
dpc-4157	116	34	of	of	ADP
dpc-4157	116	35	rapidly	rapidly	ADV
dpc-4157	116	36	progressive	progressive	ADJ
dpc-4157	116	37	,	,	PUNCT
dpc-4157	116	38	visceral	visceral	ADJ
dpc-4157	116	39	involvement	involvement	NOUN
dpc-4157	116	40	,	,	PUNCT
dpc-4157	116	41	widespread	widespread	ADJ
dpc-4157	116	42	involvement	involvement	NOUN
dpc-4157	116	43	of	of	ADP
dpc-4157	116	44	most	most	ADJ
dpc-4157	116	45	of	of	ADP
dpc-4157	116	46	the	the	DET
dpc-4157	116	47	extremities	extremity	NOUN
dpc-4157	116	48	,	,	PUNCT
dpc-4157	116	49	and	and	CCONJ
dpc-4157	116	50	severe	severe	ADJ
dpc-4157	116	51	lymphedema	lymphedema	NOUN
dpc-4157	116	52	.	.	PUNCT
dpc-4157	117	1	however	however	ADV
dpc-4157	117	2	,	,	PUNCT
dpc-4157	117	3	the	the	DET
dpc-4157	117	4	use	use	NOUN
dpc-4157	117	5	of	of	ADP
dpc-4157	117	6	systemic	systemic	ADJ
dpc-4157	117	7	treatments	treatment	NOUN
dpc-4157	117	8	is	be	AUX
dpc-4157	117	9	limited	limit	VERB
dpc-4157	117	10	because	because	SCONJ
dpc-4157	117	11	of	of	ADP
dpc-4157	117	12	their	their	PRON
dpc-4157	117	13	side	side	NOUN
dpc-4157	117	14	effects	effect	NOUN
dpc-4157	117	15	,	,	PUNCT
dpc-4157	117	16	and	and	CCONJ
dpc-4157	117	17	these	these	DET
dpc-4157	117	18	aggressive	aggressive	ADJ
dpc-4157	117	19	treatments	treatment	NOUN
dpc-4157	117	20	should	should	AUX
dpc-4157	117	21	not	not	PART
dpc-4157	117	22	be	be	AUX
dpc-4157	117	23	given	give	VERB
dpc-4157	117	24	to	to	ADP
dpc-4157	117	25	patients	patient	NOUN
dpc-4157	117	26	in	in	ADP
dpc-4157	117	27	the	the	DET
dpc-4157	117	28	early	early	ADJ
dpc-4157	117	29	stage	stage	NOUN
dpc-4157	117	30	with	with	ADP
dpc-4157	117	31	limited	limited	ADJ
dpc-4157	117	32	skin	skin	NOUN
dpc-4157	117	33	disease	disease	NOUN
dpc-4157	118	1	[	[	X
dpc-4157	118	2	2	2	NUM
dpc-4157	118	3	,	,	PUNCT
dpc-4157	118	4	7	7	NUM
dpc-4157	118	5	]	]	PUNCT
dpc-4157	118	6	.	.	PUNCT
dpc-4157	119	1	the	the	DET
dpc-4157	119	2	primary	primary	ADJ
dpc-4157	119	3	treatment	treatment	NOUN
dpc-4157	119	4	goals	goal	NOUN
dpc-4157	119	5	for	for	ADP
dpc-4157	119	6	cks	ck	NOUN
dpc-4157	119	7	should	should	AUX
dpc-4157	119	8	be	be	AUX
dpc-4157	119	9	to	to	PART
dpc-4157	119	10	pursue	pursue	VERB
dpc-4157	119	11	a	a	DET
dpc-4157	119	12	palliative	palliative	ADJ
dpc-4157	119	13	approach	approach	NOUN
dpc-4157	119	14	to	to	PART
dpc-4157	119	15	alleviate	alleviate	VERB
dpc-4157	119	16	lymphedema	lymphedema	NOUN
dpc-4157	119	17	,	,	PUNCT
dpc-4157	119	18	reduce	reduce	VERB
dpc-4157	119	19	the	the	DET
dpc-4157	119	20	size	size	NOUN
dpc-4157	119	21	of	of	ADP
dpc-4157	119	22	cutaneous	cutaneous	ADJ
dpc-4157	119	23	lesions	lesion	NOUN
dpc-4157	119	24	,	,	PUNCT
dpc-4157	119	25	and	and	CCONJ
dpc-4157	119	26	stop	stop	VERB
dpc-4157	119	27	or	or	CCONJ
dpc-4157	119	28	delay	delay	VERB
dpc-4157	119	29	disease	disease	NOUN
dpc-4157	119	30	progression	progression	NOUN
dpc-4157	119	31	.	.	PUNCT
dpc-4157	120	1	for	for	ADP
dpc-4157	120	2	this	this	DET
dpc-4157	120	3	purpose	purpose	NOUN
dpc-4157	120	4	,	,	PUNCT
dpc-4157	120	5	local	local	ADJ
dpc-4157	120	6	treatments	treatment	NOUN
dpc-4157	120	7	,	,	PUNCT
dpc-4157	120	8	such	such	ADJ
dpc-4157	120	9	as	as	ADP
dpc-4157	120	10	elastocompression	elastocompression	NOUN
dpc-4157	120	11	,	,	PUNCT
dpc-4157	120	12	surgical	surgical	ADJ
dpc-4157	120	13	excision	excision	NOUN
dpc-4157	120	14	,	,	PUNCT
dpc-4157	120	15	cryotherapy	cryotherapy	NOUN
dpc-4157	120	16	,	,	PUNCT
dpc-4157	120	17	radiotherapy	radiotherapy	NOUN
dpc-4157	120	18	,	,	PUNCT
dpc-4157	120	19	and	and	CCONJ
dpc-4157	120	20	intralesional	intralesional	ADJ
dpc-4157	120	21	chemotherapies	chemotherapy	NOUN
dpc-4157	120	22	,	,	PUNCT
dpc-4157	120	23	should	should	AUX
dpc-4157	120	24	be	be	AUX
dpc-4157	120	25	preferred	prefer	VERB
dpc-4157	120	26	[	[	X
dpc-4157	120	27	3	3	NUM
dpc-4157	120	28	]	]	PUNCT
dpc-4157	120	29	.	.	PUNCT
dpc-4157	121	1	elastocompression	elastocompression	NOUN
dpc-4157	121	2	can	can	AUX
dpc-4157	121	3	prevent	prevent	VERB
dpc-4157	121	4	lymphedema	lymphedema	NOUN
dpc-4157	121	5	and	and	CCONJ
dpc-4157	121	6	new	new	ADJ
dpc-4157	121	7	lesion	lesion	NOUN
dpc-4157	121	8	emergence	emergence	NOUN
dpc-4157	121	9	,	,	PUNCT
dpc-4157	121	10	and	and	CCONJ
dpc-4157	121	11	surgical	surgical	ADJ
dpc-4157	121	12	excision	excision	NOUN
dpc-4157	121	13	can	can	AUX
dpc-4157	121	14	be	be	AUX
dpc-4157	121	15	performed	perform	VERB
dpc-4157	121	16	on	on	ADP
dpc-4157	121	17	selected	select	VERB
dpc-4157	121	18	well	well	ADV
dpc-4157	121	19	-	-	PUNCT
dpc-4157	121	20	circumscribed	circumscribe	VERB
dpc-4157	121	21	lesions	lesion	NOUN
dpc-4157	121	22	,	,	PUNCT
dpc-4157	121	23	but	but	CCONJ
dpc-4157	121	24	it	it	PRON
dpc-4157	121	25	is	be	AUX
dpc-4157	121	26	not	not	PART
dpc-4157	121	27	recommended	recommend	VERB
dpc-4157	121	28	for	for	ADP
dpc-4157	121	29	multiple	multiple	ADJ
dpc-4157	121	30	large	large	ADJ
dpc-4157	121	31	lesions	lesion	NOUN
dpc-4157	121	32	with	with	ADP
dpc-4157	121	33	unclear	unclear	ADJ
dpc-4157	121	34	borders	border	NOUN
dpc-4157	121	35	,	,	PUNCT
dpc-4157	121	36	and	and	CCONJ
dpc-4157	121	37	care	care	NOUN
dpc-4157	121	38	should	should	AUX
dpc-4157	121	39	be	be	AUX
dpc-4157	121	40	taken	take	VERB
dpc-4157	121	41	to	to	PART
dpc-4157	121	42	minimize	minimize	VERB
dpc-4157	121	43	scarring	scar	VERB
dpc-4157	121	44	after	after	ADP
dpc-4157	121	45	the	the	DET
dpc-4157	121	46	procedure	procedure	NOUN
dpc-4157	122	1	[	[	X
dpc-4157	122	2	3	3	NUM
dpc-4157	122	3	,	,	PUNCT
dpc-4157	122	4	6	6	NUM
dpc-4157	122	5	,	,	PUNCT
dpc-4157	122	6	7	7	NUM
dpc-4157	122	7	]	]	PUNCT
dpc-4157	122	8	.	.	PUNCT
dpc-4157	123	1	minimal	minimal	ADJ
dpc-4157	123	2	surgery	surgery	NOUN
dpc-4157	123	3	such	such	ADJ
dpc-4157	123	4	as	as	ADP
dpc-4157	123	5	curettage	curettage	NOUN
dpc-4157	123	6	may	may	AUX
dpc-4157	123	7	be	be	AUX
dpc-4157	123	8	preferred	prefer	VERB
dpc-4157	123	9	for	for	ADP
dpc-4157	123	10	the	the	DET
dpc-4157	123	11	treatment	treatment	NOUN
dpc-4157	123	12	of	of	ADP
dpc-4157	123	13	exophytic	exophytic	ADJ
dpc-4157	123	14	,	,	PUNCT
dpc-4157	123	15	oozing	oozing	ADJ
dpc-4157	123	16	,	,	PUNCT
dpc-4157	123	17	or	or	CCONJ
dpc-4157	123	18	hemorrhagic	hemorrhagic	VERB
dpc-4157	123	19	multiple	multiple	ADJ
dpc-4157	123	20	nodular	nodular	ADJ
dpc-4157	123	21	lesions	lesion	NOUN
dpc-4157	123	22	[	[	X
dpc-4157	123	23	8	8	NUM
dpc-4157	123	24	]	]	PUNCT
dpc-4157	123	25	.	.	PUNCT
dpc-4157	124	1	among	among	ADP
dpc-4157	124	2	local	local	ADJ
dpc-4157	124	3	treatments	treatment	NOUN
dpc-4157	124	4	,	,	PUNCT
dpc-4157	124	5	6–40	6–40	PROPN
dpc-4157	124	6	gy	gy	PROPN
dpc-4157	124	7	radiotherapy	radiotherapy	PROPN
dpc-4157	124	8	,	,	PUNCT
dpc-4157	124	9	intralesional	intralesional	ADJ
dpc-4157	124	10	bleomycin	bleomycin	PROPN
dpc-4157	124	11	,	,	PUNCT
dpc-4157	124	12	doxorubicin	doxorubicin	PROPN
dpc-4157	124	13	,	,	PUNCT
dpc-4157	124	14	vincristine	vincristine	NOUN
dpc-4157	124	15	,	,	PUNCT
dpc-4157	124	16	and	and	CCONJ
dpc-4157	124	17	interferon	interferon	ADJ
dpc-4157	124	18	alpha-2a	alpha-2a	ADP
dpc-4157	124	19	injections	injection	NOUN
dpc-4157	124	20	can	can	AUX
dpc-4157	124	21	be	be	AUX
dpc-4157	124	22	administered	administer	VERB
dpc-4157	124	23	[	[	PUNCT
dpc-4157	124	24	3	3	NUM
dpc-4157	124	25	]	]	PUNCT
dpc-4157	124	26	.	.	PUNCT
dpc-4157	125	1	intralesional	intralesional	ADJ
dpc-4157	125	2	vincristine	vincristine	NOUN
dpc-4157	125	3	is	be	AUX
dpc-4157	125	4	notably	notably	ADV
dpc-4157	125	5	effective	effective	ADJ
dpc-4157	125	6	and	and	CCONJ
dpc-4157	125	7	generally	generally	ADV
dpc-4157	125	8	less	less	ADV
dpc-4157	125	9	painful	painful	ADJ
dpc-4157	125	10	than	than	ADP
dpc-4157	125	11	bleomycin	bleomycin	NOUN
dpc-4157	125	12	[	[	X
dpc-4157	125	13	2	2	NUM
dpc-4157	125	14	,	,	PUNCT
dpc-4157	125	15	3	3	NUM
dpc-4157	125	16	]	]	PUNCT
dpc-4157	125	17	.	.	PUNCT
dpc-4157	126	1	however	however	ADV
dpc-4157	126	2	,	,	PUNCT
dpc-4157	126	3	it	it	PRON
dpc-4157	126	4	is	be	AUX
dpc-4157	126	5	important	important	ADJ
dpc-4157	126	6	to	to	PART
dpc-4157	126	7	note	note	VERB
dpc-4157	126	8	potential	potential	ADJ
dpc-4157	126	9	side	side	NOUN
dpc-4157	126	10	effects	effect	NOUN
dpc-4157	126	11	such	such	ADJ
dpc-4157	126	12	as	as	ADP
dpc-4157	126	13	pain	pain	NOUN
dpc-4157	126	14	,	,	PUNCT
dpc-4157	126	15	pigmentation	pigmentation	NOUN
dpc-4157	126	16	changes	change	NOUN
dpc-4157	126	17	,	,	PUNCT
dpc-4157	126	18	and	and	CCONJ
dpc-4157	126	19	edema	edema	NOUN
dpc-4157	126	20	.	.	PUNCT
dpc-4157	127	1	additionally	additionally	ADV
dpc-4157	127	2	,	,	PUNCT
dpc-4157	127	3	less	less	ADV
dpc-4157	127	4	common	common	ADJ
dpc-4157	127	5	side	side	NOUN
dpc-4157	127	6	effects	effect	NOUN
dpc-4157	127	7	like	like	ADP
dpc-4157	127	8	infection	infection	NOUN
dpc-4157	127	9	and	and	CCONJ
dpc-4157	127	10	necrosis	necrosis	NOUN
dpc-4157	127	11	can	can	AUX
dpc-4157	127	12	occur	occur	VERB
dpc-4157	127	13	.	.	PUNCT
dpc-4157	128	1	furthermore	furthermore	ADV
dpc-4157	128	2	,	,	PUNCT
dpc-4157	128	3	systemic	systemic	ADJ
dpc-4157	128	4	toxicity	toxicity	NOUN
dpc-4157	128	5	may	may	AUX
dpc-4157	128	6	develop	develop	VERB
dpc-4157	128	7	,	,	PUNCT
dpc-4157	128	8	particularly	particularly	ADV
dpc-4157	128	9	in	in	ADP
dpc-4157	128	10	patients	patient	NOUN
dpc-4157	128	11	with	with	ADP
dpc-4157	128	12	multiple	multiple	ADJ
dpc-4157	128	13	lesions	lesion	NOUN
dpc-4157	128	14	[	[	X
dpc-4157	128	15	2	2	NUM
dpc-4157	128	16	,	,	PUNCT
dpc-4157	128	17	3	3	NUM
dpc-4157	128	18	]	]	PUNCT
dpc-4157	128	19	.	.	PUNCT
dpc-4157	129	1	local	local	ADJ
dpc-4157	129	2	treatments	treatment	NOUN
dpc-4157	129	3	for	for	ADP
dpc-4157	129	4	cks	ck	NOUN
dpc-4157	129	5	include	include	VERB
dpc-4157	129	6	the	the	DET
dpc-4157	129	7	use	use	NOUN
dpc-4157	129	8	of	of	ADP
dpc-4157	129	9	co2	co2	NOUN
dpc-4157	129	10	,	,	PUNCT
dpc-4157	129	11	argon	argon	NOUN
dpc-4157	129	12	,	,	PUNCT
dpc-4157	129	13	q	q	PRON
dpc-4157	129	14	-	-	PUNCT
dpc-4157	129	15	switched	switch	VERB
dpc-4157	129	16	755	755	NUM
dpc-4157	129	17	-	-	PUNCT
dpc-4157	129	18	nm	nm	ADJ
dpc-4157	129	19	alexandrite	alexandrite	NOUN
dpc-4157	129	20	,	,	PUNCT
dpc-4157	129	21	pulsed	pulsed	NOUN
dpc-4157	129	22	-	-	PUNCT
dpc-4157	129	23	dye	dye	NOUN
dpc-4157	129	24	,	,	PUNCT
dpc-4157	129	25	and	and	CCONJ
dpc-4157	129	26	nd	nd	PRON
dpc-4157	129	27	:	:	PUNCT
dpc-4157	129	28	yag	yag	NOUN
dpc-4157	129	29	lasers	laser	NOUN
dpc-4157	129	30	[	[	X
dpc-4157	129	31	9	9	NUM
dpc-4157	129	32	,	,	PUNCT
dpc-4157	129	33	10	10	NUM
dpc-4157	129	34	]	]	PUNCT
dpc-4157	129	35	.	.	PUNCT
dpc-4157	130	1	the	the	DET
dpc-4157	130	2	nd	nd	NOUN
dpc-4157	130	3	:	:	PUNCT
dpc-4157	130	4	yag	yag	NOUN
dpc-4157	130	5	laser	laser	NOUN
dpc-4157	130	6	operates	operate	VERB
dpc-4157	130	7	at	at	ADP
dpc-4157	130	8	a	a	DET
dpc-4157	130	9	wavelength	wavelength	NOUN
dpc-4157	130	10	of	of	ADP
dpc-4157	130	11	1064	1064	NUM
dpc-4157	130	12	nm	nm	NOUN
dpc-4157	130	13	,	,	PUNCT
dpc-4157	130	14	selectively	selectively	ADV
dpc-4157	130	15	targeting	target	VERB
dpc-4157	130	16	hemoglobin	hemoglobin	NOUN
dpc-4157	130	17	and	and	CCONJ
dpc-4157	130	18	deoxyhemoglobin	deoxyhemoglobin	NOUN
dpc-4157	130	19	in	in	ADP
dpc-4157	130	20	cks	cks	PROPN
dpc-4157	130	21	lesions	lesion	NOUN
dpc-4157	130	22	[	[	X
dpc-4157	130	23	11	11	NUM
dpc-4157	130	24	]	]	PUNCT
dpc-4157	130	25	.	.	PUNCT
dpc-4157	131	1	by	by	ADP
dpc-4157	131	2	emitting	emit	VERB
dpc-4157	131	3	light	light	NOUN
dpc-4157	131	4	at	at	ADP
dpc-4157	131	5	this	this	DET
dpc-4157	131	6	specific	specific	ADJ
dpc-4157	131	7	wavelength	wavelength	NOUN
dpc-4157	131	8	,	,	PUNCT
dpc-4157	131	9	the	the	DET
dpc-4157	131	10	laser	laser	NOUN
dpc-4157	131	11	is	be	AUX
dpc-4157	131	12	able	able	ADJ
dpc-4157	131	13	of	of	ADP
dpc-4157	131	14	penetrating	penetrate	VERB
dpc-4157	131	15	deep	deep	ADJ
dpc-4157	131	16	vascular	vascular	ADJ
dpc-4157	131	17	structures	structure	NOUN
dpc-4157	131	18	with	with	ADP
dpc-4157	131	19	minimal	minimal	ADJ
dpc-4157	131	20	damage	damage	NOUN
dpc-4157	131	21	to	to	ADP
dpc-4157	131	22	surrounding	surround	VERB
dpc-4157	131	23	tissues	tissue	NOUN
dpc-4157	131	24	,	,	PUNCT
dpc-4157	131	25	effectively	effectively	ADV
dpc-4157	131	26	6	6	NUM
dpc-4157	131	27	original	original	ADJ
dpc-4157	131	28	article	article	NOUN
dpc-4157	131	29	|	|	ADV
dpc-4157	131	30	dermatol	dermatol	ADJ
dpc-4157	131	31	pract	pract	NOUN
dpc-4157	131	32	concept	concept	NOUN
dpc-4157	131	33	.	.	PUNCT
dpc-4157	132	1	2024;14(2):e2024150	2024;14(2):e2024150	NUM
dpc-4157	132	2	7	7	NUM
dpc-4157	132	3	.	.	PUNCT
dpc-4157	133	1	iftode	iftode	PROPN
dpc-4157	133	2	n	n	CCONJ
dpc-4157	133	3	,	,	PUNCT
dpc-4157	133	4	rădulescu	rădulescu	PROPN
dpc-4157	133	5	ma	ma	PROPN
dpc-4157	133	6	,	,	PUNCT
dpc-4157	133	7	aramă	aramă	PROPN
dpc-4157	134	1	ș	ș	PROPN
dpc-4157	134	2	s	s	PROPN
dpc-4157	134	3	,	,	PUNCT
dpc-4157	134	4	aramă	aramă	PROPN
dpc-4157	134	5	v.	v.	ADP
dpc-4157	134	6	update	update	NOUN
dpc-4157	134	7	on	on	ADP
dpc-4157	134	8	kaposi	kaposi	PROPN
dpc-4157	134	9	sarcoma	sarcoma	PROPN
dpc-4157	134	10	-	-	PUNCT
dpc-4157	134	11	associated	associate	VERB
dpc-4157	134	12	herpesvirus	herpesvirus	NOUN
dpc-4157	134	13	(	(	PUNCT
dpc-4157	134	14	kshv	kshv	NOUN
dpc-4157	134	15	or	or	CCONJ
dpc-4157	134	16	hhv8	hhv8	PROPN
dpc-4157	134	17	)	)	PUNCT
dpc-4157	134	18	review	review	NOUN
dpc-4157	134	19	.	.	PUNCT
dpc-4157	135	1	rom	rom	PROPN
dpc-4157	136	1	j	j	PROPN
dpc-4157	136	2	intern	intern	PROPN
dpc-4157	136	3	med	me	VERB
dpc-4157	136	4	.	.	PUNCT
dpc-4157	137	1	dec	dec	PROPN
dpc-4157	137	2	1	1	NUM
dpc-4157	137	3	2020;58(4):199	2020;58(4):199	NUM
dpc-4157	137	4	-	-	SYM
dpc-4157	137	5	208	208	NUM
dpc-4157	137	6	.	.	PUNCT
dpc-4157	138	1	doi:10.2478	doi:10.2478	PROPN
dpc-4157	138	2	/rjim-2020	/rjim-2020	NOUN
dpc-4157	138	3	-	-	PUNCT
dpc-4157	138	4	0017	0017	NUM
dpc-4157	138	5	8	8	NUM
dpc-4157	138	6	.	.	PUNCT
dpc-4157	139	1	brambilla	brambilla	PROPN
dpc-4157	139	2	l	l	PROPN
dpc-4157	139	3	,	,	PUNCT
dpc-4157	139	4	mattioli	mattioli	PROPN
dpc-4157	139	5	ma	ma	PROPN
dpc-4157	139	6	,	,	PUNCT
dpc-4157	139	7	tourlaki	tourlaki	PROPN
dpc-4157	139	8	a.	a.	PROPN
dpc-4157	139	9	multiple	multiple	PROPN
dpc-4157	139	10	kaposi	kaposi	PROPN
dpc-4157	139	11	’s	’s	PART
dpc-4157	139	12	sarcoma	sarcoma	NOUN
dpc-4157	139	13	nodules	nodule	NOUN
dpc-4157	139	14	successfully	successfully	ADV
dpc-4157	139	15	treated	treat	VERB
dpc-4157	139	16	by	by	ADP
dpc-4157	139	17	curettage	curettage	NOUN
dpc-4157	139	18	and	and	CCONJ
dpc-4157	139	19	vincristine	vincristine	NOUN
dpc-4157	139	20	injections	injection	NOUN
dpc-4157	139	21	in	in	ADP
dpc-4157	139	22	the	the	DET
dpc-4157	139	23	same	same	ADJ
dpc-4157	139	24	session	session	NOUN
dpc-4157	139	25	.	.	PUNCT
dpc-4157	140	1	australas	australas	PROPN
dpc-4157	140	2	j	j	PROPN
dpc-4157	140	3	dermatol	dermatol	NOUN
dpc-4157	140	4	.	.	PUNCT
dpc-4157	141	1	aug	aug	PROPN
dpc-4157	141	2	2023;64(3):443	2023;64(3):443	PROPN
dpc-4157	141	3	-	-	SYM
dpc-4157	141	4	445	445	NUM
dpc-4157	141	5	.	.	PUNCT
dpc-4157	142	1	doi:10.1111	doi:10.1111	NOUN
dpc-4157	142	2	/	/	SYM
dpc-4157	142	3	ajd.14075	ajd.14075	ADJ
dpc-4157	142	4	9	9	NUM
dpc-4157	142	5	.	.	PUNCT
dpc-4157	142	6	özdemir	özdemir	PROPN
dpc-4157	142	7	m	m	PROPN
dpc-4157	142	8	,	,	PUNCT
dpc-4157	142	9	balevi	balevi	ADJ
dpc-4157	142	10	a.	a.	NOUN
dpc-4157	142	11	successful	successful	ADJ
dpc-4157	142	12	treatment	treatment	NOUN
dpc-4157	142	13	of	of	ADP
dpc-4157	142	14	classic	classic	ADJ
dpc-4157	142	15	kaposi	kaposi	PROPN
dpc-4157	142	16	sarcoma	sarcoma	NOUN
dpc-4157	142	17	with	with	ADP
dpc-4157	142	18	long	long	ADJ
dpc-4157	142	19	-	-	PUNCT
dpc-4157	142	20	pulse	pulse	NOUN
dpc-4157	142	21	neodymium	neodymium	NOUN
dpc-4157	142	22	-	-	PUNCT
dpc-4157	142	23	doped	dope	VERB
dpc-4157	142	24	yttrium	yttrium	NOUN
dpc-4157	142	25	aluminum	aluminum	NOUN
dpc-4157	142	26	garnet	garnet	NOUN
dpc-4157	142	27	laser	laser	NOUN
dpc-4157	142	28	:	:	PUNCT
dpc-4157	142	29	a	a	DET
dpc-4157	142	30	preliminary	preliminary	ADJ
dpc-4157	142	31	study	study	NOUN
dpc-4157	142	32	.	.	PUNCT
dpc-4157	143	1	dermatol	dermatol	NOUN
dpc-4157	143	2	surg	surg	NOUN
dpc-4157	143	3	.	.	PUNCT
dpc-4157	144	1	mar	mar	PROPN
dpc-4157	144	2	2017;43(3):366	2017;43(3):366	PROPN
dpc-4157	144	3	-	-	PUNCT
dpc-4157	144	4	370	370	NUM
dpc-4157	144	5	.	.	PUNCT
dpc-4157	145	1	doi:10.1097	doi:10.1097	PROPN
dpc-4157	145	2	/	/	SYM
dpc-4157	145	3	dss.0000000000000973	dss.0000000000000973	PRON
dpc-4157	145	4	10	10	NUM
dpc-4157	145	5	.	.	PUNCT
dpc-4157	146	1	silvestri	silvestri	PROPN
dpc-4157	146	2	m	m	PROPN
dpc-4157	146	3	,	,	PUNCT
dpc-4157	146	4	latini	latini	PROPN
dpc-4157	146	5	a	a	PRON
dpc-4157	146	6	,	,	PUNCT
dpc-4157	146	7	lesnoni	lesnoni	PROPN
dpc-4157	146	8	la	la	PROPN
dpc-4157	146	9	parola	parola	PROPN
dpc-4157	147	1	i	i	PROPN
dpc-4157	147	2	,	,	PUNCT
dpc-4157	147	3	messina	messina	PROPN
dpc-4157	147	4	c	c	PROPN
dpc-4157	147	5	,	,	PUNCT
dpc-4157	147	6	nisticò	nisticò	NOUN
dpc-4157	147	7	sp	sp	PROPN
dpc-4157	147	8	,	,	PUNCT
dpc-4157	147	9	cameli	cameli	ADJ
dpc-4157	147	10	n.	n.	NOUN
dpc-4157	147	11	effectiveness	effectiveness	NOUN
dpc-4157	147	12	and	and	CCONJ
dpc-4157	147	13	safety	safety	NOUN
dpc-4157	147	14	of	of	ADP
dpc-4157	147	15	treatment	treatment	NOUN
dpc-4157	147	16	with	with	ADP
dpc-4157	147	17	neodymium	neodymium	NOUN
dpc-4157	147	18	:	:	PUNCT
dpc-4157	147	19	yag	yag	NOUN
dpc-4157	147	20	laser	laser	NOUN
dpc-4157	147	21	1064	1064	NUM
dpc-4157	147	22	nm	nm	NOUN
dpc-4157	147	23	in	in	ADP
dpc-4157	147	24	patients	patient	NOUN
dpc-4157	147	25	with	with	ADP
dpc-4157	147	26	classic	classic	ADJ
dpc-4157	147	27	and	and	CCONJ
dpc-4157	147	28	epidemic	epidemic	NOUN
dpc-4157	147	29	kaposi	kaposi	PROPN
dpc-4157	147	30	sarcoma	sarcoma	PROPN
dpc-4157	147	31	.	.	PUNCT
dpc-4157	148	1	bioengineering	bioengineering	NOUN
dpc-4157	148	2	(	(	PUNCT
dpc-4157	148	3	basel	basel	PROPN
dpc-4157	148	4	)	)	PUNCT
dpc-4157	148	5	.	.	PUNCT
dpc-4157	149	1	mar	mar	PROPN
dpc-4157	149	2	5	5	NUM
dpc-4157	149	3	2022;9(3	2022;9(3	NUM
dpc-4157	149	4	)	)	PUNCT
dpc-4157	149	5	doi:10.3390	doi:10.3390	NOUN
dpc-4157	149	6	/	/	SYM
dpc-4157	149	7	bioengineering9030106	bioengineering9030106	PROPN
dpc-4157	149	8	11	11	NUM
dpc-4157	149	9	.	.	PUNCT
dpc-4157	150	1	landthaler	landthaler	PROPN
dpc-4157	150	2	m	m	PROPN
dpc-4157	150	3	,	,	PUNCT
dpc-4157	150	4	hohenleutner	hohenleutner	PROPN
dpc-4157	150	5	u.	u.	PROPN
dpc-4157	150	6	laser	laser	PROPN
dpc-4157	150	7	therapy	therapy	NOUN
dpc-4157	150	8	of	of	ADP
dpc-4157	150	9	vascular	vascular	ADJ
dpc-4157	150	10	lesions	lesion	NOUN
dpc-4157	150	11	.	.	PUNCT
dpc-4157	151	1	photodermatol	photodermatol	PROPN
dpc-4157	151	2	photoimmunol	photoimmunol	PROPN
dpc-4157	151	3	photomed	photome	VERB
dpc-4157	151	4	.	.	PUNCT
dpc-4157	152	1	dec	dec	PROPN
dpc-4157	152	2	2006;22(6	2006;22(6	NUM
dpc-4157	152	3	):	):	PUNCT
dpc-4157	152	4	324	324	NUM
dpc-4157	152	5	-	-	SYM
dpc-4157	152	6	32	32	NUM
dpc-4157	152	7	.	.	PUNCT
dpc-4157	153	1	doi:10.1111	doi:10.1111	ADJ
dpc-4157	153	2	/	/	SYM
dpc-4157	153	3	j.1600	j.1600	NOUN
dpc-4157	153	4	-	-	PUNCT
dpc-4157	153	5	0781.2006.00254.x	0781.2006.00254.x	NUM
dpc-4157	153	6	12	12	NUM
dpc-4157	153	7	.	.	PUNCT
dpc-4157	154	1	nasca	nasca	PROPN
dpc-4157	154	2	mr	mr	PROPN
dpc-4157	154	3	,	,	PUNCT
dpc-4157	154	4	luppino	luppino	PROPN
dpc-4157	154	5	i	i	PROPN
dpc-4157	154	6	,	,	PUNCT
dpc-4157	154	7	spurio	spurio	PROPN
dpc-4157	154	8	catena	catena	PROPN
dpc-4157	154	9	a	a	PRON
dpc-4157	154	10	,	,	PUNCT
dpc-4157	154	11	micali	micali	NOUN
dpc-4157	154	12	g.	g.	PROPN
dpc-4157	154	13	nodular	nodular	PROPN
dpc-4157	154	14	classic	classic	ADJ
dpc-4157	154	15	kaposi	kaposi	PROPN
dpc-4157	154	16	’s	’s	PART
dpc-4157	154	17	sarcoma	sarcoma	NOUN
dpc-4157	154	18	treated	treat	VERB
dpc-4157	154	19	with	with	ADP
dpc-4157	154	20	neodymium	neodymium	NOUN
dpc-4157	154	21	-	-	PUNCT
dpc-4157	154	22	doped	dope	VERB
dpc-4157	154	23	yttrium	yttrium	NOUN
dpc-4157	154	24	aluminum	aluminum	NOUN
dpc-4157	154	25	garnet	garnet	NOUN
dpc-4157	154	26	laser	laser	NOUN
dpc-4157	154	27	delivered	deliver	VERB
dpc-4157	154	28	through	through	ADP
dpc-4157	154	29	a	a	DET
dpc-4157	154	30	tilted	tilted	ADJ
dpc-4157	154	31	angle	angle	NOUN
dpc-4157	154	32	:	:	PUNCT
dpc-4157	154	33	outcome	outcome	NOUN
dpc-4157	154	34	and	and	CCONJ
dpc-4157	154	35	12	12	NUM
dpc-4157	154	36	-	-	PUNCT
dpc-4157	154	37	month	month	NOUN
dpc-4157	154	38	follow	follow	NOUN
dpc-4157	154	39	up	up	ADP
dpc-4157	154	40	.	.	PUNCT
dpc-4157	155	1	lasers	laser	NOUN
dpc-4157	155	2	surg	surg	PROPN
dpc-4157	155	3	med	me	VERB
dpc-4157	155	4	.	.	PUNCT
dpc-4157	156	1	dec	dec	PROPN
dpc-4157	156	2	2020;52(10):979	2020;52(10):979	PROPN
dpc-4157	156	3	-	-	SYM
dpc-4157	156	4	983	983	NUM
dpc-4157	156	5	.	.	PUNCT
dpc-4157	157	1	doi:10.1002	doi:10.1002	NOUN
dpc-4157	157	2	/	/	SYM
dpc-4157	157	3	lsm.23242	lsm.23242	PROPN
dpc-4157	157	4	13	13	NUM
dpc-4157	157	5	.	.	PUNCT
dpc-4157	158	1	nasca	nasca	PROPN
dpc-4157	158	2	mr	mr	PROPN
dpc-4157	158	3	,	,	PUNCT
dpc-4157	158	4	luppino	luppino	PROPN
dpc-4157	158	5	i	i	PROPN
dpc-4157	158	6	,	,	PUNCT
dpc-4157	158	7	micali	micali	PROPN
dpc-4157	158	8	g.	g.	PROPN
dpc-4157	158	9	kaposi	kaposi	PROPN
dpc-4157	158	10	’s	’s	PART
dpc-4157	158	11	sarcoma	sarcoma	NOUN
dpc-4157	158	12	-	-	PUNCT
dpc-4157	158	13	related	relate	VERB
dpc-4157	158	14	lymphedema	lymphedema	NOUN
dpc-4157	158	15	treated	treat	VERB
dpc-4157	158	16	by	by	ADP
dpc-4157	158	17	a	a	DET
dpc-4157	158	18	nd	nd	NOUN
dpc-4157	158	19	:	:	PUNCT
dpc-4157	158	20	yag	yag	NOUN
dpc-4157	158	21	laser	laser	NOUN
dpc-4157	158	22	.	.	PUNCT
dpc-4157	159	1	dermatol	dermatol	NOUN
dpc-4157	159	2	surg	surg	NOUN
dpc-4157	159	3	.	.	PUNCT
dpc-4157	160	1	aug	aug	PROPN
dpc-4157	160	2	1	1	NUM
dpc-4157	160	3	2021;47(8):1139	2021;47(8):1139	PROPN
dpc-4157	160	4	-	-	PUNCT
dpc-4157	160	5	1140	1140	NUM
dpc-4157	160	6	.	.	PUNCT
dpc-4157	161	1	doi:10.1097	doi:10.1097	NOUN
dpc-4157	161	2	/	/	SYM
dpc-4157	161	3	dss.0000000000002904	dss.0000000000002904	PROPN
dpc-4157	161	4	14	14	NUM
dpc-4157	161	5	.	.	PUNCT
dpc-4157	162	1	martinez	martinez	PROPN
dpc-4157	162	2	v	v	PROPN
dpc-4157	162	3	,	,	PUNCT
dpc-4157	162	4	caumes	caume	NOUN
dpc-4157	162	5	e	e	NOUN
dpc-4157	162	6	,	,	PUNCT
dpc-4157	162	7	gambotti	gambotti	NOUN
dpc-4157	162	8	l	l	PROPN
dpc-4157	162	9	,	,	PUNCT
dpc-4157	162	10	et	et	PROPN
dpc-4157	162	11	al	al	PROPN
dpc-4157	162	12	.	.	PROPN
dpc-4157	162	13	remission	remission	NOUN
dpc-4157	162	14	from	from	ADP
dpc-4157	162	15	kaposi	kaposi	PROPN
dpc-4157	162	16	’s	’s	PART
dpc-4157	162	17	sarcoma	sarcoma	NOUN
dpc-4157	162	18	on	on	ADP
dpc-4157	162	19	haart	haart	PROPN
dpc-4157	162	20	is	be	AUX
dpc-4157	162	21	associated	associate	VERB
dpc-4157	162	22	with	with	ADP
dpc-4157	162	23	suppression	suppression	NOUN
dpc-4157	162	24	of	of	ADP
dpc-4157	162	25	hiv	hiv	PROPN
dpc-4157	162	26	replication	replication	NOUN
dpc-4157	162	27	and	and	CCONJ
dpc-4157	162	28	is	be	AUX
dpc-4157	162	29	independent	independent	ADJ
dpc-4157	162	30	of	of	ADP
dpc-4157	162	31	protease	protease	NOUN
dpc-4157	162	32	inhibitor	inhibitor	NOUN
dpc-4157	162	33	therapy	therapy	NOUN
dpc-4157	162	34	.	.	PUNCT
dpc-4157	163	1	br	br	PROPN
dpc-4157	163	2	j	j	PROPN
dpc-4157	163	3	cancer	cancer	NOUN
dpc-4157	163	4	.	.	PUNCT
dpc-4157	164	1	apr	apr	VERB
dpc-4157	164	2	10	10	NUM
dpc-4157	164	3	2006;94(7):1000	2006;94(7):1000	NUM
dpc-4157	164	4	-	-	SYM
dpc-4157	164	5	6	6	NUM
dpc-4157	164	6	.	.	PUNCT
dpc-4157	164	7	doi:10.1038	doi:10.1038	NOUN
dpc-4157	164	8	/sj.bjc.6603056	/sj.bjc.6603056	PUNCT
dpc-4157	164	9	receiving	receive	VERB
dpc-4157	164	10	systemic	systemic	ADJ
dpc-4157	164	11	therapy	therapy	NOUN
dpc-4157	164	12	.	.	PUNCT
dpc-4157	165	1	the	the	DET
dpc-4157	165	2	treatment	treatment	NOUN
dpc-4157	165	3	is	be	AUX
dpc-4157	165	4	well	well	ADV
dpc-4157	165	5	tolerated	tolerate	VERB
dpc-4157	165	6	,	,	PUNCT
dpc-4157	165	7	yielding	yield	VERB
dpc-4157	165	8	rapid	rapid	ADJ
dpc-4157	165	9	improvement	improvement	NOUN
dpc-4157	165	10	within	within	ADP
dpc-4157	165	11	2–3	2–3	NUM
dpc-4157	165	12	weeks	week	NOUN
dpc-4157	165	13	.	.	PUNCT
dpc-4157	166	1	nd	nd	PRON
dpc-4157	166	2	:	:	PUNCT
dpc-4157	166	3	yag	yag	NOUN
dpc-4157	166	4	laser	laser	NOUN
dpc-4157	166	5	therapy	therapy	NOUN
dpc-4157	166	6	may	may	AUX
dpc-4157	166	7	also	also	ADV
dpc-4157	166	8	be	be	AUX
dpc-4157	166	9	beneficial	beneficial	ADJ
dpc-4157	166	10	for	for	ADP
dpc-4157	166	11	hiv+	hiv+	ADJ
dpc-4157	166	12	patients	patient	NOUN
dpc-4157	166	13	due	due	ADP
dpc-4157	166	14	to	to	ADP
dpc-4157	166	15	its	its	PRON
dpc-4157	166	16	immunosuppression	immunosuppression	NOUN
dpc-4157	166	17	-	-	PUNCT
dpc-4157	166	18	free	free	ADJ
dpc-4157	166	19	nature	nature	NOUN
dpc-4157	166	20	,	,	PUNCT
dpc-4157	166	21	ease	ease	NOUN
dpc-4157	166	22	of	of	ADP
dpc-4157	166	23	application	application	NOUN
dpc-4157	166	24	for	for	ADP
dpc-4157	166	25	recurrent	recurrent	ADJ
dpc-4157	166	26	lesions	lesion	NOUN
dpc-4157	166	27	,	,	PUNCT
dpc-4157	166	28	and	and	CCONJ
dpc-4157	166	29	overall	overall	ADJ
dpc-4157	166	30	effectiveness	effectiveness	NOUN
dpc-4157	166	31	and	and	CCONJ
dpc-4157	166	32	safety	safety	NOUN
dpc-4157	166	33	.	.	PUNCT
dpc-4157	167	1	references	reference	NOUN
dpc-4157	167	2	1	1	NUM
dpc-4157	167	3	.	.	PUNCT
dpc-4157	167	4	ferlay	ferlay	PROPN
dpc-4157	167	5	j	j	PROPN
dpc-4157	167	6	,	,	PUNCT
dpc-4157	167	7	soerjomataram	soerjomataram	PROPN
dpc-4157	167	8	i	i	PROPN
dpc-4157	167	9	,	,	PUNCT
dpc-4157	167	10	dikshit	dikshit	PROPN
dpc-4157	167	11	r	r	PROPN
dpc-4157	167	12	,	,	PUNCT
dpc-4157	167	13	et	et	PROPN
dpc-4157	167	14	al	al	PROPN
dpc-4157	167	15	.	.	PUNCT
dpc-4157	167	16	cancer	cancer	NOUN
dpc-4157	167	17	incidence	incidence	NOUN
dpc-4157	167	18	and	and	CCONJ
dpc-4157	167	19	mortality	mortality	NOUN
dpc-4157	167	20	worldwide	worldwide	ADV
dpc-4157	167	21	:	:	PUNCT
dpc-4157	167	22	sources	source	NOUN
dpc-4157	167	23	,	,	PUNCT
dpc-4157	167	24	methods	method	NOUN
dpc-4157	167	25	and	and	CCONJ
dpc-4157	167	26	major	major	ADJ
dpc-4157	167	27	patterns	pattern	NOUN
dpc-4157	167	28	in	in	ADP
dpc-4157	167	29	globocan	globocan	PROPN
dpc-4157	167	30	2012	2012	NUM
dpc-4157	167	31	.	.	PUNCT
dpc-4157	168	1	int	int	NOUN
dpc-4157	168	2	j	j	PROPN
dpc-4157	168	3	cancer	cancer	NOUN
dpc-4157	168	4	.	.	PUNCT
dpc-4157	169	1	mar	mar	PROPN
dpc-4157	169	2	1	1	NUM
dpc-4157	169	3	2015;136(5):e359	2015;136(5):e359	NUM
dpc-4157	169	4	-	-	SYM
dpc-4157	169	5	86	86	NUM
dpc-4157	169	6	.	.	PUNCT
dpc-4157	170	1	doi:10.1002	doi:10.1002	NOUN
dpc-4157	170	2	/	/	SYM
dpc-4157	170	3	ijc.29210	ijc.29210	NUM
dpc-4157	170	4	2	2	NUM
dpc-4157	170	5	.	.	PUNCT
dpc-4157	171	1	lebbe	lebbe	NOUN
dpc-4157	171	2	c	c	NOUN
dpc-4157	171	3	,	,	PUNCT
dpc-4157	171	4	garbe	garbe	NOUN
dpc-4157	171	5	c	c	PROPN
dpc-4157	171	6	,	,	PUNCT
dpc-4157	171	7	stratigos	stratigos	PROPN
dpc-4157	171	8	aj	aj	PROPN
dpc-4157	171	9	,	,	PUNCT
dpc-4157	171	10	et	et	PROPN
dpc-4157	171	11	al	al	PROPN
dpc-4157	171	12	.	.	PUNCT
dpc-4157	171	13	diagnosis	diagnosis	NOUN
dpc-4157	171	14	and	and	CCONJ
dpc-4157	171	15	treatment	treatment	NOUN
dpc-4157	171	16	of	of	ADP
dpc-4157	171	17	kaposi	kaposi	PROPN
dpc-4157	171	18	’s	’s	PART
dpc-4157	171	19	sarcoma	sarcoma	NOUN
dpc-4157	171	20	:	:	PUNCT
dpc-4157	171	21	european	european	ADJ
dpc-4157	171	22	consensus	consensus	NOUN
dpc-4157	171	23	-	-	PUNCT
dpc-4157	171	24	based	base	VERB
dpc-4157	171	25	interdisciplinary	interdisciplinary	ADJ
dpc-4157	171	26	guideline	guideline	NOUN
dpc-4157	171	27	(	(	PUNCT
dpc-4157	171	28	edf	edf	PROPN
dpc-4157	171	29	/	/	SYM
dpc-4157	171	30	eado	eado	ADJ
dpc-4157	171	31	/	/	SYM
dpc-4157	171	32	eortc	eortc	ADJ
dpc-4157	171	33	)	)	PUNCT
dpc-4157	171	34	.	.	PUNCT
dpc-4157	172	1	eur	eur	PROPN
dpc-4157	172	2	j	j	PROPN
dpc-4157	172	3	cancer	cancer	NOUN
dpc-4157	172	4	.	.	PUNCT
dpc-4157	173	1	jun	jun	PROPN
dpc-4157	173	2	2019;114:117	2019;114:117	NUM
dpc-4157	173	3	-	-	SYM
dpc-4157	173	4	127	127	NUM
dpc-4157	173	5	.	.	PUNCT
dpc-4157	174	1	doi:10.1016	doi:10.1016	PROPN
dpc-4157	174	2	/	/	SYM
dpc-4157	174	3	j.ejca.2018.12.036	j.ejca.2018.12.036	PROPN
dpc-4157	174	4	3	3	NUM
dpc-4157	174	5	.	.	PUNCT
dpc-4157	175	1	brambilla	brambilla	PROPN
dpc-4157	175	2	l	l	PROPN
dpc-4157	175	3	,	,	PUNCT
dpc-4157	175	4	genovese	genovese	NOUN
dpc-4157	175	5	g	g	PROPN
dpc-4157	175	6	,	,	PUNCT
dpc-4157	175	7	berti	berti	PROPN
dpc-4157	175	8	e	e	PROPN
dpc-4157	175	9	,	,	PUNCT
dpc-4157	175	10	et	et	PROPN
dpc-4157	175	11	al	al	PROPN
dpc-4157	175	12	.	.	PUNCT
dpc-4157	175	13	diagnosis	diagnosis	NOUN
dpc-4157	175	14	and	and	CCONJ
dpc-4157	175	15	treatment	treatment	NOUN
dpc-4157	175	16	of	of	ADP
dpc-4157	175	17	classic	classic	ADJ
dpc-4157	175	18	and	and	CCONJ
dpc-4157	175	19	iatrogenic	iatrogenic	ADJ
dpc-4157	175	20	kaposi	kaposi	PROPN
dpc-4157	175	21	’s	’s	PART
dpc-4157	175	22	sarcoma	sarcoma	NOUN
dpc-4157	175	23	:	:	PUNCT
dpc-4157	175	24	italian	italian	ADJ
dpc-4157	175	25	recommendations	recommendation	NOUN
dpc-4157	175	26	.	.	PUNCT
dpc-4157	176	1	ital	ital	PROPN
dpc-4157	176	2	j	j	PROPN
dpc-4157	176	3	dermatol	dermatol	PROPN
dpc-4157	176	4	venerol	venerol	PROPN
dpc-4157	176	5	.	.	PUNCT
dpc-4157	177	1	jun	jun	PROPN
dpc-4157	177	2	2021;156(3):356	2021;156(3):356	PROPN
dpc-4157	177	3	-	-	SYM
dpc-4157	177	4	365	365	NUM
dpc-4157	177	5	.	.	PUNCT
dpc-4157	178	1	doi:10.23736	doi:10.23736	PROPN
dpc-4157	178	2	/	/	SYM
dpc-4157	178	3	s2784	s2784	PROPN
dpc-4157	178	4	-	-	PUNCT
dpc-4157	178	5	8671.20.06703	8671.20.06703	NUM
dpc-4157	178	6	-	-	SYM
dpc-4157	178	7	6	6	NUM
dpc-4157	178	8	4	4	NUM
dpc-4157	178	9	.	.	PUNCT
dpc-4157	179	1	régnier	régnier	NOUN
dpc-4157	179	2	-	-	PUNCT
dpc-4157	179	3	rosencher	rosencher	PROPN
dpc-4157	179	4	e	e	NOUN
dpc-4157	179	5	,	,	PUNCT
dpc-4157	179	6	guillot	guillot	ADJ
dpc-4157	179	7	b	b	NOUN
dpc-4157	179	8	,	,	PUNCT
dpc-4157	179	9	dupin	dupin	PROPN
dpc-4157	179	10	n.	n.	NOUN
dpc-4157	179	11	treatments	treatment	NOUN
dpc-4157	179	12	for	for	ADP
dpc-4157	179	13	classic	classic	ADJ
dpc-4157	179	14	kaposi	kaposi	PROPN
dpc-4157	179	15	sarcoma	sarcoma	PROPN
dpc-4157	179	16	:	:	PUNCT
dpc-4157	179	17	a	a	DET
dpc-4157	179	18	systematic	systematic	ADJ
dpc-4157	179	19	review	review	NOUN
dpc-4157	179	20	of	of	ADP
dpc-4157	179	21	the	the	DET
dpc-4157	179	22	literature	literature	NOUN
dpc-4157	179	23	.	.	PUNCT
dpc-4157	180	1	j	j	PROPN
dpc-4157	180	2	  	  	SPACE
dpc-4157	180	3	am	be	AUX
dpc-4157	180	4	acad	acad	ADJ
dpc-4157	180	5	dermatol	dermatol	NOUN
dpc-4157	180	6	.	.	PUNCT
dpc-4157	181	1	feb	feb	PROPN
dpc-4157	181	2	2013;68(2):313	2013;68(2):313	PROPN
dpc-4157	181	3	-	-	SYM
dpc-4157	181	4	31	31	NUM
dpc-4157	181	5	.	.	PUNCT
dpc-4157	182	1	doi:10.1016	doi:10.1016	PROPN
dpc-4157	182	2	/	/	SYM
dpc-4157	182	3	j	j	PROPN
dpc-4157	182	4	.jaad.2012.04.018	.jaad.2012.04.018	NUM
dpc-4157	183	1	5	5	X
dpc-4157	183	2	.	.	X
dpc-4157	183	3	ertürk	ertürk	PROPN
dpc-4157	183	4	yılmaz	yılmaz	PROPN
dpc-4157	183	5	t	t	PROPN
dpc-4157	183	6	,	,	PUNCT
dpc-4157	183	7	akay	akay	PROPN
dpc-4157	183	8	bn	bn	PROPN
dpc-4157	183	9	,	,	PUNCT
dpc-4157	183	10	okçu	okçu	PROPN
dpc-4157	183	11	heper	heper	NOUN
dpc-4157	183	12	a.	a.	NOUN
dpc-4157	183	13	dermoscopic	dermoscopic	PROPN
dpc-4157	183	14	findings	finding	NOUN
dpc-4157	183	15	of	of	ADP
dpc-4157	183	16	kaposi	kaposi	PROPN
dpc-4157	183	17	sarcoma	sarcoma	PROPN
dpc-4157	183	18	and	and	CCONJ
dpc-4157	183	19	dermatopathological	dermatopathological	ADJ
dpc-4157	183	20	correlations	correlation	NOUN
dpc-4157	183	21	.	.	PUNCT
dpc-4157	184	1	australas	australas	PROPN
dpc-4157	184	2	j	j	PROPN
dpc-4157	184	3	dermatol	dermatol	PROPN
dpc-4157	184	4	.	.	PUNCT
dpc-4157	185	1	feb	feb	PROPN
dpc-4157	185	2	2020;61(1):e46	2020;61(1):e46	NUM
dpc-4157	185	3	-	-	PUNCT
dpc-4157	185	4	e53	e53	PROPN
dpc-4157	185	5	.	.	PUNCT
dpc-4157	186	1	doi:10.1111	doi:10.1111	PROPN
dpc-4157	186	2	/ajd.13150	/ajd.13150	PROPN
dpc-4157	187	1	6	6	X
dpc-4157	187	2	.	.	PUNCT
dpc-4157	187	3	dupin	dupin	NOUN
dpc-4157	187	4	n.	n.	PROPN
dpc-4157	187	5	update	update	NOUN
dpc-4157	187	6	on	on	ADP
dpc-4157	187	7	oncogenesis	oncogenesis	NOUN
dpc-4157	187	8	and	and	CCONJ
dpc-4157	187	9	therapy	therapy	NOUN
dpc-4157	187	10	for	for	ADP
dpc-4157	187	11	kaposi	kaposi	PROPN
dpc-4157	187	12	sarcoma	sarcoma	PROPN
dpc-4157	187	13	.	.	PUNCT
dpc-4157	188	1	curr	curr	PROPN
dpc-4157	188	2	opin	opin	PROPN
dpc-4157	188	3	oncol	oncol	PROPN
dpc-4157	188	4	.	.	PUNCT
dpc-4157	189	1	mar	mar	PROPN
dpc-4157	189	2	2020;32(2):122	2020;32(2):122	PROPN
dpc-4157	189	3	-	-	SYM
dpc-4157	189	4	128	128	NUM
dpc-4157	189	5	.	.	PUNCT
dpc-4157	190	1	doi:10.1097	doi:10.1097	NOUN
dpc-4157	190	2	/cco.0000000000000601	/cco.0000000000000601	PUNCT